Drug Description in Trials / DrugBank / KEGG DRUG

  

Search results

No. Drug (Description in trials) DrugBank KEGG DRUG KEGG GENES KEGG PATHWAY Disease ID
1P 140----[1] 49
2P-1037----[1] 299
3P-188 NF----[1] 113
4P-552----[1] 53
5P144----[1] 51
6P144 cream----[1] 51
7P144 Cytokine Inhibitor----[1] 51
8P144 Cytokines Inhibitors----[1] 51
9P144 DIGNA CREAM----[1] 51
10P144. Cytokines Inhibitors----[1] 51
11P28GST----[1] 96
12P2B001----[1] 6
13P2B001 once daily (pramipexole 0.3 mg / rasagiline 0.75 mg),[2] Pramipexole,
Rasagiline		[5] D00559 ,
D02562 ,
D05575 ,
D08469 ,
D10829 		[4] DRD2,
DRD3,
DRD4,
MAOB 💬		[18] Alcoholism, Amphetamine addiction, Arginine and proline metabolism, Cocaine addiction, Dopaminergic synapse, Drug metabolism - cytochrome P450, Gap junction, Glycine, serine and threonine metabolism, Histidine metabolism, Metabolic pathways, Neuroactive ligand-receptor interaction, Parkinson disease, Phenylalanine metabolism, Rap1 signaling pathway, Serotonergic synapse, Tryptophan metabolism, Tyrosine metabolism, cAMP signaling pathway 💬[1] 6
14P2B001 once daily (pramipexole 0.6 mg / rasagiline 0.75 mg),[2] Pramipexole,
Rasagiline		[5] D00559 ,
D02562 ,
D05575 ,
D08469 ,
D10829 		[4] DRD2,
DRD3,
DRD4,
MAOB 💬		[18] Alcoholism, Amphetamine addiction, Arginine and proline metabolism, Cocaine addiction, Dopaminergic synapse, Drug metabolism - cytochrome P450, Gap junction, Glycine, serine and threonine metabolism, Histidine metabolism, Metabolic pathways, Neuroactive ligand-receptor interaction, Parkinson disease, Phenylalanine metabolism, Rap1 signaling pathway, Serotonergic synapse, Tryptophan metabolism, Tyrosine metabolism, cAMP signaling pathway 💬[1] 6
15P32----[1] 37
16P32/98----[1] 37
17P32/98 3%----[1] 37
18P38 (4) Map Kinase Inhibitor----[1] 46
19P38 Inhibitor (4)----[1] 46
20P38 Inhibitor (4) 150mg----[1] 46
21P38 Inhibitor (4) 25mg----[1] 46
22P38 Inhibitor (4) 300mg----[1] 46
23P38 Inhibitor (4) 50mg----[1] 46
24P38 Inhibitor (4) 75mg----[1] 46
25P38 Map Kinase Inhibitor----[1] 46
26P38(4) Map Kinase Inhibitor----[1] 46
27PA101----[1] 85
28PAAG15----[1] 299
29Pabinafusp alfa[1] Pabinafusp alfa[1] D11812 [2] IDS,
TFRC 💬		[8] Endocytosis, Ferroptosis, Glycosaminoglycan degradation, HIF-1 signaling pathway, Hematopoietic cell lineage, Lysosome, Metabolic pathways, Phagosome 💬[1] 19
30Paclitaxel[1] Paclitaxel[2] D00491 ,
D05333 		[9] TUBB,
TUBB1,
TUBB2A,
TUBB2B,
TUBB3,
TUBB4A,
TUBB4B,
TUBB6,
TUBB8 💬		[10] Alzheimer disease, Amyotrophic lateral sclerosis, Gap junction, Huntington disease, Parkinson disease, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Phagosome, Prion disease, Salmonella infection 💬[2] 46, 85
31PADN----[1] 86
32Padsevonil[1] Padsevonil[1] D11842 [3] SV2A,
SV2B,
SV2C 💬		[1] ECM-receptor interaction 💬[1] 149
33PAH----[3] 49, 53, 86
34PAH medication----[1] 86
35PAH Therapies----[1] 86
36Paired associative stimulation (PAS)----[1] 13
37Palifermin[1] Palifermin[1] D05338 [1] FGFR2 💬[13] Calcium signaling pathway, Central carbon metabolism in cancer, EGFR tyrosine kinase inhibitor resistance, Endocytosis, Gastric cancer, MAPK signaling pathway, PI3K-Akt signaling pathway, Pathways in cancer, Prostate cancer, Rap1 signaling pathway, Ras signaling pathway, Regulation of actin cytoskeleton, Signaling pathways regulating pluripotency of stem cells 💬[5] 13, 36, 38, 39, 65
38Palmitate[1] Palmitic Acid[1] D05341 --[1] 63
39Palmitoleic Acid[1] Palmitoleic Acid---[1] 97
40Palmitoylethanolamide[1] Palmidrol[1] D08328 --[1] 2
41Palopegteriparatide----[1] 235
42PALOVAROTENE[1] Palovarotene[1] D09365 [1] RARG 💬-[1] 272
43PALOVAROTENE - 1.5mg[1] Palovarotene[1] D09365 [1] RARG 💬-[1] 272
44PALOVAROTENE - 10 mg[1] Palovarotene[1] D09365 [1] RARG 💬-[1] 272
45PALOVAROTENE - 1mg[1] Palovarotene[1] D09365 [1] RARG 💬-[1] 272
46PALOVAROTENE - 2 mg[1] Palovarotene[1] D09365 [1] RARG 💬-[1] 272
47PALOVAROTENE - 2.5 mg[1] Palovarotene[1] D09365 [1] RARG 💬-[1] 272
48PALOVAROTENE - 3 mg[1] Palovarotene[1] D09365 [1] RARG 💬-[1] 272
49PALOVAROTENE - 4 mg[1] Palovarotene[1] D09365 [1] RARG 💬-[1] 272
50PALOVAROTENE - 5 mg[1] Palovarotene[1] D09365 [1] RARG 💬-[1] 272
51PALOVAROTENE 1.5 mg[1] Palovarotene[1] D09365 [1] RARG 💬-[1] 272
52Palovarotene dose level 1[1] Palovarotene[1] D09365 [1] RARG 💬-[1] 272
53Palovarotene dose level 2[1] Palovarotene[1] D09365 [1] RARG 💬-[1] 272
54Palovarotene dose level 3[1] Palovarotene[1] D09365 [1] RARG 💬-[1] 272
55Palovarotene dose level 4[1] Palovarotene[1] D09365 [1] RARG 💬-[1] 272
56PALOVAROTENE-2 mg[1] Palovarotene[1] D09365 [1] RARG 💬-[1] 272
57PALOVAROTENE-3 mg[1] Palovarotene[1] D09365 [1] RARG 💬-[1] 272
58PALOVAROTENE-4 mg[1] Palovarotene[1] D09365 [1] RARG 💬-[1] 272
59Palynziq[1] Pegvaliase[1] D11077 [1] PAH 💬[5] Biosynthesis of amino acids, Folate biosynthesis, Metabolic pathways, Phenylalanine metabolism, Phenylalanine, tyrosine and tryptophan biosynthesis 💬[1] 240
60Pamidronate[1] Pamidronic acid[2] D00941 ,
D07281 		[1] FDPS 💬[4] Human T-cell leukemia virus 1 infection, Influenza A, Metabolic pathways, Terpenoid backbone biosynthesis 💬[3] 270, 271, 274
61Pamidronate (Aredia)[1] Pamidronic acid[2] D00941 ,
D07281 		[1] FDPS 💬[4] Human T-cell leukemia virus 1 infection, Influenza A, Metabolic pathways, Terpenoid backbone biosynthesis 💬[1] 274
62PAMREVLUMAB[1] Pamrevlumab[1] D10969 [1] CCN2 💬[2] Apelin signaling pathway, Hippo signaling pathway 💬[2] 85, 113
63Pamrevlumab (FG-3019)[1] Pamrevlumab[1] D10969 [1] CCN2 💬[2] Apelin signaling pathway, Hippo signaling pathway 💬[1] 113
64Panax Quinquefolius[1] Panax quinquefolius whole---[1] 46
65Pancreas Powder----[1] 299
66Pancrease----[1] 299
67PANCREASE MT----[1] 299
68Pancrease MT 10.5, or MT 21----[1] 299
69PANCREASLIPASE----[1] 299
70Pancreatic enzyme(Pancreatin Enteric-coated Capsules or Oryz-Aspergillus Enzyme and Pancreatin Table), antidiabetic medicine(Acarbose Tablets, Glucophage, Glimepirde Tablets)[2] Acarbose,
Pancrelipase		[2] D00216 ,
D05349 		[5] AMY2A,
AMY2B,
GAA,
GANC,
MGAM 💬		[7] Carbohydrate digestion and absorption, Galactose metabolism, Lysosome, Metabolic pathways, Pancreatic secretion, Salivary secretion, Starch and sucrose metabolism 💬[1] 298
71Pancreatic enzymes----[1] 298
72Pancreatin[1] Pancrelipase[1] D05349 --[2] 298, 299
73PANCREATIN (PAncreas Powder)[1] Pancrelipase[1] D05349 --[1] 299
74PANCREATINA----[1] 299
75PANCREATINA (Páncreas Polvo----[1] 299
76PANCREATINA (Páncreas Polvo)----[1] 299
77PANCREAZE----[1] 299
78PANCREAZE®----[1] 299
79PANCRECARB® (pancrelipase)[1] Pancrelipase[1] D05349 --[1] 299
80Pancrelipase[1] Pancrelipase[1] D05349 --[2] 298, 299
81PANCRELIPASE AMYLASE[2] Pancrelipase,
Pancrelipase amylase		[1] D05349 --[1] 299
82Pancrelipase Delayed Release[1] Pancrelipase[1] D05349 --[1] 299
83Pancrelipase Delayed Release Capsule[1] Pancrelipase[1] D05349 --[2] 298, 299
84Pancrelipase Microtablets[1] Pancrelipase[1] D05349 --[1] 299
85Pancrelipase with bicarbonate[1] Pancrelipase[1] D05349 --[1] 299
86Pancrelipase/Pancreas Powder[1] Pancrelipase[1] D05349 --[2] 298, 299
87Pandemrix,----[1] 46
88Panhematin[1] Hemin[1] D10003 [2] ALAS1,
ALAS2 💬		[4] Biosynthesis of cofactors, Glycine, serine and threonine metabolism, Metabolic pathways, Porphyrin metabolism 💬[1] 254
89Pankreatin----[1] 299
90Pantethine[1] Pantethine[1] D01234 --[1] 120
91Pantoprazole[1] Pantoprazole[2] D02593 ,
D05353 		[2] ATP4A,
ATP4B 💬		[4] Collecting duct acid secretion, Gastric acid secretion, Metabolic pathways, Oxidative phosphorylation 💬[2] 13, 65
92Pantoprazolo 20 mg gastro-resistant tablets----[1] 65
93PANZYGA----[1] 14
94Panzytrat----[1] 298
95Panzytrat 25.000----[1] 298
96Panzytrat 25.000 FIP-E units of Lipase----[1] 298
97PANZYTRAT 25000----[1] 299
98Panzytrat® 25,000----[1] 299
99Panzytrat® ok----[1] 299
100Paquinimod[1] Paquinimod---[2] 49, 51
101Paquinimod (ABR-215757)[1] Paquinimod---[1] 49
102PARACETAMOL[1] Acetaminophen[1] D00217 [2] PTGS1,
PTGS2 💬		[23] Alzheimer disease, Arachidonic acid metabolism, C-type lectin receptor signaling pathway, Chemical carcinogenesis - DNA adducts, Human cytomegalovirus infection, Human papillomavirus infection, IL-17 signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Leishmaniasis, Metabolic pathways, MicroRNAs in cancer, NF-kappa B signaling pathway, Ovarian steroidogenesis, Oxytocin signaling pathway, Pathways in cancer, Pathways of neurodegeneration - multiple diseases, Platelet activation, Regulation of lipolysis in adipocytes, Retrograde endocannabinoid signaling, Serotonergic synapse, Small cell lung cancer, TNF signaling pathway, VEGF signaling pathway 💬[6] 3, 6, 13, 35, 46, 49
103Paracetamol (acetaminophen)[1] Acetaminophen[1] D00217 [2] PTGS1,
PTGS2 💬		[23] Alzheimer disease, Arachidonic acid metabolism, C-type lectin receptor signaling pathway, Chemical carcinogenesis - DNA adducts, Human cytomegalovirus infection, Human papillomavirus infection, IL-17 signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Leishmaniasis, Metabolic pathways, MicroRNAs in cancer, NF-kappa B signaling pathway, Ovarian steroidogenesis, Oxytocin signaling pathway, Pathways in cancer, Pathways of neurodegeneration - multiple diseases, Platelet activation, Regulation of lipolysis in adipocytes, Retrograde endocannabinoid signaling, Serotonergic synapse, Small cell lung cancer, TNF signaling pathway, VEGF signaling pathway 💬[1] 46
104Paracetamol 120Mg/5mL Oral Suspension[1] Acetaminophen[1] D00217 [2] PTGS1,
PTGS2 💬		[23] Alzheimer disease, Arachidonic acid metabolism, C-type lectin receptor signaling pathway, Chemical carcinogenesis - DNA adducts, Human cytomegalovirus infection, Human papillomavirus infection, IL-17 signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Leishmaniasis, Metabolic pathways, MicroRNAs in cancer, NF-kappa B signaling pathway, Ovarian steroidogenesis, Oxytocin signaling pathway, Pathways in cancer, Pathways of neurodegeneration - multiple diseases, Platelet activation, Regulation of lipolysis in adipocytes, Retrograde endocannabinoid signaling, Serotonergic synapse, Small cell lung cancer, TNF signaling pathway, VEGF signaling pathway 💬[1] 3
105PARACETAMOLO----[8] 2, 11, 14, 28, 53, 61, 63, 300
106Paracetamolo 500 mg----[1] 13
107PARACETAMOLO DC.IT FU----[1] 46
108PARACETAMOLO NOVA ARGENTIA - 500 MG COMPRESSE 20 COMPRESSE----[1] 300
109Paracetamolo Zentiva Italia----[1] 28
110Paraffin Oil[1] Mineral oil[1] D05042 --[1] 291
111PARALEN 500----[1] 46
112Parapres----[1] 6
113Parathyroid hormon 1-84----[1] 235
114Parathyroid hormone[1] Parathyroid hormone[1] D05364 [2] PTH1R,
PTH2R 💬		[3] Endocrine and other factor-regulated calcium reabsorption, Neuroactive ligand-receptor interaction, Parathyroid hormone synthesis, secretion and action 💬[2] 70, 235
115Parathyroid Hormone (1-84) Human Recombinant[1] Parathyroid hormone[1] D05364 [2] PTH1R,
PTH2R 💬		[3] Endocrine and other factor-regulated calcium reabsorption, Neuroactive ligand-receptor interaction, Parathyroid hormone synthesis, secretion and action 💬[1] 235
116Parathyroid Hormone (rDNA)[1] Parathyroid hormone[1] D05364 [2] PTH1R,
PTH2R 💬		[3] Endocrine and other factor-regulated calcium reabsorption, Neuroactive ligand-receptor interaction, Parathyroid hormone synthesis, secretion and action 💬[1] 235
117Parathyroideahormon----[1] 235
118PARCOPA----[1] 6
119Pardaprunox----[1] 6
120Pardoprunox[1] Pardoprunox[1] D09397 [3] DRD2,
DRD3,
HTR1A 💬		[10] Alcoholism, Cocaine addiction, Dopaminergic synapse, Gap junction, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, Serotonergic synapse, Taste transduction, cAMP signaling pathway 💬[1] 6
121Pardoprunox hydrochloride[1] Pardoprunox[1] D09397 [3] DRD2,
DRD3,
HTR1A 💬		[10] Alcoholism, Cocaine addiction, Dopaminergic synapse, Gap junction, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, Serotonergic synapse, Taste transduction, cAMP signaling pathway 💬[1] 6
122Parecoxib[1] Parecoxib[1] D03716 [1] PTGS2 💬[22] Alzheimer disease, Arachidonic acid metabolism, C-type lectin receptor signaling pathway, Chemical carcinogenesis - DNA adducts, Human cytomegalovirus infection, Human papillomavirus infection, IL-17 signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Leishmaniasis, Metabolic pathways, MicroRNAs in cancer, NF-kappa B signaling pathway, Ovarian steroidogenesis, Oxytocin signaling pathway, Pathways in cancer, Pathways of neurodegeneration - multiple diseases, Regulation of lipolysis in adipocytes, Retrograde endocannabinoid signaling, Serotonergic synapse, Small cell lung cancer, TNF signaling pathway, VEGF signaling pathway 💬[2] 46, 271
123Parenteral Remodulin (treprostinil) injection[1] Treprostinil[1] D06213 [1] PTGIR 💬[3] Neuroactive ligand-receptor interaction, Platelet activation, Vascular smooth muscle contraction 💬[1] 86
124PARI eFlow nebulizer system----[1] 299
125Paricalcitol[1] Paricalcitol[1] D00930 [1] VDR 💬[5] Chemical carcinogenesis - receptor activation, Endocrine and other factor-regulated calcium reabsorption, Mineral absorption, Parathyroid hormone synthesis, secretion and action, Tuberculosis 💬[4] 19, 66, 218, 238
126Parnaparin[1] Parnaparin[1] D07510 [1] SERPINC1 💬[1] Complement and coagulation cascades 💬[1] 97
127PARNAPARIN SODIUM[1] Parnaparin[1] D07510 [1] SERPINC1 💬[1] Complement and coagulation cascades 💬[1] 97
128Paroxetine[1] Paroxetine[4] D02260 ,
D02362 ,
D05374 ,
D05375 		[1] SLC6A4 💬[2] Serotonergic synapse, Synaptic vesicle cycle 💬[4] 6, 13, 46, 85
129Paroxetine & Prednisolone[2] Paroxetine,
Prednisolone		[12] D00472 ,
D00980 ,
D00981 ,
D00982 ,
D01239 ,
D01998 ,
D02156 ,
D02260 ,
D02362 ,
D03301 ,
D05374 ,
D05375 		[2] NR3C1,
SLC6A4 💬		[3] Neuroactive ligand-receptor interaction, Serotonergic synapse, Synaptic vesicle cycle 💬[1] 46
130Paroxetine hydrochloride 10 & 20 mg and Prednisolone 1 mg BP[2] Paroxetine,
Prednisolone		[12] D00472 ,
D00980 ,
D00981 ,
D00982 ,
D01239 ,
D01998 ,
D02156 ,
D02260 ,
D02362 ,
D03301 ,
D05374 ,
D05375 		[2] NR3C1,
SLC6A4 💬		[3] Neuroactive ligand-receptor interaction, Serotonergic synapse, Synaptic vesicle cycle 💬[1] 46
131Paroxetine Hydrochloride tablets 10 & 20 mg and Prednisolone 1 mg BP[2] Paroxetine,
Prednisolone		[12] D00472 ,
D00980 ,
D00981 ,
D00982 ,
D01239 ,
D01998 ,
D02156 ,
D02260 ,
D02362 ,
D03301 ,
D05374 ,
D05375 		[2] NR3C1,
SLC6A4 💬		[3] Neuroactive ligand-receptor interaction, Serotonergic synapse, Synaptic vesicle cycle 💬[1] 46
132Parsaclisib[1] Parsaclisib[1] D11437 [1] PIK3CD 💬[106] AGE-RAGE signaling pathway in diabetic complications, AMPK signaling pathway, Acute myeloid leukemia, Aldosterone-regulated sodium reabsorption, Alzheimer disease, Amoebiasis, Apoptosis, Autophagy - animal, Axon guidance, B cell receptor signaling pathway, Bacterial invasion of epithelial cells, Breast cancer, C-type lectin receptor signaling pathway, Carbohydrate digestion and absorption, Cellular senescence, Central carbon metabolism in cancer, Chagas disease, Chemical carcinogenesis - reactive oxygen species, Chemical carcinogenesis - receptor activation, Chemokine signaling pathway, Choline metabolism in cancer, Cholinergic synapse, Chronic myeloid leukemia, Colorectal cancer, Coronavirus disease - COVID-19, Diabetic cardiomyopathy, EGFR tyrosine kinase inhibitor resistance, Endocrine resistance, Endometrial cancer, Epstein-Barr virus infection, ErbB signaling pathway, Estrogen signaling pathway, Fc epsilon RI signaling pathway, Fc gamma R-mediated phagocytosis, Fluid shear stress and atherosclerosis, Focal adhesion, FoxO signaling pathway, Gastric cancer, Glioma, GnRH secretion, Growth hormone synthesis, secretion and action, HIF-1 signaling pathway, Hepatitis B, Hepatitis C, Hepatocellular carcinoma, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Inflammatory mediator regulation of TRP channels, Influenza A, Inositol phosphate metabolism, Insulin resistance, Insulin signaling pathway, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Leukocyte transendothelial migration, Lipid and atherosclerosis, Longevity regulating pathway, Longevity regulating pathway - multiple species, Measles, Melanoma, Metabolic pathways, MicroRNAs in cancer, Natural killer cell mediated cytotoxicity, Neurotrophin signaling pathway, Neutrophil extracellular trap formation, Non-alcoholic fatty liver disease, Non-small cell lung cancer, Osteoclast differentiation, PD-L1 expression and PD-1 checkpoint pathway in cancer, PI3K-Akt signaling pathway, Pancreatic cancer, Pathways in cancer, Phosphatidylinositol signaling system, Phospholipase D signaling pathway, Platelet activation, Platinum drug resistance, Prion disease, Progesterone-mediated oocyte maturation, Prolactin signaling pathway, Prostate cancer, Proteoglycans in cancer, Rap1 signaling pathway, Ras signaling pathway, Regulation of actin cytoskeleton, Regulation of lipolysis in adipocytes, Relaxin signaling pathway, Renal cell carcinoma, Salmonella infection, Shigellosis, Signaling pathways regulating pluripotency of stem cells, Small cell lung cancer, Sphingolipid signaling pathway, Spinocerebellar ataxia, T cell receptor signaling pathway, TNF signaling pathway, Thyroid hormone signaling pathway, Toll-like receptor signaling pathway, Type II diabetes mellitus, VEGF signaling pathway, Viral carcinogenesis, Yersinia infection, cAMP signaling pathway, mTOR signaling pathway 💬[3] 35, 53, 61
133Parsaclisib (1 mg)[1] Parsaclisib[1] D11437 [1] PIK3CD 💬[106] AGE-RAGE signaling pathway in diabetic complications, AMPK signaling pathway, Acute myeloid leukemia, Aldosterone-regulated sodium reabsorption, Alzheimer disease, Amoebiasis, Apoptosis, Autophagy - animal, Axon guidance, B cell receptor signaling pathway, Bacterial invasion of epithelial cells, Breast cancer, C-type lectin receptor signaling pathway, Carbohydrate digestion and absorption, Cellular senescence, Central carbon metabolism in cancer, Chagas disease, Chemical carcinogenesis - reactive oxygen species, Chemical carcinogenesis - receptor activation, Chemokine signaling pathway, Choline metabolism in cancer, Cholinergic synapse, Chronic myeloid leukemia, Colorectal cancer, Coronavirus disease - COVID-19, Diabetic cardiomyopathy, EGFR tyrosine kinase inhibitor resistance, Endocrine resistance, Endometrial cancer, Epstein-Barr virus infection, ErbB signaling pathway, Estrogen signaling pathway, Fc epsilon RI signaling pathway, Fc gamma R-mediated phagocytosis, Fluid shear stress and atherosclerosis, Focal adhesion, FoxO signaling pathway, Gastric cancer, Glioma, GnRH secretion, Growth hormone synthesis, secretion and action, HIF-1 signaling pathway, Hepatitis B, Hepatitis C, Hepatocellular carcinoma, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Inflammatory mediator regulation of TRP channels, Influenza A, Inositol phosphate metabolism, Insulin resistance, Insulin signaling pathway, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Leukocyte transendothelial migration, Lipid and atherosclerosis, Longevity regulating pathway, Longevity regulating pathway - multiple species, Measles, Melanoma, Metabolic pathways, MicroRNAs in cancer, Natural killer cell mediated cytotoxicity, Neurotrophin signaling pathway, Neutrophil extracellular trap formation, Non-alcoholic fatty liver disease, Non-small cell lung cancer, Osteoclast differentiation, PD-L1 expression and PD-1 checkpoint pathway in cancer, PI3K-Akt signaling pathway, Pancreatic cancer, Pathways in cancer, Phosphatidylinositol signaling system, Phospholipase D signaling pathway, Platelet activation, Platinum drug resistance, Prion disease, Progesterone-mediated oocyte maturation, Prolactin signaling pathway, Prostate cancer, Proteoglycans in cancer, Rap1 signaling pathway, Ras signaling pathway, Regulation of actin cytoskeleton, Regulation of lipolysis in adipocytes, Relaxin signaling pathway, Renal cell carcinoma, Salmonella infection, Shigellosis, Signaling pathways regulating pluripotency of stem cells, Small cell lung cancer, Sphingolipid signaling pathway, Spinocerebellar ataxia, T cell receptor signaling pathway, TNF signaling pathway, Thyroid hormone signaling pathway, Toll-like receptor signaling pathway, Type II diabetes mellitus, VEGF signaling pathway, Viral carcinogenesis, Yersinia infection, cAMP signaling pathway, mTOR signaling pathway 💬[1] 61
134Parsaclisib (2.5 mg)[1] Parsaclisib[1] D11437 [1] PIK3CD 💬[106] AGE-RAGE signaling pathway in diabetic complications, AMPK signaling pathway, Acute myeloid leukemia, Aldosterone-regulated sodium reabsorption, Alzheimer disease, Amoebiasis, Apoptosis, Autophagy - animal, Axon guidance, B cell receptor signaling pathway, Bacterial invasion of epithelial cells, Breast cancer, C-type lectin receptor signaling pathway, Carbohydrate digestion and absorption, Cellular senescence, Central carbon metabolism in cancer, Chagas disease, Chemical carcinogenesis - reactive oxygen species, Chemical carcinogenesis - receptor activation, Chemokine signaling pathway, Choline metabolism in cancer, Cholinergic synapse, Chronic myeloid leukemia, Colorectal cancer, Coronavirus disease - COVID-19, Diabetic cardiomyopathy, EGFR tyrosine kinase inhibitor resistance, Endocrine resistance, Endometrial cancer, Epstein-Barr virus infection, ErbB signaling pathway, Estrogen signaling pathway, Fc epsilon RI signaling pathway, Fc gamma R-mediated phagocytosis, Fluid shear stress and atherosclerosis, Focal adhesion, FoxO signaling pathway, Gastric cancer, Glioma, GnRH secretion, Growth hormone synthesis, secretion and action, HIF-1 signaling pathway, Hepatitis B, Hepatitis C, Hepatocellular carcinoma, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Inflammatory mediator regulation of TRP channels, Influenza A, Inositol phosphate metabolism, Insulin resistance, Insulin signaling pathway, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Leukocyte transendothelial migration, Lipid and atherosclerosis, Longevity regulating pathway, Longevity regulating pathway - multiple species, Measles, Melanoma, Metabolic pathways, MicroRNAs in cancer, Natural killer cell mediated cytotoxicity, Neurotrophin signaling pathway, Neutrophil extracellular trap formation, Non-alcoholic fatty liver disease, Non-small cell lung cancer, Osteoclast differentiation, PD-L1 expression and PD-1 checkpoint pathway in cancer, PI3K-Akt signaling pathway, Pancreatic cancer, Pathways in cancer, Phosphatidylinositol signaling system, Phospholipase D signaling pathway, Platelet activation, Platinum drug resistance, Prion disease, Progesterone-mediated oocyte maturation, Prolactin signaling pathway, Prostate cancer, Proteoglycans in cancer, Rap1 signaling pathway, Ras signaling pathway, Regulation of actin cytoskeleton, Regulation of lipolysis in adipocytes, Relaxin signaling pathway, Renal cell carcinoma, Salmonella infection, Shigellosis, Signaling pathways regulating pluripotency of stem cells, Small cell lung cancer, Sphingolipid signaling pathway, Spinocerebellar ataxia, T cell receptor signaling pathway, TNF signaling pathway, Thyroid hormone signaling pathway, Toll-like receptor signaling pathway, Type II diabetes mellitus, VEGF signaling pathway, Viral carcinogenesis, Yersinia infection, cAMP signaling pathway, mTOR signaling pathway 💬[1] 61
135Parsaclisinib----[1] 61
136Part 1 Levulan injection----[1] 34
137Part 1 Levulan surface application----[1] 34
138Part 1 Levulan surface application twice----[1] 34
139Part 1 Levulan surface application twice with microneedling----[1] 34
140Part 1, JM-010 component Group A----[1] 6
141Part 1, JM-010 component Group B----[1] 6
142Part 1, JM-010 component Group C----[1] 6
143Part 1: LJN452----[1] 93
144Part 2, JM-010 combination Group A----[1] 6
145Part 2, JM-010 combination Group B----[1] 6
146Part 2, JM-010 component Group C----[1] 6
147Part 2: LJN452 Dose level 1----[1] 93
148Part 2: LJN452 Dose level 2----[1] 93
149Part A----[1] 46
150Part A: 100 mg/mL GSK2618960----[1] 13
151Part B----[1] 46
152Part B Open-Label Extension----[1] 51
153Part B: Dose of GSK2618960 decided from Part A----[1] 13
154Part C: Dose of GSK2618960 decided from Part A and B----[1] 13
155Part I - etoricoxib 60 mg[1] Etoricoxib[1] D03710 [1] PTGS2 💬[22] Alzheimer disease, Arachidonic acid metabolism, C-type lectin receptor signaling pathway, Chemical carcinogenesis - DNA adducts, Human cytomegalovirus infection, Human papillomavirus infection, IL-17 signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Leishmaniasis, Metabolic pathways, MicroRNAs in cancer, NF-kappa B signaling pathway, Ovarian steroidogenesis, Oxytocin signaling pathway, Pathways in cancer, Pathways of neurodegeneration - multiple diseases, Regulation of lipolysis in adipocytes, Retrograde endocannabinoid signaling, Serotonergic synapse, Small cell lung cancer, TNF signaling pathway, VEGF signaling pathway 💬[1] 271
156Part I - etoricoxib 90 mg[1] Etoricoxib[1] D03710 [1] PTGS2 💬[22] Alzheimer disease, Arachidonic acid metabolism, C-type lectin receptor signaling pathway, Chemical carcinogenesis - DNA adducts, Human cytomegalovirus infection, Human papillomavirus infection, IL-17 signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Leishmaniasis, Metabolic pathways, MicroRNAs in cancer, NF-kappa B signaling pathway, Ovarian steroidogenesis, Oxytocin signaling pathway, Pathways in cancer, Pathways of neurodegeneration - multiple diseases, Regulation of lipolysis in adipocytes, Retrograde endocannabinoid signaling, Serotonergic synapse, Small cell lung cancer, TNF signaling pathway, VEGF signaling pathway 💬[1] 271
157Part I- naproxen 1000 mg[1] Naproxen[1] D00118 [2] PTGS1,
PTGS2 💬		[23] Alzheimer disease, Arachidonic acid metabolism, C-type lectin receptor signaling pathway, Chemical carcinogenesis - DNA adducts, Human cytomegalovirus infection, Human papillomavirus infection, IL-17 signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Leishmaniasis, Metabolic pathways, MicroRNAs in cancer, NF-kappa B signaling pathway, Ovarian steroidogenesis, Oxytocin signaling pathway, Pathways in cancer, Pathways of neurodegeneration - multiple diseases, Platelet activation, Regulation of lipolysis in adipocytes, Retrograde endocannabinoid signaling, Serotonergic synapse, Small cell lung cancer, TNF signaling pathway, VEGF signaling pathway 💬[1] 271
158Part II- etoricoxib 60 mg[1] Etoricoxib[1] D03710 [1] PTGS2 💬[22] Alzheimer disease, Arachidonic acid metabolism, C-type lectin receptor signaling pathway, Chemical carcinogenesis - DNA adducts, Human cytomegalovirus infection, Human papillomavirus infection, IL-17 signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Leishmaniasis, Metabolic pathways, MicroRNAs in cancer, NF-kappa B signaling pathway, Ovarian steroidogenesis, Oxytocin signaling pathway, Pathways in cancer, Pathways of neurodegeneration - multiple diseases, Regulation of lipolysis in adipocytes, Retrograde endocannabinoid signaling, Serotonergic synapse, Small cell lung cancer, TNF signaling pathway, VEGF signaling pathway 💬[1] 271
159Part II- etoricoxib 90 mg[1] Etoricoxib[1] D03710 [1] PTGS2 💬[22] Alzheimer disease, Arachidonic acid metabolism, C-type lectin receptor signaling pathway, Chemical carcinogenesis - DNA adducts, Human cytomegalovirus infection, Human papillomavirus infection, IL-17 signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Leishmaniasis, Metabolic pathways, MicroRNAs in cancer, NF-kappa B signaling pathway, Ovarian steroidogenesis, Oxytocin signaling pathway, Pathways in cancer, Pathways of neurodegeneration - multiple diseases, Regulation of lipolysis in adipocytes, Retrograde endocannabinoid signaling, Serotonergic synapse, Small cell lung cancer, TNF signaling pathway, VEGF signaling pathway 💬[1] 271
160Part II- naproxen 1000 mg[1] Naproxen[1] D00118 [2] PTGS1,
PTGS2 💬		[23] Alzheimer disease, Arachidonic acid metabolism, C-type lectin receptor signaling pathway, Chemical carcinogenesis - DNA adducts, Human cytomegalovirus infection, Human papillomavirus infection, IL-17 signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Leishmaniasis, Metabolic pathways, MicroRNAs in cancer, NF-kappa B signaling pathway, Ovarian steroidogenesis, Oxytocin signaling pathway, Pathways in cancer, Pathways of neurodegeneration - multiple diseases, Platelet activation, Regulation of lipolysis in adipocytes, Retrograde endocannabinoid signaling, Serotonergic synapse, Small cell lung cancer, TNF signaling pathway, VEGF signaling pathway 💬[1] 271
161Partial Enteral Nutrition----[1] 96
162Parts A/B: Adrabetadex[1] Adrabetadex---[1] 19
163PAS----[1] 13
164Pasireotida[1] Pasireotide[1] D10147 [4] SSTR1,
SSTR2,
SSTR3,
SSTR5 💬		[4] Gastric acid secretion, Growth hormone synthesis, secretion and action, Neuroactive ligand-receptor interaction, cAMP signaling pathway 💬[1] 75
165Pasireotida 300[1] Pasireotide[1] D10147 [4] SSTR1,
SSTR2,
SSTR3,
SSTR5 💬		[4] Gastric acid secretion, Growth hormone synthesis, secretion and action, Neuroactive ligand-receptor interaction, cAMP signaling pathway 💬[1] 75
166Pasireotida 600[1] Pasireotide[1] D10147 [4] SSTR1,
SSTR2,
SSTR3,
SSTR5 💬		[4] Gastric acid secretion, Growth hormone synthesis, secretion and action, Neuroactive ligand-receptor interaction, cAMP signaling pathway 💬[1] 75
167Pasireotida 900[1] Pasireotide[1] D10147 [4] SSTR1,
SSTR2,
SSTR3,
SSTR5 💬		[4] Gastric acid secretion, Growth hormone synthesis, secretion and action, Neuroactive ligand-receptor interaction, cAMP signaling pathway 💬[1] 75
168Pasireotide[1] Pasireotide[1] D10147 [4] SSTR1,
SSTR2,
SSTR3,
SSTR5 💬		[4] Gastric acid secretion, Growth hormone synthesis, secretion and action, Neuroactive ligand-receptor interaction, cAMP signaling pathway 💬[3] 67, 74, 75
169Pasireotide 0.3mg[1] Pasireotide[1] D10147 [4] SSTR1,
SSTR2,
SSTR3,
SSTR5 💬		[4] Gastric acid secretion, Growth hormone synthesis, secretion and action, Neuroactive ligand-receptor interaction, cAMP signaling pathway 💬[1] 75
170Pasireotide 0.6 MG/ML[1] Pasireotide[1] D10147 [4] SSTR1,
SSTR2,
SSTR3,
SSTR5 💬		[4] Gastric acid secretion, Growth hormone synthesis, secretion and action, Neuroactive ligand-receptor interaction, cAMP signaling pathway 💬[1] 75
171Pasireotide 0.6mg[1] Pasireotide[1] D10147 [4] SSTR1,
SSTR2,
SSTR3,
SSTR5 💬		[4] Gastric acid secretion, Growth hormone synthesis, secretion and action, Neuroactive ligand-receptor interaction, cAMP signaling pathway 💬[1] 75
172Pasireotide 0.9 mg[1] Pasireotide[1] D10147 [4] SSTR1,
SSTR2,
SSTR3,
SSTR5 💬		[4] Gastric acid secretion, Growth hormone synthesis, secretion and action, Neuroactive ligand-receptor interaction, cAMP signaling pathway 💬[1] 75
173Pasireotide 20mg[1] Pasireotide[1] D10147 [4] SSTR1,
SSTR2,
SSTR3,
SSTR5 💬		[4] Gastric acid secretion, Growth hormone synthesis, secretion and action, Neuroactive ligand-receptor interaction, cAMP signaling pathway 💬[1] 75
174Pasireotide 40mg[1] Pasireotide[1] D10147 [4] SSTR1,
SSTR2,
SSTR3,
SSTR5 💬		[4] Gastric acid secretion, Growth hormone synthesis, secretion and action, Neuroactive ligand-receptor interaction, cAMP signaling pathway 💬[1] 75
175Pasireotide 60mg[1] Pasireotide[1] D10147 [4] SSTR1,
SSTR2,
SSTR3,
SSTR5 💬		[4] Gastric acid secretion, Growth hormone synthesis, secretion and action, Neuroactive ligand-receptor interaction, cAMP signaling pathway 💬[1] 75
176PASIREOTIDE DIASPARTATE[1] Pasireotide[1] D10147 [4] SSTR1,
SSTR2,
SSTR3,
SSTR5 💬		[4] Gastric acid secretion, Growth hormone synthesis, secretion and action, Neuroactive ligand-receptor interaction, cAMP signaling pathway 💬[1] 75
177Pasireotide LAR[1] Pasireotide[1] D10147 [4] SSTR1,
SSTR2,
SSTR3,
SSTR5 💬		[4] Gastric acid secretion, Growth hormone synthesis, secretion and action, Neuroactive ligand-receptor interaction, cAMP signaling pathway 💬[2] 67, 75
178PASIREOTIDE PAMOATE[1] Pasireotide[1] D10147 [4] SSTR1,
SSTR2,
SSTR3,
SSTR5 💬		[4] Gastric acid secretion, Growth hormone synthesis, secretion and action, Neuroactive ligand-receptor interaction, cAMP signaling pathway 💬[1] 75
179Pasireotide s.c.[1] Pasireotide[1] D10147 [4] SSTR1,
SSTR2,
SSTR3,
SSTR5 💬		[4] Gastric acid secretion, Growth hormone synthesis, secretion and action, Neuroactive ligand-receptor interaction, cAMP signaling pathway 💬[1] 75
180Pasireotide sub-cutaneous[1] Pasireotide[1] D10147 [4] SSTR1,
SSTR2,
SSTR3,
SSTR5 💬		[4] Gastric acid secretion, Growth hormone synthesis, secretion and action, Neuroactive ligand-receptor interaction, cAMP signaling pathway 💬[1] 75
181Pasireotide with or without cabergoline[2] Cabergoline,
Pasireotide		[2] D00987 ,
D10147 		[6] DRD2,
PRL,
SSTR1,
SSTR2,
SSTR3,
SSTR5 💬		[14] Alcoholism, Cocaine addiction, Cytokine-cytokine receptor interaction, Dopaminergic synapse, Gap junction, Gastric acid secretion, Growth hormone synthesis, secretion and action, JAK-STAT signaling pathway, Neuroactive ligand-receptor interaction, PI3K-Akt signaling pathway, Parkinson disease, Prolactin signaling pathway, Rap1 signaling pathway, cAMP signaling pathway 💬[1] 75
182Pasireotode----[1] 75
183PAT----[3] 6, 13, 160
184PAT-001, 0.1%----[1] 160
185PAT-001, 0.2%----[1] 160
186Patient Current Care----[1] 46
187Patient treated with DMARD----[1] 46
188Patients will be randomized to receive EHP-101----[1] 51
189Patients' existing non-steroidal anti-inflammatory drug (NSAID) at approved doses----[1] 46
190Pazopanib[1] Pazopanib---[1] 227
191PB----[2] 67, 225
192PB006----[1] 13
193PB1046----[1] 86
194PB1046 Injection----[1] 113
195PB1046 Subcutaneous Injection----[1] 86
196PB1046, VIP-ELP1-120, Vasomera----[1] 86
197PBA----[1] 231
198PBF-509----[1] 6
199PBF-677----[1] 97
200PBF-999----[1] 8
201PBF-999 / 160 mg----[1] 8
202PBF-999 / 320 mg----[1] 8
203PBFT02----[1] 127
204PBGM01----[1] 19
205PBI4050----[2] 85, 299
206PBKR03----[1] 19
207PBMC autotransplantation----[1] 2
208PBT2----[1] 8
209PC945----[1] 299
210PCA----[2] 46, 70
211PCO371----[1] 235
212PCT (PureCell Technologies Complex)----[1] 97
213PCV----[1] 13
214PD 0299685----[1] 226
215PD 0299685 at 15mg BID----[1] 226
216PD 0299685 at 30mg BID----[1] 226
217PD 0360324----[2] 46, 84
218PD patients H&Y=1.5-2 Medications OFF----[1] 6
219PD patients H&Y=1.5-2 Medications ON----[1] 6
220PD patients H&Y=3 Medications OFF----[1] 6
221PD patients H&Y=3 Medications ON----[1] 6
222PD vitamin supplementation----[1] 6
223PD-0299685[1] PD-0299685---[1] 226
224PD-0325901[1] PD-0325901---[1] 34
225PD00377 Na-salt----[1] 85
226PDA001----[2] 46, 96
227PDA001 (cenplacel-L)----[1] 84
228PDE5 inhibitor----[1] 86
229PEA-LUT----[1] 127
230Peanut[1] Peanut---[1] 13
231Pectin[1] Pectin[1] D02316 --[1] 96
232Pednisone----[2] 43, 44
233Peficitinib[1] Peficitinib[1] D10653 [3] JAK1,
JAK2,
JAK3 💬		[37] AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, Chemical carcinogenesis - receptor activation, Chemokine signaling pathway, Cholinergic synapse, Coronavirus disease - COVID-19, EGFR tyrosine kinase inhibitor resistance, Epstein-Barr virus infection, Growth hormone synthesis, secretion and action, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human papillomavirus infection, Influenza A, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Leishmaniasis, Lipid and atherosclerosis, Measles, NOD-like receptor signaling pathway, Necroptosis, Non-small cell lung cancer, Osteoclast differentiation, PD-L1 expression and PD-1 checkpoint pathway in cancer, PI3K-Akt signaling pathway, Pancreatic cancer, Pathways in cancer, Primary immunodeficiency, Prolactin signaling pathway, Signaling pathways regulating pluripotency of stem cells, Th1 and Th2 cell differentiation, Th17 cell differentiation, Toxoplasmosis, Tuberculosis, Viral carcinogenesis 💬[1] 46
234PEG----[12] 6, 13, 41, 46, 65, 78, 96, 97, 140, 144, 240, 299
235PEG tube----[1] 6
236Peg-Ada----[1] 65
237PEG-ADA ERT----[1] 65
238Peg-Interferon alpha-2b[1] Interferon alfa-2b[1] D02745 [2] IFNAR1,
IFNAR2 💬		[18] Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Epstein-Barr virus infection, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human papillomavirus infection, Influenza A, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Measles, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Osteoclast differentiation, PI3K-Akt signaling pathway, Pathways in cancer, Toll-like receptor signaling pathway 💬[1] 34
239PEG-interleukin-2[1] Human interleukin-2---[1] 65
240PEG-liposomal Prednisolone Sodium Phosphate[2] Phosphate ion,
Prednisolone		[8] D00472 ,
D00980 ,
D00981 ,
D00982 ,
D01239 ,
D01998 ,
D02156 ,
D03301 		[1] NR3C1 💬[1] Neuroactive ligand-receptor interaction 💬[2] 13, 97
241PEG-somatropin[1] Somatotropin[1] D02691 [1] GHR 💬[5] Cytokine-cytokine receptor interaction, Growth hormone synthesis, secretion and action, JAK-STAT signaling pathway, Neuroactive ligand-receptor interaction, PI3K-Akt signaling pathway 💬[1] 78
242Pegcetacoplam----[1] 2
243PEGCETACOPLAN[1] Pegcetacoplan[1] D11613 [1] C3 💬[17] Alcoholic liver disease, Chagas disease, Complement and coagulation cascades, Coronavirus disease - COVID-19, Herpes simplex virus 1 infection, Kaposi sarcoma-associated herpesvirus infection, Legionellosis, Leishmaniasis, Neuroactive ligand-receptor interaction, Neutrophil extracellular trap formation, Pertussis, Phagosome, Shigellosis, Staphylococcus aureus infection, Systemic lupus erythematosus, Tuberculosis, Viral carcinogenesis 💬[3] 2, 62, 222
244Pegcetacoplan (APL-2)[1] Pegcetacoplan[1] D11613 [1] C3 💬[17] Alcoholic liver disease, Chagas disease, Complement and coagulation cascades, Coronavirus disease - COVID-19, Herpes simplex virus 1 infection, Kaposi sarcoma-associated herpesvirus infection, Legionellosis, Leishmaniasis, Neuroactive ligand-receptor interaction, Neutrophil extracellular trap formation, Pertussis, Phagosome, Shigellosis, Staphylococcus aureus infection, Systemic lupus erythematosus, Tuberculosis, Viral carcinogenesis 💬[2] 2, 62
245Pegfilgrastim[1] Pegfilgrastim[1] D06889 [1] CSF3R 💬[5] Cytokine-cytokine receptor interaction, Hematopoietic cell lineage, JAK-STAT signaling pathway, PI3K-Akt signaling pathway, Pathways in cancer 💬[1] 60
246Peginesatide[1] Peginesatide[1] D09946 [1] EPOR 💬[5] Cytokine-cytokine receptor interaction, Hematopoietic cell lineage, JAK-STAT signaling pathway, PI3K-Akt signaling pathway, Pathways in cancer 💬[1] 283
247PEGINTERFERON BETA-1A[1] Peginterferon beta-1a[1] D10483 [2] IFNAR1,
IFNAR2 💬		[18] Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Epstein-Barr virus infection, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human papillomavirus infection, Influenza A, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Measles, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Osteoclast differentiation, PI3K-Akt signaling pathway, Pathways in cancer, Toll-like receptor signaling pathway 💬[1] 13
248Peginterferone beta 1a----[1] 13
249PEGINTERFERONE BETA-1A----[1] 13
250PEGINTERFERONE LAMBDA-1A----[1] 13
251Pegsunercept[1] Pegsunercept[1] D05393 [1] TNF 💬[67] AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Alcoholic liver disease, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antifolate resistance, Antigen processing and presentation, Apoptosis, Asthma, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Dilated cardiomyopathy, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, Graft-versus-host disease, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Influenza A, Insulin resistance, Legionellosis, Leishmaniasis, Lipid and atherosclerosis, MAPK signaling pathway, Malaria, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Non-alcoholic fatty liver disease, Osteoclast differentiation, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway 💬[1] 46
252Pegsunercept (PEG sTNF-RI)[1] Pegsunercept[1] D05393 [1] TNF 💬[67] AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Alcoholic liver disease, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antifolate resistance, Antigen processing and presentation, Apoptosis, Asthma, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Dilated cardiomyopathy, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, Graft-versus-host disease, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Influenza A, Insulin resistance, Legionellosis, Leishmaniasis, Lipid and atherosclerosis, MAPK signaling pathway, Malaria, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Non-alcoholic fatty liver disease, Osteoclast differentiation, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway 💬[1] 46
253Pegtibatinase----[1] 337
254PEGUNIGALSIDASE ALFA[1] Pegunigalsidase alfa[1] D11685 --[1] 19
255Pegunigalsidase alpha----[1] 19
256PEGVALIASE[1] Pegvaliase[1] D11077 [1] PAH 💬[5] Biosynthesis of amino acids, Folate biosynthesis, Metabolic pathways, Phenylalanine metabolism, Phenylalanine, tyrosine and tryptophan biosynthesis 💬[1] 240
257Pegvisomant[1] Pegvisomant[1] D05394 [1] GHR 💬[5] Cytokine-cytokine receptor interaction, Growth hormone synthesis, secretion and action, JAK-STAT signaling pathway, Neuroactive ligand-receptor interaction, PI3K-Akt signaling pathway 💬[1] 78
258PEGylated Intereron Beta-1a----[1] 13
259Pegylated interferon alfa[1] Interferon alfa[1] D03305 [2] IFNAR1,
IFNAR2 💬		[18] Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Epstein-Barr virus infection, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human papillomavirus infection, Influenza A, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Measles, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Osteoclast differentiation, PI3K-Akt signaling pathway, Pathways in cancer, Toll-like receptor signaling pathway 💬[1] 96
260Pegylated Interferon Alpha2b----[1] 227
261PEGylated Interferon Beta-1a[2] Human interferon beta,
Interferon beta-1a		[1] D04554 [2] IFNAR1,
IFNAR2 💬		[18] Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Epstein-Barr virus infection, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human papillomavirus infection, Influenza A, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Measles, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Osteoclast differentiation, PI3K-Akt signaling pathway, Pathways in cancer, Toll-like receptor signaling pathway 💬[1] 13
262Pegylated polypeptide hormone of human recombinant origin PEG-hGH----[1] 78
263Pegylated recombinant human growth hormone[1] Somatotropin[1] D02691 [1] GHR 💬[5] Cytokine-cytokine receptor interaction, Growth hormone synthesis, secretion and action, JAK-STAT signaling pathway, Neuroactive ligand-receptor interaction, PI3K-Akt signaling pathway 💬[1] 78
264PEGYLATED RECOMBINANT HUMAN HYALURONIDASE PH20[2] Hyaluronidase,
Hyaluronidase (human recombinant)		[3] D04455 ,
D04456 ,
D06604 		--[1] 28
265Pegylated Somatropin[1] Somatotropin[1] D02691 [1] GHR 💬[5] Cytokine-cytokine receptor interaction, Growth hormone synthesis, secretion and action, JAK-STAT signaling pathway, Neuroactive ligand-receptor interaction, PI3K-Akt signaling pathway 💬[1] 78
266Pelubiprofen[1] Pelubiprofen[1] D01865 --[1] 46
267Pelubiprofen 30 mg[1] Pelubiprofen[1] D01865 --[1] 46
268Pelvic Floor Physical Therapy----[1] 226
269Pemafibrate[1] Pemafibrate[1] D10711 [1] PPARA 💬[10] Adipocytokine signaling pathway, Alcoholic liver disease, Chemical carcinogenesis - receptor activation, Diabetic cardiomyopathy, Glucagon signaling pathway, Hepatitis C, Insulin resistance, Non-alcoholic fatty liver disease, PPAR signaling pathway, cAMP signaling pathway 💬[1] 93
270Pembrolizumab[1] Pembrolizumab[1] D10574 [1] PDCD1 💬[3] Cell adhesion molecules, PD-L1 expression and PD-1 checkpoint pathway in cancer, T cell receptor signaling pathway 💬[2] 25, 285
271PEMINE - 150 MG CAPSULE RIGIDE 50 CAPSULE----[1] 171
272PEMIROLAST[1] Pemirolast[2] D01088 ,
D07476 		--[1] 113
273Pemziviptadil (PB1046)----[1] 86
274Pemziviptadil (PB1046) Injection----[1] 86
275Pending----[6] 13, 19, 96, 97, 113, 302
276Penicillamine[1] Penicillamine[1] D00496 --[2] 51, 171
277Pentamidina[1] Pentamidine[2] D00834 ,
D08333 		--[1] 61
278PENTAMIDINA ISETIONATO[1] Pentamidine[2] D00834 ,
D08333 		--[1] 61
279Pentamidine[1] Pentamidine[2] D00834 ,
D08333 		--[2] 61, 65
280Pentasa[1] Mesalazine[1] D00377 --[2] 96, 97
281Pentasa 2g sachet prolonged release granules (95%)[2] Manganese citrate,
Mesalazine		[1] D00377 --[1] 97
282Pentasa 500 mg Retardtabletten[1] Mesalazine[1] D00377 --[1] 97
283Pentasa Compact 2g, granulate with prolonged release[2] Manganese citrate,
Mesalazine		[1] D00377 --[1] 97
284Pentasa Compact 4g, granulate with prolonged release[2] Manganese citrate,
Mesalazine		[1] D00377 --[1] 97
285Pentasa enema[1] Mesalazine[1] D00377 --[1] 97
286Pentasa prolonged release granules 2g[2] Manganese citrate,
Mesalazine		[1] D00377 --[1] 97
287PENTASA Sachet[1] Mesalazine[1] D00377 --[2] 96, 97
288Pentasa Sachet 1 g[1] Mesalazine[1] D00377 --[2] 96, 97
289Pentasa Sachet 1 g prolonged release granules[2] Manganese citrate,
Mesalazine		[1] D00377 --[1] 96
290Pentasa Sachet 1g[1] Mesalazine[1] D00377 --[1] 97
291Pentasa Sachet 2 g[1] Mesalazine[1] D00377 --[1] 97
292Pentetreotide[1] Pentetreotide[1] D01859 --[1] 75
293Pentosan Polysulfat SP 54® injection solution----[1] 19
294Pentosan polysulfate[1] Pentosan polysulfate[1] D05428 --[3] 19, 26, 226
295PENTOSAN POLYSULFATE SODIUM[1] Pentosan polysulfate[1] D05428 --[1] 19
296Pentosan polysulfate sodium 100 mg[1] Pentosan polysulfate[1] D05428 --[1] 226
297Pentosan Polysulphate SP54----[1] 19
298Pentosan Polysulphate SP54®----[1] 19
299Pentoxifylline[1] Pentoxifylline[1] D00501 --[10] 26, 56, 84, 93, 96, 113, 220, 222, 296, 298
300Peppermint[1] Peppermint[1] D05431 --[1] 226
301Peppermint oil[2] Peppermint,
Peppermint oil		[2] D05431 ,
D05432 		--[1] 226
302Peptide-conjugated phosphorodiamidate morpholino oligomer for exon 51 skipping----[1] 113
303Peptidic+Probiotic----[1] 96
304Perampanel[1] Perampanel[1] D08964 [4] GRIA1,
GRIA2,
GRIA3,
GRIA4 💬		[16] Amphetamine addiction, Amyotrophic lateral sclerosis, Circadian entrainment, Cocaine addiction, Dopaminergic synapse, Glutamatergic synapse, Huntington disease, Long-term depression, Long-term potentiation, Neuroactive ligand-receptor interaction, Nicotine addiction, Pathways of neurodegeneration - multiple diseases, Retrograde endocannabinoid signaling, Spinocerebellar ataxia, Transcriptional misregulation in cancer, cAMP signaling pathway 💬[3] 2, 6, 144
305Percutaneous endoscopic gastrostomy tube----[1] 6
306Percutaneous endoscopic gastrostomy tube (PEG tube)----[1] 6
307Percutaneous Endoscopic Gastrostomy with Jejunal Extension (PEG-J)----[1] 6
308Percutaneous Lumbar Decompression----[1] 70
309Percutaneous sirolimus[1] Sirolimus[1] D00753 [1] MTOR 💬[51] AMPK signaling pathway, Acute myeloid leukemia, Adipocytokine signaling pathway, Alzheimer disease, Amyotrophic lateral sclerosis, Apelin signaling pathway, Autophagy - animal, Autophagy - other, Breast cancer, Cellular senescence, Central carbon metabolism in cancer, Chemical carcinogenesis - receptor activation, Choline metabolism in cancer, Colorectal cancer, Diabetic cardiomyopathy, EGFR tyrosine kinase inhibitor resistance, Endocrine resistance, ErbB signaling pathway, Gastric cancer, Glioma, Growth hormone synthesis, secretion and action, HIF-1 signaling pathway, Hepatocellular carcinoma, Herpes simplex virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Huntington disease, Insulin resistance, Insulin signaling pathway, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Longevity regulating pathway, Longevity regulating pathway - multiple species, MicroRNAs in cancer, Neutrophil extracellular trap formation, PD-L1 expression and PD-1 checkpoint pathway in cancer, PI3K-Akt signaling pathway, Pancreatic cancer, Pathways in cancer, Pathways of neurodegeneration - multiple diseases, Phospholipase D signaling pathway, Prostate cancer, Proteoglycans in cancer, Shigellosis, Spinocerebellar ataxia, Th17 cell differentiation, Thermogenesis, Thyroid hormone signaling pathway, Type II diabetes mellitus, mTOR signaling pathway 💬[1] 278
310Perdix----[1] 19
311PERFALGAN----[1] 2
312Perflubutane[1] Perflubutane[1] D05440 --[2] 298, 300
313Perfluorinated gas/oxygen mixture[1] Oxygen[1] D00003 --[1] 299
314Perform blood cells and fibroblasts biochemical and immuno-labeled investigations----[1] 265
315Perform three multiple breath nitrogen washout tests (N2-MBW-test)[1] Nitrogen[1] D00083 --[1] 299
316PERGOLIDE[1] Pergolide[2] D00502 ,
D08339 		[2] DRD1,
DRD2 💬		[11] Alcoholism, Amphetamine addiction, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Morphine addiction, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway 💬[1] 6
317Perhexiline[1] Perhexiline[2] D05442 ,
D08340 		[8] CACNA1C,
CACNA1D,
CACNA1F,
CACNA1S,
CPT1A,
CPT1B,
CPT1C,
CPT2 💬		[47] AMPK signaling pathway, Adipocytokine signaling pathway, Adrenergic signaling in cardiomyocytes, Alcoholic liver disease, Aldosterone synthesis and secretion, Alzheimer disease, Amphetamine addiction, Arrhythmogenic right ventricular cardiomyopathy, Calcium signaling pathway, Carbohydrate digestion and absorption, Cardiac muscle contraction, Cellular senescence, Chemical carcinogenesis - receptor activation, Cholinergic synapse, Circadian entrainment, Cortisol synthesis and secretion, Cushing syndrome, Diabetic cardiomyopathy, Dilated cardiomyopathy, Dopaminergic synapse, Fatty acid degradation, Fatty acid metabolism, GABAergic synapse, Glucagon signaling pathway, Glutamatergic synapse, GnRH secretion, GnRH signaling pathway, Growth hormone synthesis, secretion and action, Hypertrophic cardiomyopathy, Insulin resistance, Insulin secretion, Long-term potentiation, MAPK signaling pathway, Oxytocin signaling pathway, PPAR signaling pathway, Pathways of neurodegeneration - multiple diseases, Prion disease, Renin secretion, Retrograde endocannabinoid signaling, Serotonergic synapse, Taste transduction, Thermogenesis, Tight junction, Type II diabetes mellitus, Vascular smooth muscle contraction, cAMP signaling pathway, cGMP-PKG signaling pathway 💬[2] 58, 272
318Peri-neural Dexamethasone 1 mg[1] Dexamethasone[9] D00292 ,
D00975 ,
D01510 ,
D01615 ,
D01632 ,
D01948 ,
D02174 ,
D02591 ,
D02592 		[1] NR3C1 💬[1] Neuroactive ligand-receptor interaction 💬[1] 46
319Perindopril[1] Perindopril[2] D00624 ,
D03753 		[1] ACE 💬[6] Chagas disease, Coronavirus disease - COVID-19, Diabetic cardiomyopathy, Hypertrophic cardiomyopathy, Renin secretion, Renin-angiotensin system 💬[4] 58, 113, 167, 222
320Perindopril 2mg Tablets[1] Perindopril[2] D00624 ,
D03753 		[1] ACE 💬[6] Chagas disease, Coronavirus disease - COVID-19, Diabetic cardiomyopathy, Hypertrophic cardiomyopathy, Renin secretion, Renin-angiotensin system 💬[1] 113
321PERINDOPRIL ARGININA[2] Arginine,
Perindopril		[3] D00624 ,
D02982 ,
D03753 		[1] ACE 💬[6] Chagas disease, Coronavirus disease - COVID-19, Diabetic cardiomyopathy, Hypertrophic cardiomyopathy, Renin secretion, Renin-angiotensin system 💬[1] 58
322Perindopril arginine[2] Arginine,
Perindopril		[3] D00624 ,
D02982 ,
D03753 		[1] ACE 💬[6] Chagas disease, Coronavirus disease - COVID-19, Diabetic cardiomyopathy, Hypertrophic cardiomyopathy, Renin secretion, Renin-angiotensin system 💬[1] 58
323Peripheral blood stem cell----[1] 285
324Peripheral Blood Stem Cell Infusion----[1] 96
325Peripheral Blood Stem Cell Transplantation----[12] 11, 13, 14, 28, 51, 60, 62, 65, 283, 284, 285, 286
326Peripheral blood stem cell transplantation (PBSCT)----[1] 60
327Peripheral Blood Stem Cells----[2] 51, 65
328Permitted DMARDs----[1] 46
329Persantin----[1] 46
330Persantin 100 mg----[1] 46
331Persantin 100 mg and----[1] 46
332Personalized extended interval dosing of natalizumab[1] Natalizumab[1] D06886 [1] ITGA4 💬[14] Arrhythmogenic right ventricular cardiomyopathy, Cell adhesion molecules, Dilated cardiomyopathy, ECM-receptor interaction, Focal adhesion, Hematopoietic cell lineage, Human papillomavirus infection, Hypertrophic cardiomyopathy, Intestinal immune network for IgA production, Leishmaniasis, Leukocyte transendothelial migration, PI3K-Akt signaling pathway, Regulation of actin cytoskeleton, Yersinia infection 💬[1] 13
333Pertactin[1] Bordetella pertussis pertactin antigen---[1] 46
334Pertactin adsorbed[1] Bordetella pertussis pertactin antigen---[1] 46
335PERTUSSIS FILAMENTOUS HAEMAGGLUTININ ADSORBED ON ALUMINIUM HYDROXIDE[4] Aluminium,
Aluminum hydroxide,
Bordetella pertussis filamentous hemagglutinin antigen (formaldehyde inactivated),
Hydroxide ion		[1] D02416 --[1] 46
336PERTUSSIS PERTACTIN ADSORBED ON ALUMINIUM HYDROXIDE[4] Aluminium,
Aluminum hydroxide,
Bordetella pertussis pertactin antigen,
Hydroxide ion		[1] D02416 --[1] 46
337Pertussis toxoid[1] Bordetella pertussis toxoid antigen (formaldehyde, glutaraldehyde inactivated)---[1] 46
338PERTUSSIS TOXOID ADSORBED ON ALUMINIUM HYDROXIDE[4] Aluminium,
Aluminum hydroxide,
Bordetella pertussis toxoid antigen (formaldehyde, glutaraldehyde inactivated),
Hydroxide ion		[1] D02416 --[1] 46
339Pertussis vaccine[1] Pertussis vaccine[1] D06514 --[2] 13, 46
340PERTZYE----[1] 299
341Perxexiline----[1] 58
342PET----[1] 6
343PET with 11C-Flumazenil[1] Flumazenil[1] D00697 [16] GABRA1,
GABRA2,
GABRA3,
GABRA4,
GABRA5,
GABRA6,
GABRB1,
GABRB2,
GABRB3,
GABRD,
GABRE,
GABRG1,
GABRG2,
GABRG3,
GABRP,
GABRQ 💬		[7] GABAergic synapse, Morphine addiction, Neuroactive ligand-receptor interaction, Nicotine addiction, Retrograde endocannabinoid signaling, Serotonergic synapse, Taste transduction 💬[1] 13
344PET-MRI with [18F]-Florbetaben and PET-MRI with [18F]-DPA-714----[1] 13
345PET/CT----[1] 6
346PET/CT using PET ligands [F-18]FDG and [F-18]DPA-714----[1] 85
347PET10----[1] 41
348PET3----[1] 41
349Pethidine[1] Meperidine[2] D01383 ,
D08343 		[1] OPRM1 💬[3] Estrogen signaling pathway, Morphine addiction, Neuroactive ligand-receptor interaction 💬[1] 298
350Petrolatum[1] Petrolatum[1] D05331 --[3] 35, 158, 162
351Pexsig----[1] 58
352PF 06687234----[2] 96, 97
353PF-00489791[1] PF-00489791---[1] 86
354PF-00547659----[2] 96, 97
355PF-00547659 SC injection----[2] 96, 97
356PF-02545920----[1] 8
357PF-04171327----[1] 46
358PF-04171327 10 mg----[1] 46
359PF-04171327 25 mg----[1] 46
360PF-04236921----[2] 49, 96
361PF-04236921 SC injection----[1] 96
362PF-04383119----[1] 226
363PF-05208763----[1] 67
364PF-05230917----[1] 97
365PF-05280586----[1] 46
366PF-05285401----[1] 97
367PF-06252616[1] Domagrozumab[1] D11047 [1] MSTN 💬[1] Cytokine-cytokine receptor interaction 💬[1] 113
368PF-06291826-83/Fx-1006A[1] Fx-1006A---[1] 28
369PF-06342674 0.25 mg/kg----[1] 13
370PF-06342674 1.5 mg/kg----[1] 13
371PF-06342674 6.0 mg/kg----[1] 13
372PF-06410293----[1] 46
373PF-06412562----[1] 6
374PF-06438179----[1] 46
375PF-06462700----[1] 60
376PF-06480605----[1] 97
377PF-06480605 100 mg/ml----[1] 97
378PF-06649751[1] Tavapadon[1] D11431 [2] DRD1,
DRD5 💬		[10] Alcoholism, Amphetamine addiction, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Morphine addiction, Neuroactive ligand-receptor interaction, Parkinson disease, cAMP signaling pathway 💬[1] 6
379PF-06649751 - 15mg[1] Tavapadon[1] D11431 [2] DRD1,
DRD5 💬		[10] Alcoholism, Amphetamine addiction, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Morphine addiction, Neuroactive ligand-receptor interaction, Parkinson disease, cAMP signaling pathway 💬[1] 6
380PF-06649751 - 1mg[1] Tavapadon[1] D11431 [2] DRD1,
DRD5 💬		[10] Alcoholism, Amphetamine addiction, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Morphine addiction, Neuroactive ligand-receptor interaction, Parkinson disease, cAMP signaling pathway 💬[1] 6
381PF-06649751 - 5mg[1] Tavapadon[1] D11431 [2] DRD1,
DRD5 💬		[10] Alcoholism, Amphetamine addiction, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Morphine addiction, Neuroactive ligand-receptor interaction, Parkinson disease, cAMP signaling pathway 💬[1] 6
382PF-06649751 high dose (15 mg QD)[1] Tavapadon[1] D11431 [2] DRD1,
DRD5 💬		[10] Alcoholism, Amphetamine addiction, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Morphine addiction, Neuroactive ligand-receptor interaction, Parkinson disease, cAMP signaling pathway 💬[1] 6
383PF-06649751 low dose (1 mg QD)[1] Tavapadon[1] D11431 [2] DRD1,
DRD5 💬		[10] Alcoholism, Amphetamine addiction, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Morphine addiction, Neuroactive ligand-receptor interaction, Parkinson disease, cAMP signaling pathway 💬[1] 6
384PF-06649751 middle dose 1 (3 mg QD)[1] Tavapadon[1] D11431 [2] DRD1,
DRD5 💬		[10] Alcoholism, Amphetamine addiction, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Morphine addiction, Neuroactive ligand-receptor interaction, Parkinson disease, cAMP signaling pathway 💬[1] 6
385PF-06649751 middle dose 2 (7 mg QD)[1] Tavapadon[1] D11431 [2] DRD1,
DRD5 💬		[10] Alcoholism, Amphetamine addiction, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Morphine addiction, Neuroactive ligand-receptor interaction, Parkinson disease, cAMP signaling pathway 💬[1] 6
386PF-06650833[1] PF-06650833---[1] 46
387PF-06650833 100 mg[1] PF-06650833---[1] 46
388PF-06650833 20 mg[1] PF-06650833---[1] 46
389PF-06651600[1] PF-06651600---[3] 46, 96, 97
390PF-06651600 10 mg[1] PF-06651600---[1] 97
391PF-06651600 50 mg[1] PF-06651600---[2] 96, 97
392PF-06651600 50mg[1] PF-06651600---[1] 96
393PF-06651600-15[1] PF-06651600---[2] 96, 97
394PF-06669571----[1] 6
395PF-06687234----[1] 97
396PF-06700841[1] PF-06700841---[3] 49, 96, 97
397PF-06700841 15 mg[1] PF-06700841---[1] 49
398PF-06700841 25 mg[1] PF-06700841---[2] 96, 97
399PF-06700841 25mg[1] PF-06700841---[1] 49
400PF-06700841 30 mg[1] PF-06700841---[1] 49
401PF-06700841 45 mg[1] PF-06700841---[1] 49
402PF-06700841 5 mg[1] PF-06700841---[3] 49, 96, 97
403PF-06700841 5mg[1] PF-06700841---[1] 49
404PF-06700841-15[1] PF-06700841---[3] 49, 96, 97
405PF-06730512----[1] 222
406PF-06755347 intravenous healthy participant----[1] 63
407PF-06755347 subcutaneous healthy participant----[1] 63
408PF-06755347 subcutaneous ITP----[1] 63
409PF-06823859----[1] 50
410PF-06823859 high----[1] 50
411PF-06823859 low----[1] 50
412PF-06826647----[1] 97
413PF-06826647 100 mg QD----[1] 97
414PF-06826647 300 mg QD----[1] 97
415PF-06826647 600 mg QD----[1] 97
416PF-06835375----[3] 46, 49, 63
417PF-06836922----[1] 78
418PF-06939926----[1] 113
419PF-07256472----[1] 276
420PF-6826647 400 mg QD----[1] 97
421PFD----[3] 51, 117, 298
422Pfefferminzblätter 1ml/10ml----[1] 97
423PFP----[1] 299
424PFP and SF6 Human Lung Coil----[1] 299
425PFT----[3] 89, 113, 299
426PG----[1] 46
427PG-760564----[1] 46
428PG2----[1] 63
429PG203----[1] 6
430PGM169/GL67A----[1] 299
431PH-797804[1] PH-797804---[1] 46
432Ph. Eur.: (2S)-2-amino-3-(3,4-dihydroxyphenyl)propanoic acid[1] Propanoic acid[1] D02310 --[1] 6
433Ph. Eur.: (2S)-3-(3,4-dihydroxyphenyl)-2hydrazino-2methylprop acid----[1] 6
434PHA-022121----[1] 65
435PHA-794,428----[1] 78
436PHA-794428----[1] 78
437Phagocyte Oxidase Subunit Transduced CD34 Hematopoietic Stem Cells----[1] 65
438Pharmacodynamics----[1] 34
439Pharmacokinetics of certolizumab pegol[1] Certolizumab pegol[1] D03441 [1] TNF 💬[67] AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Alcoholic liver disease, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antifolate resistance, Antigen processing and presentation, Apoptosis, Asthma, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Dilated cardiomyopathy, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, Graft-versus-host disease, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Influenza A, Insulin resistance, Legionellosis, Leishmaniasis, Lipid and atherosclerosis, MAPK signaling pathway, Malaria, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Non-alcoholic fatty liver disease, Osteoclast differentiation, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway 💬[2] 46, 96
440Pharmacopuncture----[1] 70
441Phase 1: Conventiaonal DMARD----[1] 46
442Phase 1: Etanercept[1] Etanercept[1] D00742 [2] LTA,
TNF 💬		[67] AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Alcoholic liver disease, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antifolate resistance, Antigen processing and presentation, Apoptosis, Asthma, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Dilated cardiomyopathy, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, Graft-versus-host disease, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Influenza A, Insulin resistance, Legionellosis, Leishmaniasis, Lipid and atherosclerosis, MAPK signaling pathway, Malaria, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Non-alcoholic fatty liver disease, Osteoclast differentiation, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway 💬[1] 46
443Phase 1: Methotrexate[1] Methotrexate[2] D00142 ,
D02115 		[2] DHFR,
DHFR2 💬		[5] Antifolate resistance, Biosynthesis of cofactors, Folate biosynthesis, Metabolic pathways, One carbon pool by folate 💬[1] 46
444Phase 2: Optional ETN, SSZ, HCQ, MTX----[1] 46
445Phase A Tolvaptan[1] Tolvaptan[1] D01213 [1] AVPR2 💬[3] Neuroactive ligand-receptor interaction, Phospholipase D signaling pathway, Vasopressin-regulated water reabsorption 💬[1] 67
446Phase B Tolvaptan[1] Tolvaptan[1] D01213 [1] AVPR2 💬[3] Neuroactive ligand-receptor interaction, Phospholipase D signaling pathway, Vasopressin-regulated water reabsorption 💬[1] 67
447Phase1 : CDED/Modulen™IBD® + Maintenance therapy----[1] 96
448Phase2 and 3 :----[1] 96
449Phe----[2] 75, 240
450Pheburane[1] Phenylbutyric acid---[1] 21
451Phenlarmide Tablets----[1] 6
452Phenoptin----[2] 124, 240
453Phenothiazine[1] Phenothiazine[1] D02601 --[1] 127
454Phentermine[1] Phentermine[2] D05458 ,
D05459 		[5] MAOA,
MAOB,
SLC6A2,
SLC6A3,
SLC6A4 💬		[16] Alcoholism, Amphetamine addiction, Arginine and proline metabolism, Cocaine addiction, Dopaminergic synapse, Drug metabolism - cytochrome P450, Glycine, serine and threonine metabolism, Histidine metabolism, Metabolic pathways, Parkinson disease, Pathways of neurodegeneration - multiple diseases, Phenylalanine metabolism, Serotonergic synapse, Synaptic vesicle cycle, Tryptophan metabolism, Tyrosine metabolism 💬[1] 97
455Phentermine-Topiramate[2] Phentermine,
Topiramate		[3] D00537 ,
D05458 ,
D05459 		[41] CA2,
CA4,
CACNA1C,
CACNA1D,
CACNA1F,
CACNA1S,
GABRA1,
GABRA2,
GABRA3,
GABRA4,
GABRA5,
GABRA6,
GABRB1,
GABRB2,
GABRB3,
GABRD,
GABRE,
GABRG1,
GABRG2,
GABRG3,
GABRP,
GABRQ,
GRIA1,
GRIA2,
GRIA3,
GRIA4,
GRIK1,
GRIK2,
GRIK3,
GRIK4,
GRIK5,
MAOA,
MAOB,
SCN1A,
SCN2A,
SCN3A,
SCN5A,
SCN9A,
SLC6A2,
SLC6A3,
SLC6A4 💬		[63] Adrenergic signaling in cardiomyocytes, Alcoholism, Aldosterone synthesis and secretion, Alzheimer disease, Amphetamine addiction, Amyotrophic lateral sclerosis, Arginine and proline metabolism, Arrhythmogenic right ventricular cardiomyopathy, Bile secretion, Calcium signaling pathway, Carbohydrate digestion and absorption, Cardiac muscle contraction, Cellular senescence, Chemical carcinogenesis - receptor activation, Cholinergic synapse, Circadian entrainment, Cocaine addiction, Collecting duct acid secretion, Cortisol synthesis and secretion, Cushing syndrome, Dilated cardiomyopathy, Dopaminergic synapse, Drug metabolism - cytochrome P450, GABAergic synapse, Gastric acid secretion, Glutamatergic synapse, Glycine, serine and threonine metabolism, GnRH secretion, GnRH signaling pathway, Growth hormone synthesis, secretion and action, Histidine metabolism, Huntington disease, Hypertrophic cardiomyopathy, Insulin secretion, Long-term depression, Long-term potentiation, MAPK signaling pathway, Metabolic pathways, Morphine addiction, Neuroactive ligand-receptor interaction, Nicotine addiction, Nitrogen metabolism, Oxytocin signaling pathway, Pancreatic secretion, Parkinson disease, Pathways of neurodegeneration - multiple diseases, Phenylalanine metabolism, Prion disease, Proximal tubule bicarbonate reclamation, Renin secretion, Retrograde endocannabinoid signaling, Serotonergic synapse, Spinocerebellar ataxia, Synaptic vesicle cycle, Taste transduction, Tight junction, Transcriptional misregulation in cancer, Tryptophan metabolism, Type II diabetes mellitus, Tyrosine metabolism, Vascular smooth muscle contraction, cAMP signaling pathway, cGMP-PKG signaling pathway 💬[1] 97
456Phenylalanine[1] Phenylalanine[1] D00021 --[1] 240
457Phenylalanine restricted diet[1] Phenylalanine[1] D00021 --[1] 240
458Phenylalanine-free protein substitute in tablet form (XPhe minis)[1] Phenylalanine[1] D00021 --[1] 240
459Phenylalanine-free protein substitute tablets[1] Phenylalanine[1] D00021 --[1] 240
460PHENYLBUTYRATE[1] Phenylbutyric acid---[12] 2, 3, 6, 8, 15, 93, 94, 244, 251, 297, 299, 338
461Phenylbutyrate Oral Tablet[1] Phenylbutyric acid---[1] 15
462PHENYLCYCLOPROPYLAMINE DERIVATIVES AND DUAL LSD1/MAO-B (LYSINE-SPECIFIC DEMETHYLASE 1 AND MONOAMINE OXIDASE-B) INHIBITOR[1] Lysine[1] D02304 --[1] 13
463Phenylephrine[1] Phenylephrine[2] D00511 ,
D08365 		[3] ADRA1A,
ADRA1B,
ADRA1D 💬		[7] AMPK signaling pathway, Adrenergic signaling in cardiomyocytes, Calcium signaling pathway, Neuroactive ligand-receptor interaction, Salivary secretion, Vascular smooth muscle contraction, cGMP-PKG signaling pathway 💬[1] 22
464Phenylketonuria-type diet----[1] 240
465Phenytoin[1] Phenytoin[2] D00512 ,
D02103 		[5] SCN1A,
SCN2A,
SCN3A,
SCN5A,
SCN9A 💬		[3] Adrenergic signaling in cardiomyocytes, Dopaminergic synapse, Taste transduction 💬[1] 13
466PhEur.: (2S)-2-amino-3-(3,4-dihydroxyphenyl)propanoic acid[1] Propanoic acid[1] D02310 --[1] 6
467PhEur.: (2S)-3-(3,4-dihydroxyphenyl)-2hydrazino-2methylpropanoic acid----[1] 6
468Philips Intelivue MP70 monitor[1] Methamidophos---[1] 70
469Phlebotomy----[1] 254
470Phosphate[1] Phosphate ion---[33] 2, 3, 6, 11, 12, 13, 15, 28, 36, 46, 49, 51, 53, 60, 62, 65, 70, 78, 81, 83, 90, 96, 97, 164, 235, 238, 256, 276, 283, 284, 285, 286, 299
471Phosphate and betamethasone acetate, 2 mL.[3] Acetate,
Betamethasone,
Phosphate ion		[7] D00244 ,
D00972 ,
D01357 ,
D01402 ,
D01637 ,
D02032 ,
D02286 		[1] NR3C1 💬[1] Neuroactive ligand-receptor interaction 💬[1] 235
472Phosphate sandoz[1] Phosphate ion---[1] 78
473Phosphate tablets.[1] Phosphate ion---[1] 238
474Phosphate-buffered saline[1] Phosphate ion---[1] 49
475Phosphate.[1] Phosphate ion---[1] 238
476Phosphatidylcholine[1] Lecithin[1] D04682 --[1] 97
477Phosphodiesterase Inhibitors----[1] 51
478Phospholipids[1] Omega-3 fatty acids---[1] 79
479Phosphorodiamidate Morpholino Oligomer----[1] 113
480Phosphorodiamidate morpholino oligomer for exon 45 skipping----[1] 113
481Phosphorodiamidate morpholino oligomer for exon 53 skipping----[1] 113
482Phosphorous[1] Phosphorus---[1] 58
483Phosphorus[1] Phosphorus---[2] 8, 238
484Photodynamic therapy with Gliolan[1] Aminolevulinic acid[2] D02908 ,
D07567 		--[1] 97
485Phototherapy (Bright Light)----[1] 202
486PHP-303----[1] 231
487PHVS416----[1] 65
488Phylloquinone[1] Phylloquinone[1] D00148 --[1] 96
489Phylloquinone (vitamin K1)[1] Phylloquinone[1] D00148 --[1] 96
490Physical Exam----[1] 215
491Physical exam and UPDRS part III assessment----[1] 6
492Physician standard-of-care----[1] 96
493Physiologic serum nebulized nasally----[1] 299
494Physiological saline----[1] 51
495Physiological serum (Sodium chloride)[2] Chloride ion,
Sodium chloride		[1] D02056 --[1] 193
496Physiological solution----[1] 299
497PHYSIOLOGISCHE Kochsalzloesung Fresenius - Infusionsloesung----[1] 227
498Physiologische Kochsalzlösung Fresenius - Infusionslösung----[1] 288
499Physiotherapy, exercise, percutaneous gastrostomy feeds----[1] 299
500Phytomenadione[1] Phylloquinone[1] D00148 --[1] 288
501PI-0824[1] PI-0824---[1] 35
502PI-2301----[1] 13
503Picibanil----[1] 278
504Piclidenoson[1] Piclidenoson[1] D10971 [1] ADORA3 💬[3] Neuroactive ligand-receptor interaction, Sphingolipid signaling pathway, cGMP-PKG signaling pathway 💬[1] 46
505Piclozotan[1] Piclozotan---[1] 6
506Picosulfate[1] Picosulfuric acid---[2] 97, 291
507PID----[1] 65
508Pig whipworm eggs----[1] 46
509Pilocarpine[1] Pilocarpine[3] D00525 ,
D02200 ,
D05478 		[2] CHRM2,
CHRM3 💬		[13] Alzheimer disease, Calcium signaling pathway, Cholinergic synapse, Gastric acid secretion, Insulin secretion, Neuroactive ligand-receptor interaction, PI3K-Akt signaling pathway, Pancreatic secretion, Pathways of neurodegeneration - multiple diseases, Regulation of actin cytoskeleton, Salivary secretion, Taste transduction, cAMP signaling pathway 💬[3] 6, 53, 299
510Pilocarpine Hydrochloride[1] Pilocarpine[3] D00525 ,
D02200 ,
D05478 		[2] CHRM2,
CHRM3 💬		[13] Alzheimer disease, Calcium signaling pathway, Cholinergic synapse, Gastric acid secretion, Insulin secretion, Neuroactive ligand-receptor interaction, PI3K-Akt signaling pathway, Pancreatic secretion, Pathways of neurodegeneration - multiple diseases, Regulation of actin cytoskeleton, Salivary secretion, Taste transduction, cAMP signaling pathway 💬[1] 53
511Pilocarpine Iontophoresis[1] Pilocarpine[3] D00525 ,
D02200 ,
D05478 		[2] CHRM2,
CHRM3 💬		[13] Alzheimer disease, Calcium signaling pathway, Cholinergic synapse, Gastric acid secretion, Insulin secretion, Neuroactive ligand-receptor interaction, PI3K-Akt signaling pathway, Pancreatic secretion, Pathways of neurodegeneration - multiple diseases, Regulation of actin cytoskeleton, Salivary secretion, Taste transduction, cAMP signaling pathway 💬[1] 299
512Pilocarpine microneedle patch[1] Pilocarpine[3] D00525 ,
D02200 ,
D05478 		[2] CHRM2,
CHRM3 💬		[13] Alzheimer disease, Calcium signaling pathway, Cholinergic synapse, Gastric acid secretion, Insulin secretion, Neuroactive ligand-receptor interaction, PI3K-Akt signaling pathway, Pancreatic secretion, Pathways of neurodegeneration - multiple diseases, Regulation of actin cytoskeleton, Salivary secretion, Taste transduction, cAMP signaling pathway 💬[1] 299
513Pilocarpine Nitrate 5%[2] Nitrate,
Pilocarpine		[4] D00525 ,
D02200 ,
D02313 ,
D05478 		[2] CHRM2,
CHRM3 💬		[13] Alzheimer disease, Calcium signaling pathway, Cholinergic synapse, Gastric acid secretion, Insulin secretion, Neuroactive ligand-receptor interaction, PI3K-Akt signaling pathway, Pancreatic secretion, Pathways of neurodegeneration - multiple diseases, Regulation of actin cytoskeleton, Salivary secretion, Taste transduction, cAMP signaling pathway 💬[1] 299
514Pimavanserin[1] Pimavanserin---[1] 6
515Pimavanserin (ACP-103)[1] Pimavanserin---[1] 6
516Pimavanserin tartrate[1] Pimavanserin---[1] 6
517Pimavanserin tartrate (ACP-103)[1] Pimavanserin---[1] 6
518Pimecrolimus[1] Pimecrolimus[1] D05480 [5] PPP3CA,
PPP3CB,
PPP3CC,
PPP3R1,
PPP3R2 💬		[33] Alzheimer disease, Amphetamine addiction, Amyotrophic lateral sclerosis, Axon guidance, B cell receptor signaling pathway, C-type lectin receptor signaling pathway, Calcium signaling pathway, Cellular senescence, Dopaminergic synapse, Glucagon signaling pathway, Glutamatergic synapse, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Kaposi sarcoma-associated herpesvirus infection, Lipid and atherosclerosis, Long-term potentiation, MAPK signaling pathway, Natural killer cell mediated cytotoxicity, Oocyte meiosis, Osteoclast differentiation, Oxytocin signaling pathway, PD-L1 expression and PD-1 checkpoint pathway in cancer, Pathways of neurodegeneration - multiple diseases, Prion disease, Renin secretion, T cell receptor signaling pathway, Th1 and Th2 cell differentiation, Th17 cell differentiation, Tuberculosis, VEGF signaling pathway, Wnt signaling pathway, cGMP-PKG signaling pathway 💬[1] 160
519Pimecrolimus 1% Cream[1] Pimecrolimus[1] D05480 [5] PPP3CA,
PPP3CB,
PPP3CC,
PPP3R1,
PPP3R2 💬		[33] Alzheimer disease, Amphetamine addiction, Amyotrophic lateral sclerosis, Axon guidance, B cell receptor signaling pathway, C-type lectin receptor signaling pathway, Calcium signaling pathway, Cellular senescence, Dopaminergic synapse, Glucagon signaling pathway, Glutamatergic synapse, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Kaposi sarcoma-associated herpesvirus infection, Lipid and atherosclerosis, Long-term potentiation, MAPK signaling pathway, Natural killer cell mediated cytotoxicity, Oocyte meiosis, Osteoclast differentiation, Oxytocin signaling pathway, PD-L1 expression and PD-1 checkpoint pathway in cancer, Pathways of neurodegeneration - multiple diseases, Prion disease, Renin secretion, T cell receptor signaling pathway, Th1 and Th2 cell differentiation, Th17 cell differentiation, Tuberculosis, VEGF signaling pathway, Wnt signaling pathway, cGMP-PKG signaling pathway 💬[1] 160
520Pimozide[1] Pimozide[1] D00560 [2] ADRA2A,
DRD2 💬		[9] Alcoholism, Cocaine addiction, Dopaminergic synapse, Gap junction, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway, cGMP-PKG signaling pathway 💬[1] 2
521Pimozide 2 mg per day[1] Pimozide[1] D00560 [2] ADRA2A,
DRD2 💬		[9] Alcoholism, Cocaine addiction, Dopaminergic synapse, Gap junction, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway, cGMP-PKG signaling pathway 💬[1] 2
522Pimozide 2mg/day (current) or 4 mg/day (study initiation)[1] Pimozide[1] D00560 [2] ADRA2A,
DRD2 💬		[9] Alcoholism, Cocaine addiction, Dopaminergic synapse, Gap junction, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway, cGMP-PKG signaling pathway 💬[1] 2
523Pimozide 4 mg per day[1] Pimozide[1] D00560 [2] ADRA2A,
DRD2 💬		[9] Alcoholism, Cocaine addiction, Dopaminergic synapse, Gap junction, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway, cGMP-PKG signaling pathway 💬[1] 2
524Pioglitazone[1] Pioglitazone[2] D00945 ,
D08378 		[1] PPARG 💬[11] AMPK signaling pathway, Huntington disease, Lipid and atherosclerosis, Longevity regulating pathway, Non-alcoholic fatty liver disease, Osteoclast differentiation, PPAR signaling pathway, Pathways in cancer, Thermogenesis, Thyroid cancer, Transcriptional misregulation in cancer 💬[17] 2, 6, 13, 15, 20, 46, 49, 65, 67, 78, 81, 86, 96, 229, 265, 298, 299
525Pioglitazone 15 mg[1] Pioglitazone[2] D00945 ,
D08378 		[1] PPARG 💬[11] AMPK signaling pathway, Huntington disease, Lipid and atherosclerosis, Longevity regulating pathway, Non-alcoholic fatty liver disease, Osteoclast differentiation, PPAR signaling pathway, Pathways in cancer, Thermogenesis, Thyroid cancer, Transcriptional misregulation in cancer 💬[1] 96
526Pioglitazone and Tretinoin[2] Pioglitazone,
Tretinoin		[3] D00094 ,
D00945 ,
D08378 		[4] PML,
PPARG,
RARA,
RARB 💬		[21] AMPK signaling pathway, Acute myeloid leukemia, Endocytosis, Estrogen signaling pathway, Gastric cancer, Herpes simplex virus 1 infection, Huntington disease, Influenza A, Lipid and atherosclerosis, Longevity regulating pathway, Non-alcoholic fatty liver disease, Non-small cell lung cancer, Osteoclast differentiation, PPAR signaling pathway, Pathways in cancer, Small cell lung cancer, Th17 cell differentiation, Thermogenesis, Thyroid cancer, Transcriptional misregulation in cancer, Ubiquitin mediated proteolysis 💬[1] 2
527Pioglitazone or metformin[2] Metformin,
Pioglitazone		[4] D00944 ,
D00945 ,
D04966 ,
D08378 		[3] PPARG,
PRKAA1,
PRKAA2 💬		[27] AMPK signaling pathway, Adipocytokine signaling pathway, Alcoholic liver disease, Apelin signaling pathway, Autophagy - animal, Circadian rhythm, Fluid shear stress and atherosclerosis, FoxO signaling pathway, Glucagon signaling pathway, Huntington disease, Hypertrophic cardiomyopathy, Insulin resistance, Insulin signaling pathway, Lipid and atherosclerosis, Longevity regulating pathway, Longevity regulating pathway - multiple species, Non-alcoholic fatty liver disease, Osteoclast differentiation, Oxytocin signaling pathway, PI3K-Akt signaling pathway, PPAR signaling pathway, Pathways in cancer, Thermogenesis, Thyroid cancer, Tight junction, Transcriptional misregulation in cancer, mTOR signaling pathway 💬[1] 265
528PIPE-307----[1] 13
529PIPERACILLIN[1] Piperacillin[3] D00466 ,
D02251 ,
D08380 		--[1] 299
530PIPERACILLIN SODIUM[1] Piperacillin[3] D00466 ,
D02251 ,
D08380 		--[1] 299
531Piperacillin sodium , tazobactam sodium[2] Piperacillin,
Tazobactam		[4] D00466 ,
D00660 ,
D02251 ,
D08380 		--[1] 299
532Piperacillin with Tazobactam (tazocin)[1] Piperacillin[3] D00466 ,
D02251 ,
D08380 		--[1] 299
533Piperacillin-tazobactam combination product[2] Piperacillin,
Tazobactam		[4] D00466 ,
D00660 ,
D02251 ,
D08380 		--[1] 299
534Piperacillin/Tazobactam[2] Piperacillin,
Tazobactam		[4] D00466 ,
D00660 ,
D02251 ,
D08380 		--[1] 299
535Piperacillin/Tazobactam Kabi - Fresenius Kabi Austria[2] Piperacillin,
Tazobactam		[4] D00466 ,
D00660 ,
D02251 ,
D08380 		--[1] 299
536Piperacilline/Tazobactam Fresenius Kabi 2 g/0,25 g poeder voor oplossing voor infusie[1] Tazobactam[1] D00660 --[1] 299
537Piperacilline/Tazobactam Fresenius Kabi 4 g/0,5 g poeder voor oplossing voor infusie[1] Tazobactam[1] D00660 --[1] 299
538Piperazine[1] Piperazine[6] D00807 ,
D01393 ,
D02127 ,
D02145 ,
D05486 ,
D06224 		--[2] 58, 272
539PIR, S-7701----[1] 85
540Pirepemat----[1] 6
541Pirfenidone[1] Pirfenidone[1] D01583 [6] CCL2,
IL10,
IL1A,
IL1B,
IL6,
TNF 💬		[84] AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Alcoholic liver disease, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antifolate resistance, Antigen processing and presentation, Apoptosis, Asthma, Autoimmune thyroid disease, C-type lectin receptor signaling pathway, Cellular senescence, Chagas disease, Chemokine signaling pathway, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Cytosolic DNA-sensing pathway, Dilated cardiomyopathy, EGFR tyrosine kinase inhibitor resistance, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, FoxO signaling pathway, Graft-versus-host disease, HIF-1 signaling pathway, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Inflammatory mediator regulation of TRP channels, Influenza A, Insulin resistance, Intestinal immune network for IgA production, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Legionellosis, Leishmaniasis, Lipid and atherosclerosis, MAPK signaling pathway, Malaria, Measles, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Non-alcoholic fatty liver disease, Osteoclast differentiation, PI3K-Akt signaling pathway, Pathogenic Escherichia coli infection, Pathways in cancer, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Staphylococcus aureus infection, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Th17 cell differentiation, Toll-like receptor signaling pathway, Toxoplasmosis, Transcriptional misregulation in cancer, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway 💬[11] 13, 34, 46, 50, 51, 58, 84, 85, 164, 222, 228
542Pirfenidone (PFD)[1] Pirfenidone[1] D01583 [6] CCL2,
IL10,
IL1A,
IL1B,
IL6,
TNF 💬		[84] AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Alcoholic liver disease, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antifolate resistance, Antigen processing and presentation, Apoptosis, Asthma, Autoimmune thyroid disease, C-type lectin receptor signaling pathway, Cellular senescence, Chagas disease, Chemokine signaling pathway, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Cytosolic DNA-sensing pathway, Dilated cardiomyopathy, EGFR tyrosine kinase inhibitor resistance, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, FoxO signaling pathway, Graft-versus-host disease, HIF-1 signaling pathway, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Inflammatory mediator regulation of TRP channels, Influenza A, Insulin resistance, Intestinal immune network for IgA production, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Legionellosis, Leishmaniasis, Lipid and atherosclerosis, MAPK signaling pathway, Malaria, Measles, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Non-alcoholic fatty liver disease, Osteoclast differentiation, PI3K-Akt signaling pathway, Pathogenic Escherichia coli infection, Pathways in cancer, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Staphylococcus aureus infection, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Th17 cell differentiation, Toll-like receptor signaling pathway, Toxoplasmosis, Transcriptional misregulation in cancer, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway 💬[1] 51
543Pirfenidone 267 MG [Esbriet][1] Pirfenidone[1] D01583 [6] CCL2,
IL10,
IL1A,
IL1B,
IL6,
TNF 💬		[84] AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Alcoholic liver disease, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antifolate resistance, Antigen processing and presentation, Apoptosis, Asthma, Autoimmune thyroid disease, C-type lectin receptor signaling pathway, Cellular senescence, Chagas disease, Chemokine signaling pathway, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Cytosolic DNA-sensing pathway, Dilated cardiomyopathy, EGFR tyrosine kinase inhibitor resistance, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, FoxO signaling pathway, Graft-versus-host disease, HIF-1 signaling pathway, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Inflammatory mediator regulation of TRP channels, Influenza A, Insulin resistance, Intestinal immune network for IgA production, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Legionellosis, Leishmaniasis, Lipid and atherosclerosis, MAPK signaling pathway, Malaria, Measles, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Non-alcoholic fatty liver disease, Osteoclast differentiation, PI3K-Akt signaling pathway, Pathogenic Escherichia coli infection, Pathways in cancer, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Staphylococcus aureus infection, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Th17 cell differentiation, Toll-like receptor signaling pathway, Toxoplasmosis, Transcriptional misregulation in cancer, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway 💬[1] 228
544Pirfenidone and nintedanib[2] Nintedanib,
Pirfenidone		[2] D01583 ,
D10481 		[14] CCL2,
FGFR1,
FGFR2,
FGFR3,
FLT1,
FLT4,
IL10,
IL1A,
IL1B,
IL6,
KDR,
PDGFRA,
PDGFRB,
TNF 💬		[106] AGE-RAGE signaling pathway in diabetic complications, Adherens junction, Adipocytokine signaling pathway, African trypanosomiasis, Alcoholic liver disease, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antifolate resistance, Antigen processing and presentation, Apoptosis, Asthma, Autoimmune thyroid disease, Bladder cancer, Breast cancer, C-type lectin receptor signaling pathway, Calcium signaling pathway, Cellular senescence, Central carbon metabolism in cancer, Chagas disease, Chemokine signaling pathway, Choline metabolism in cancer, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Cytosolic DNA-sensing pathway, Dilated cardiomyopathy, EGFR tyrosine kinase inhibitor resistance, Endocytosis, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, Focal adhesion, FoxO signaling pathway, Gap junction, Gastric cancer, Glioma, Graft-versus-host disease, HIF-1 signaling pathway, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Inflammatory mediator regulation of TRP channels, Influenza A, Insulin resistance, Intestinal immune network for IgA production, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Legionellosis, Leishmaniasis, Lipid and atherosclerosis, MAPK signaling pathway, Malaria, Measles, Melanoma, MicroRNAs in cancer, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Non-alcoholic fatty liver disease, Osteoclast differentiation, PI3K-Akt signaling pathway, Parathyroid hormone synthesis, secretion and action, Pathogenic Escherichia coli infection, Pathways in cancer, Pathways of neurodegeneration - multiple diseases, Pertussis, Phospholipase D signaling pathway, Prion disease, Prostate cancer, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rap1 signaling pathway, Ras signaling pathway, Regulation of actin cytoskeleton, Rheumatoid arthritis, Salmonella infection, Shigellosis, Signaling pathways regulating pluripotency of stem cells, Sphingolipid signaling pathway, Staphylococcus aureus infection, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Th17 cell differentiation, Thermogenesis, Toll-like receptor signaling pathway, Toxoplasmosis, Transcriptional misregulation in cancer, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, VEGF signaling pathway, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway 💬[1] 85
545Pirfenidone or nintedanib[2] Nintedanib,
Pirfenidone		[2] D01583 ,
D10481 		[14] CCL2,
FGFR1,
FGFR2,
FGFR3,
FLT1,
FLT4,
IL10,
IL1A,
IL1B,
IL6,
KDR,
PDGFRA,
PDGFRB,
TNF 💬		[106] AGE-RAGE signaling pathway in diabetic complications, Adherens junction, Adipocytokine signaling pathway, African trypanosomiasis, Alcoholic liver disease, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antifolate resistance, Antigen processing and presentation, Apoptosis, Asthma, Autoimmune thyroid disease, Bladder cancer, Breast cancer, C-type lectin receptor signaling pathway, Calcium signaling pathway, Cellular senescence, Central carbon metabolism in cancer, Chagas disease, Chemokine signaling pathway, Choline metabolism in cancer, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Cytosolic DNA-sensing pathway, Dilated cardiomyopathy, EGFR tyrosine kinase inhibitor resistance, Endocytosis, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, Focal adhesion, FoxO signaling pathway, Gap junction, Gastric cancer, Glioma, Graft-versus-host disease, HIF-1 signaling pathway, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Inflammatory mediator regulation of TRP channels, Influenza A, Insulin resistance, Intestinal immune network for IgA production, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Legionellosis, Leishmaniasis, Lipid and atherosclerosis, MAPK signaling pathway, Malaria, Measles, Melanoma, MicroRNAs in cancer, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Non-alcoholic fatty liver disease, Osteoclast differentiation, PI3K-Akt signaling pathway, Parathyroid hormone synthesis, secretion and action, Pathogenic Escherichia coli infection, Pathways in cancer, Pathways of neurodegeneration - multiple diseases, Pertussis, Phospholipase D signaling pathway, Prion disease, Prostate cancer, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rap1 signaling pathway, Ras signaling pathway, Regulation of actin cytoskeleton, Rheumatoid arthritis, Salmonella infection, Shigellosis, Signaling pathways regulating pluripotency of stem cells, Sphingolipid signaling pathway, Staphylococcus aureus infection, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Th17 cell differentiation, Thermogenesis, Toll-like receptor signaling pathway, Toxoplasmosis, Transcriptional misregulation in cancer, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, VEGF signaling pathway, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway 💬[1] 85
546Pirfenidone Solution for Inhalation[1] Pirfenidone[1] D01583 [6] CCL2,
IL10,
IL1A,
IL1B,
IL6,
TNF 💬		[84] AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Alcoholic liver disease, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antifolate resistance, Antigen processing and presentation, Apoptosis, Asthma, Autoimmune thyroid disease, C-type lectin receptor signaling pathway, Cellular senescence, Chagas disease, Chemokine signaling pathway, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Cytosolic DNA-sensing pathway, Dilated cardiomyopathy, EGFR tyrosine kinase inhibitor resistance, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, FoxO signaling pathway, Graft-versus-host disease, HIF-1 signaling pathway, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Inflammatory mediator regulation of TRP channels, Influenza A, Insulin resistance, Intestinal immune network for IgA production, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Legionellosis, Leishmaniasis, Lipid and atherosclerosis, MAPK signaling pathway, Malaria, Measles, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Non-alcoholic fatty liver disease, Osteoclast differentiation, PI3K-Akt signaling pathway, Pathogenic Escherichia coli infection, Pathways in cancer, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Staphylococcus aureus infection, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Th17 cell differentiation, Toll-like receptor signaling pathway, Toxoplasmosis, Transcriptional misregulation in cancer, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway 💬[1] 85
547Pirfenidoneone----[1] 85
548Piribedil[1] Piribedil[1] D07305 [2] DRD2,
DRD3 💬		[8] Alcoholism, Cocaine addiction, Dopaminergic synapse, Gap junction, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway 💬[1] 6
549Piribedil (Clarium)[1] Piribedil[1] D07305 [2] DRD2,
DRD3 💬		[8] Alcoholism, Cocaine addiction, Dopaminergic synapse, Gap junction, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway 💬[1] 6
550Pitavastatin[1] Pitavastatin---[1] 49
551Pitolisant[1] Pitolisant[1] D10749 [1] HRH3 💬[1] Neuroactive ligand-receptor interaction 💬[3] 6, 113, 193
552Pitolisant Oral Tablet[1] Pitolisant[1] D10749 [1] HRH3 💬[1] Neuroactive ligand-receptor interaction 💬[1] 113
553Pitolisant oral tablets[1] Pitolisant[1] D10749 [1] HRH3 💬[1] Neuroactive ligand-receptor interaction 💬[1] 193
554Pittsburgh Compound B[1] Pittsburgh Compound B---[2] 6, 127
555Pittsburgh Compound B (C-11 PiB)[1] Pittsburgh Compound B---[1] 127
556PIXANTRONE[1] Pixantrone[1] D05522 [2] TOP2A,
TOP2B 💬		[1] Platinum drug resistance 💬[2] 11, 13
557PK-Merz----[1] 6
558PK-Merz® 200mg/500ml inj(Amantadine) , Normal saline 500ml inj[1] Amantadine[2] D00777 ,
D07441 		[5] GRIN1,
GRIN2A,
GRIN2B,
GRIN2C,
GRIN2D 💬		[20] Alcoholism, Alzheimer disease, Amphetamine addiction, Amyotrophic lateral sclerosis, Calcium signaling pathway, Circadian entrainment, Cocaine addiction, Dopaminergic synapse, Glutamatergic synapse, Huntington disease, Long-term potentiation, Neuroactive ligand-receptor interaction, Nicotine addiction, Pathways of neurodegeneration - multiple diseases, Prion disease, Rap1 signaling pathway, Ras signaling pathway, Spinocerebellar ataxia, Systemic lupus erythematosus, cAMP signaling pathway 💬[1] 6
559PKU Explore----[1] 240
560PKU express plus----[1] 240
561PKU Sphere----[1] 240
562PKU sphere liquid----[1] 240
563PKU Start----[1] 240
564PKU/TYR GMP Protein Substitute----[1] 240
565PL 00095/5079R----[1] 46
566PL 0010/0211----[1] 299
567PL 00512/0150----[1] 298
568PL 04515/0127----[1] 13
569PL 12185/0002 & PL 12185/0005(WATER FOR INJECTION)[1] Water[1] D00001 --[1] 57
570PL 12762/0049----[1] 13
571PL 17901/0122----[1] 96
572PL 20532/0012----[1] 96
573PL101----[1] 8
574PLA + MTX switched to ABA+ MTX, DB----[1] 46
575PLA-695----[1] 46
576PLA-PRU-PLA-PRU----[1] 99
577PLA-PRU-PRU-PLA----[1] 99
578Placebo----[27] 3, 5, 6, 13, 14, 37, 40, 46, 49, 50, 51, 53, 63, 66, 67, 79, 85, 86, 88, 96, 97, 140, 144, 149, 226, 271, 276
579Placebo (physiological saline)----[2] 43, 45
580Placebo IV----[1] 50
581Placebo SC----[1] 50
582Placental Mesenchymal Stem Cells[1] Placental Mesenchymal Stem Cells---[1] 118
583Placental Mesenchymal Stem Cells seeded on a commercially available dural graft extracellular matrix[1] Placental Mesenchymal Stem Cells---[1] 118
584PLACENTEX ® Polydeoxyribonucleotide----[1] 51
585PLACENTEX ¿ Polydeoxyribonucleotide 5.625 mg/3 ml----[1] 51
586PLACENTEX ¿5.625 mg/3 ml soluzione iniettabile¿----[1] 51
587Plaebo----[1] 46
588Planar Image with both Hands in Field of View----[1] 46
589Plant cell expressed recombinant glucocerebrosidase (prGCD)[1] Taliglucerase alfa[1] D09675 [1] GBA 💬[4] Lysosome, Metabolic pathways, Other glycan degradation, Sphingolipid metabolism 💬[1] 19
590Plant Cell Recombinant Glucocerebrosidase----[1] 19
591Plantago ovata husk----[1] 6
592Plantain NSP----[1] 96
593Plaquenil----[4] 46, 49, 53, 96
594Plaquenil - Hydroxychloroquine 200mg Film coated tablets[1] Hydroxychloroquine[1] D08050 --[3] 43, 44, 45
595Plaquenil 200 mg filmdrasjerte tabletter----[1] 46
596PLAQUENIL*25CPR RIV 200MG[1] Hydroxychloroquine[1] D08050 --[1] 84
597Plasma analysis for bacterial translocation----[1] 46
598Plasma exchange----[5] 13, 43, 44, 64, 222
599Plasma exchange (PE)----[3] 64, 66, 220
600Plasma from healthy young people treatment + Riluzole[1] Riluzole[1] D00775 [14] GRIA1,
GRIA2,
GRIA3,
GRIA4,
GRIK1,
GRIK2,
GRIK3,
GRIK4,
GRIK5,
GRIN1,
GRIN2A,
GRIN2B,
GRIN2C,
GRIN2D 💬		[23] Alcoholism, Alzheimer disease, Amphetamine addiction, Amyotrophic lateral sclerosis, Calcium signaling pathway, Circadian entrainment, Cocaine addiction, Dopaminergic synapse, Glutamatergic synapse, Huntington disease, Long-term depression, Long-term potentiation, Neuroactive ligand-receptor interaction, Nicotine addiction, Pathways of neurodegeneration - multiple diseases, Prion disease, Rap1 signaling pathway, Ras signaling pathway, Retrograde endocannabinoid signaling, Spinocerebellar ataxia, Systemic lupus erythematosus, Transcriptional misregulation in cancer, cAMP signaling pathway 💬[1] 2
601Plasma Lyso-GB3----[1] 19
602Plasma rico en plaquetas y coagulo de fibrina procesados mediante la tecnología PRGF-System (BTI)----[1] 96
603Plasma-derived FVIII/VWF concentrate----[1] 288
604Plasmapheresis----[3] 11, 49, 222
605PLASMASAFE----[1] 274
606PLASMASAFE - SOLUZIONE PER INFUSIONE 1 SACCA DA 200 ML----[1] 274
607Platelet enriched plasma----[1] 226
608Platelet Gel----[1] 51
609Platelet Rich Plasma----[2] 46, 90
610Platelet transfusion----[1] 13
611Platelet-Rich Plasma----[1] 226
612Platform----[1] 13
613Plecebo----[1] 256
614PLECONARIL[1] Pleconaril[1] D05528 --[1] 2
615PLEDIGRY----[1] 13
616Plegridy[1] Peginterferon beta-1a[1] D10483 [2] IFNAR1,
IFNAR2 💬		[18] Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Epstein-Barr virus infection, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human papillomavirus infection, Influenza A, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Measles, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Osteoclast differentiation, PI3K-Akt signaling pathway, Pathways in cancer, Toll-like receptor signaling pathway 💬[1] 13
617Plegridy (peginterferon beta-1a), Biogen Idec Ltd[1] Peginterferon beta-1a[1] D10483 [2] IFNAR1,
IFNAR2 💬		[18] Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Epstein-Barr virus infection, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human papillomavirus infection, Influenza A, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Measles, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Osteoclast differentiation, PI3K-Akt signaling pathway, Pathways in cancer, Toll-like receptor signaling pathway 💬[1] 13
618PLEGRIDY - 125 MCG - SOLUZIONE INIETTABILE - USO SOTTOCUTANEO - PENNA PRERIEMPITA - 0,5 ML - 6 PENNE PRERIEMPITE[1] Peginterferon beta-1a[1] D10483 [2] IFNAR1,
IFNAR2 💬		[18] Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Epstein-Barr virus infection, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human papillomavirus infection, Influenza A, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Measles, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Osteoclast differentiation, PI3K-Akt signaling pathway, Pathways in cancer, Toll-like receptor signaling pathway 💬[1] 13
619Plegridy 125 micrograms[1] Peginterferon beta-1a[1] D10483 [2] IFNAR1,
IFNAR2 💬		[18] Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Epstein-Barr virus infection, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human papillomavirus infection, Influenza A, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Measles, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Osteoclast differentiation, PI3K-Akt signaling pathway, Pathways in cancer, Toll-like receptor signaling pathway 💬[1] 13
620Plegridy 63 micrograms[1] Peginterferon beta-1a[1] D10483 [2] IFNAR1,
IFNAR2 💬		[18] Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Epstein-Barr virus infection, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human papillomavirus infection, Influenza A, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Measles, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Osteoclast differentiation, PI3K-Akt signaling pathway, Pathways in cancer, Toll-like receptor signaling pathway 💬[1] 13
621Plenadren 20 mg modified-release tablets[2] Hydrocortisone,
Manganese citrate		[1] D00088 [1] NR3C1 💬[1] Neuroactive ligand-receptor interaction 💬[1] 78
622Plenadren 5 mg modified-release tablets[2] Hydrocortisone,
Manganese citrate		[1] D00088 [1] NR3C1 💬[1] Neuroactive ligand-receptor interaction 💬[1] 78
623Pleneva TM BGC20-0134----[1] 13
624PLENUR----[1] 2
625PLERIXAFOR[1] Plerixafor[1] D08971 [1] CXCR4 💬[12] Axon guidance, Calcium signaling pathway, Chemokine signaling pathway, Cytokine-cytokine receptor interaction, Endocytosis, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Intestinal immune network for IgA production, Leukocyte transendothelial migration, Pathways in cancer, Regulation of actin cytoskeleton, Viral protein interaction with cytokine and cytokine receptor 💬[5] 20, 51, 65, 285, 299
626Plerixafor for Conditioning before HSCT.[1] Plerixafor[1] D08971 [1] CXCR4 💬[12] Axon guidance, Calcium signaling pathway, Chemokine signaling pathway, Cytokine-cytokine receptor interaction, Endocytosis, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Intestinal immune network for IgA production, Leukocyte transendothelial migration, Pathways in cancer, Regulation of actin cytoskeleton, Viral protein interaction with cytokine and cytokine receptor 💬[1] 65
627Plerixafor mobilization of autologous CD117 stem cells[1] Plerixafor[1] D08971 [1] CXCR4 💬[12] Axon guidance, Calcium signaling pathway, Chemokine signaling pathway, Cytokine-cytokine receptor interaction, Endocytosis, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Intestinal immune network for IgA production, Leukocyte transendothelial migration, Pathways in cancer, Regulation of actin cytoskeleton, Viral protein interaction with cytokine and cytokine receptor 💬[1] 299
628PLETAL[1] Cilostazol[1] D01896 [3] PDE3A,
PDE3B,
TBXA2R 💬		[14] Apelin signaling pathway, Calcium signaling pathway, Glucagon signaling pathway, Insulin signaling pathway, Metabolic pathways, Morphine addiction, Neuroactive ligand-receptor interaction, Platelet activation, Progesterone-mediated oocyte maturation, Purine metabolism, Regulation of lipolysis in adipocytes, Renin secretion, cAMP signaling pathway, cGMP-PKG signaling pathway 💬[1] 51
629Pleth Variability Index (PVI)----[1] 70
630PLEX----[1] 11
631PLF with autograft----[1] 70
632PLF with NeoFuse----[1] 70
633PLN-74809----[2] 85, 94
634PLN-74809-000----[1] 85
635PLN-74809-020----[1] 85
636Plovamer acetate[1] Acetate---[1] 13
637Plovamer acetate 0.5 milligram (mg)[1] Acetate---[1] 13
638Plovamer acetate 10 mg[1] Acetate---[1] 13
639Plovamer acetate 20 mg[1] Acetate---[1] 13
640Plovamer acetate 3 mg[1] Acetate---[1] 13
641PLP----[1] 13
642PLP peptide----[1] 13
643PLX-200----[1] 19
644PLX-PAD[1] Placental Mesenchymal Stem Cells---[1] 86
645PLX3397----[1] 46
646PLX5622----[1] 46
647Plérixafor----[1] 285
648PMA-zeolite----[1] 96
649PMG1015 Dose 1----[1] 85
650PMG1015 Dose 2----[1] 85
651PMG1015 Dose 3----[1] 85
652PMG1015 Dose 4----[1] 85
653PMG1015 Dose 5----[1] 85
654PMG1015 Dose 6----[1] 85
655PN 200 tablets (500 mg naproxen and 20 mg omeprazole)[2] Naproxen,
Omeprazole		[5] D00118 ,
D00455 ,
D01207 ,
D05259 ,
D05261 		[4] ATP4A,
ATP4B,
PTGS1,
PTGS2 💬		[26] Alzheimer disease, Arachidonic acid metabolism, C-type lectin receptor signaling pathway, Chemical carcinogenesis - DNA adducts, Collecting duct acid secretion, Gastric acid secretion, Human cytomegalovirus infection, Human papillomavirus infection, IL-17 signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Leishmaniasis, Metabolic pathways, MicroRNAs in cancer, NF-kappa B signaling pathway, Ovarian steroidogenesis, Oxidative phosphorylation, Oxytocin signaling pathway, Pathways in cancer, Pathways of neurodegeneration - multiple diseases, Platelet activation, Regulation of lipolysis in adipocytes, Retrograde endocannabinoid signaling, Serotonergic synapse, Small cell lung cancer, TNF signaling pathway, VEGF signaling pathway 💬[2] 46, 271
656PN-101----[1] 50
657PN-10884A----[1] 97
658PN-180307----[1] 78
659PN-943----[1] 97
660PnCJ PPS----[1] 65
661Pnemovax----[1] 96
662PNEUMO 23----[1] 65
663Pneumo23----[1] 107
664Pneumo23 / Pneumovax----[1] 46
665Pneumococcal conjugate vaccine----[1] 46
666PNEUMOCOCCAL POLYSACCHARIDE CONJUGATE VACCINE (13-VALENT, ADSORBED)----[2] 13, 14
667PNEUMOCOCCAL POLYSACCHARIDE CONJUGATE VACCINE (13-VALENT, ADSORBED) CONJUGATED TO CRM197 CARRIER PROTEIN AND ADSORBED ON ALUMINIUM PHOSPHATE[4] Aluminium,
Aluminium phosphate,
Corynebacterium diphtheriae CRM197 protein,
Phosphate ion		---[1] 46
668Pneumococcal polysaccharide serotype 1, 2, 3, 4, 5, 6B, 7F, 8, 9N, 9V, 10A, 11A, 12F, 14, 15B, 17F, 18C, 19A, 19F, 20, 22F, 23F and 33F----[1] 46
669Pneumococcal polysaccharide serotype 1, 3, 4, 5, 6A, 6B, 7F, 9V, 14, 18C, 19A, 19F and 23F----[1] 46
670Pneumococcal polysaccharide serotype 1, 3, 4, 5, 6A, 6B, 7F, 9V, 14, 18C, 19A, 19F, 23F----[1] 222
671Pneumococcal polysaccharide serotype 11 2.2 µg----[1] 222
672Pneumococcal polysaccharide vaccine----[3] 13, 46, 222
673PNEUMOCOCCAL POLYSACCHARIDE VACCINE (23 VALENT)----[1] 46
674Pneumococcal polysaccharide vaccine 23 valent----[1] 265
675Pneumococcal polysaccharide vaccine solution for injection in a vial----[1] 222
676Pneumococcal serotypes----[1] 46
677Pneumovax----[3] 46, 49, 96
678Pneumovax 23[1] Streptococcus pneumoniae type 1 capsular polysaccharide antigen---[2] 46, 50
679Pneumovax II----[1] 13
680PNEUMOVAX – Soluzione iniettabile in siringa preriempita da 0,5 ml----[2] 62, 66
681Pneumovax® (pneumococcal polysaccharide vaccine)----[1] 65
682PNEUMOVAX® 23----[1] 46
683PNU-215062 sodium salt----[1] 13
684PO----[1] 13
685PO azithromycin[1] Azithromycin[3] D02134 ,
D06390 ,
D07486 		--[1] 299
686PO ciprofloxacin[1] Ciprofloxacin[2] D00186 ,
D02216 		--[1] 299
687POL6014----[1] 299
688POL7080----[1] 299
689Polaprezinc[1] Polaprezinc[1] D01611 --[2] 96, 97
690Polidocanol[1] Polidocanol[1] D01993 --[1] 279
691Poly ICLC----[1] 34
692POLY(OXY-1,2-ETHANEDIYL), A----[1] 235
693POLY(OXY-1,2-ETHANEDIYL), ALPHA-HYDRO-OMEGA-METHOXY, ETHER WITH N-[[[2-[1] Diethyl ether[1] D01772 --[1] 235
694POLY(OXY-1,2-ETHANEDIYL), ALPHA-HYDRO-OMEGA-METHOXY, ETHER WITH N-[[[2-[[6-[[1-[3-[[3-(2,3-DIHYDROXYPROPOXY)PROPYL]AMINO]-3-OXOPROPYL]-2,5-DI[1] Diethyl ether[1] D01772 --[1] 235
695POLY(OXY-1,2-ETHANEDIYL), ALPHA-HYDRO-OMEGA-METHOXY, ETHER WITH N-[[[2-[[6-[[1-[3-[[3-(2,3-DIHYDROXYPROPOXY)PROPYL]AMINO]-3-OXOPROPYL]-2,5-DIOXO-3-PYRROLIDINYL]THIO]HEXYL]AMINO]ETHYL]AMINO]CARBONYL]-2-METHYLALANYL-TERIPARATIDE (2:1)[2] Diethyl ether,
Teriparatide		[2] D01772 ,
D06078 		[1] PTH1R 💬[3] Endocrine and other factor-regulated calcium reabsorption, Neuroactive ligand-receptor interaction, Parathyroid hormone synthesis, secretion and action 💬[1] 235
696POLY-L-LACTIC ACID[3] L-Lactic acid,
Lactic acid,
Poly(lactic acid)		[1] D00111 --[1] 265
697Polyclonal IgG----[1] 65
698POLYDEOXYRIBONUCLEOTIDES----[2] 51, 70
699Polyethylene glycol[1] Polyethylene glycol[1] D03370 --[7] 6, 78, 96, 97, 235, 276, 299
700Polyethylene Glycol 3350[1] Polyethylene glycol[1] D03370 --[2] 96, 299
701PolyMVA----[1] 2
702Polyphenon E----[2] 13, 36
703Polyphenon E®----[1] 97
704Pomalidomida[1] Pomalidomide[1] D08976 [2] IL6,
TNF 💬		[80] AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Alcoholic liver disease, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antifolate resistance, Antigen processing and presentation, Apoptosis, Asthma, C-type lectin receptor signaling pathway, Cellular senescence, Chagas disease, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Cytosolic DNA-sensing pathway, Dilated cardiomyopathy, EGFR tyrosine kinase inhibitor resistance, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, FoxO signaling pathway, Graft-versus-host disease, HIF-1 signaling pathway, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Influenza A, Insulin resistance, Intestinal immune network for IgA production, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Legionellosis, Leishmaniasis, Lipid and atherosclerosis, MAPK signaling pathway, Malaria, Measles, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Non-alcoholic fatty liver disease, Osteoclast differentiation, PI3K-Akt signaling pathway, Pathogenic Escherichia coli infection, Pathways in cancer, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Th17 cell differentiation, Toll-like receptor signaling pathway, Toxoplasmosis, Transcriptional misregulation in cancer, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway 💬[1] 51
705Pomalidomide[1] Pomalidomide[1] D08976 [2] IL6,
TNF 💬		[80] AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Alcoholic liver disease, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antifolate resistance, Antigen processing and presentation, Apoptosis, Asthma, C-type lectin receptor signaling pathway, Cellular senescence, Chagas disease, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Cytosolic DNA-sensing pathway, Dilated cardiomyopathy, EGFR tyrosine kinase inhibitor resistance, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, FoxO signaling pathway, Graft-versus-host disease, HIF-1 signaling pathway, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Influenza A, Insulin resistance, Intestinal immune network for IgA production, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Legionellosis, Leishmaniasis, Lipid and atherosclerosis, MAPK signaling pathway, Malaria, Measles, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Non-alcoholic fatty liver disease, Osteoclast differentiation, PI3K-Akt signaling pathway, Pathogenic Escherichia coli infection, Pathways in cancer, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Th17 cell differentiation, Toll-like receptor signaling pathway, Toxoplasmosis, Transcriptional misregulation in cancer, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway 💬[6] 28, 34, 51, 85, 227, 331
706Pomalidomide (CC-4047[1] Pomalidomide[1] D08976 [2] IL6,
TNF 💬		[80] AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Alcoholic liver disease, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antifolate resistance, Antigen processing and presentation, Apoptosis, Asthma, C-type lectin receptor signaling pathway, Cellular senescence, Chagas disease, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Cytosolic DNA-sensing pathway, Dilated cardiomyopathy, EGFR tyrosine kinase inhibitor resistance, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, FoxO signaling pathway, Graft-versus-host disease, HIF-1 signaling pathway, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Influenza A, Insulin resistance, Intestinal immune network for IgA production, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Legionellosis, Leishmaniasis, Lipid and atherosclerosis, MAPK signaling pathway, Malaria, Measles, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Non-alcoholic fatty liver disease, Osteoclast differentiation, PI3K-Akt signaling pathway, Pathogenic Escherichia coli infection, Pathways in cancer, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Th17 cell differentiation, Toll-like receptor signaling pathway, Toxoplasmosis, Transcriptional misregulation in cancer, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway 💬[1] 85
707Pomalidomide (CC-4047)[1] Pomalidomide[1] D08976 [2] IL6,
TNF 💬		[80] AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Alcoholic liver disease, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antifolate resistance, Antigen processing and presentation, Apoptosis, Asthma, C-type lectin receptor signaling pathway, Cellular senescence, Chagas disease, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Cytosolic DNA-sensing pathway, Dilated cardiomyopathy, EGFR tyrosine kinase inhibitor resistance, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, FoxO signaling pathway, Graft-versus-host disease, HIF-1 signaling pathway, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Influenza A, Insulin resistance, Intestinal immune network for IgA production, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Legionellosis, Leishmaniasis, Lipid and atherosclerosis, MAPK signaling pathway, Malaria, Measles, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Non-alcoholic fatty liver disease, Osteoclast differentiation, PI3K-Akt signaling pathway, Pathogenic Escherichia coli infection, Pathways in cancer, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Th17 cell differentiation, Toll-like receptor signaling pathway, Toxoplasmosis, Transcriptional misregulation in cancer, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway 💬[1] 51
708Pomalidomide and Dexamethasone[2] Dexamethasone,
Pomalidomide		[10] D00292 ,
D00975 ,
D01510 ,
D01615 ,
D01632 ,
D01948 ,
D02174 ,
D02591 ,
D02592 ,
D08976 		[3] IL6,
NR3C1,
TNF 💬		[81] AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Alcoholic liver disease, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antifolate resistance, Antigen processing and presentation, Apoptosis, Asthma, C-type lectin receptor signaling pathway, Cellular senescence, Chagas disease, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Cytosolic DNA-sensing pathway, Dilated cardiomyopathy, EGFR tyrosine kinase inhibitor resistance, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, FoxO signaling pathway, Graft-versus-host disease, HIF-1 signaling pathway, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Influenza A, Insulin resistance, Intestinal immune network for IgA production, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Legionellosis, Leishmaniasis, Lipid and atherosclerosis, MAPK signaling pathway, Malaria, Measles, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Neuroactive ligand-receptor interaction, Non-alcoholic fatty liver disease, Osteoclast differentiation, PI3K-Akt signaling pathway, Pathogenic Escherichia coli infection, Pathways in cancer, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Th17 cell differentiation, Toll-like receptor signaling pathway, Toxoplasmosis, Transcriptional misregulation in cancer, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway 💬[1] 28
709Pomalidomide Oral Product[1] Pomalidomide[1] D08976 [2] IL6,
TNF 💬		[80] AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Alcoholic liver disease, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antifolate resistance, Antigen processing and presentation, Apoptosis, Asthma, C-type lectin receptor signaling pathway, Cellular senescence, Chagas disease, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Cytosolic DNA-sensing pathway, Dilated cardiomyopathy, EGFR tyrosine kinase inhibitor resistance, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, FoxO signaling pathway, Graft-versus-host disease, HIF-1 signaling pathway, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Influenza A, Insulin resistance, Intestinal immune network for IgA production, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Legionellosis, Leishmaniasis, Lipid and atherosclerosis, MAPK signaling pathway, Malaria, Measles, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Non-alcoholic fatty liver disease, Osteoclast differentiation, PI3K-Akt signaling pathway, Pathogenic Escherichia coli infection, Pathways in cancer, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Th17 cell differentiation, Toll-like receptor signaling pathway, Toxoplasmosis, Transcriptional misregulation in cancer, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway 💬[1] 227
710Pomegranate[1] Pomegranate---[2] 96, 97
711PONESIMOD[1] Ponesimod[1] D11215 [1] S1PR1 💬[3] FoxO signaling pathway, Neuroactive ligand-receptor interaction, Sphingolipid signaling pathway 💬[1] 13
712Ponesimod 10 mg[1] Ponesimod[1] D11215 [1] S1PR1 💬[3] FoxO signaling pathway, Neuroactive ligand-receptor interaction, Sphingolipid signaling pathway 💬[1] 13
713Ponesimod 20 mg[1] Ponesimod[1] D11215 [1] S1PR1 💬[3] FoxO signaling pathway, Neuroactive ligand-receptor interaction, Sphingolipid signaling pathway 💬[1] 13
714Ponesimod 40 mg[1] Ponesimod[1] D11215 [1] S1PR1 💬[3] FoxO signaling pathway, Neuroactive ligand-receptor interaction, Sphingolipid signaling pathway 💬[1] 13
715Ponticelli Regimen----[1] 222
716Pooled mesenchymal stem cell----[1] 49
717Pooled Plasma (Human), Solvent/Detergent Treated----[1] 64
718Porcine (pig) PERT----[1] 299
719Porcine PERT----[1] 299
720Porphobilinogen[1] Porphobilinogen---[1] 254
721Posaconazole[1] Posaconazole[1] D02555 --[4] 60, 65, 96, 299
722Posaconazole (PSZ)[1] Posaconazole[1] D02555 --[1] 65
723Posaconazole 100 MG [Noxafil][1] Posaconazole[1] D02555 --[1] 299
724Posaconazole 40 MG/ML[1] Posaconazole[1] D02555 --[1] 299
725Posaconazole Delayed Release Oral Tablet[1] Posaconazole[1] D02555 --[1] 96
726POSACONAZOLO----[1] 299
727Posiphen[1] Posiphen---[1] 6
728Positive expiratory pressure----[1] 299
729Positron Emission Tomography----[4] 40, 46, 49, 96
730Positron Emission Tomography using [11 Carbon]-3-amino-4-(2-dimethylaminomethylphenylsulfanyl)-benzonitrile ([11C]-DASB) and [18 Fluorine]-altanserin ([18F]-altanserin)[1] Activated charcoal---[1] 6
731Positron Emission Tomography using [18 Fluorine]-altanserin ([18F]-altanserin)----[1] 6
732Post-CPB Drug: Dobutamine Hydrochloride[1] Dobutamine[4] D00632 ,
D03879 ,
D03880 ,
D03881 		[1] ADRB1 💬[11] Adrenergic signaling in cardiomyocytes, Calcium signaling pathway, Chemical carcinogenesis - receptor activation, Dilated cardiomyopathy, Gap junction, Neuroactive ligand-receptor interaction, Regulation of lipolysis in adipocytes, Renin secretion, Salivary secretion, cAMP signaling pathway, cGMP-PKG signaling pathway 💬[1] 58
733Posterior RA----[1] 75
734Posterolateral spinal fusion with instrumentation[1] Iron polymaltose---[1] 70
735Postoperative 3-month exclusive enteral nutrition----[1] 96
736Potassium[1] Potassium[1] D08403 --[12] 36, 46, 66, 67, 88, 94, 98, 115, 167, 179, 215, 235
737Potassium sparing diuretic[1] Potassium[1] D08403 --[1] 235
738Potassium supplement[1] Potassium[1] D08403 --[1] 46
739Potiga[1] Ezogabine[1] D09569 [5] KCNQ1,
KCNQ2,
KCNQ3,
KCNQ4,
KCNQ5 💬		[6] Adrenergic signaling in cardiomyocytes, Cholinergic synapse, Gastric acid secretion, Pancreatic secretion, Protein digestion and absorption, Vibrio cholerae infection 💬[1] 144
740Powder for Oral Suspension)----[1] 113
741Power doppler ultrasonography----[1] 46
742PowerLung trainer----[1] 2
743Pozelimab[1] Pozelimab[1] D11477 [1] C5 💬[10] Alcoholic liver disease, Complement and coagulation cascades, Coronavirus disease - COVID-19, Herpes simplex virus 1 infection, Neuroactive ligand-receptor interaction, Neutrophil extracellular trap formation, Pertussis, Prion disease, Staphylococcus aureus infection, Systemic lupus erythematosus 💬[2] 11, 62
744Pozelimab (REGN3918) + Cemdisiran[2] Cemdisiran,
Pozelimab		[1] D11477 [1] C5 💬[10] Alcoholic liver disease, Complement and coagulation cascades, Coronavirus disease - COVID-19, Herpes simplex virus 1 infection, Neuroactive ligand-receptor interaction, Neutrophil extracellular trap formation, Pertussis, Prion disease, Staphylococcus aureus infection, Systemic lupus erythematosus 💬[1] 11
745PPI treatment----[1] 299
746PPS----[1] 65
747Pr----[1] 41
748PR Oxycodone[1] Oxycodone[3] D03783 ,
D05312 ,
D05462 		[3] OPRD1,
OPRK1,
OPRM1 💬		[5] Estrogen signaling pathway, Morphine addiction, Neuroactive ligand-receptor interaction, Sphingolipid signaling pathway, cGMP-PKG signaling pathway 💬[1] 6
749PR-06410293----[1] 46
750PR001----[2] 6, 19
751PR006----[1] 127
752PR1----[1] 51
753PRA023----[2] 96, 97
754PRA023 IV----[3] 51, 96, 97
755PRALIA 60 mg Subcutaneous Injection Syringe(denosumab)[1] Denosumab[1] D03684 [1] TNFSF11 💬[8] Breast cancer, Chemical carcinogenesis - receptor activation, Cytokine-cytokine receptor interaction, NF-kappa B signaling pathway, Osteoclast differentiation, Parathyroid hormone synthesis, secretion and action, Prolactin signaling pathway, Rheumatoid arthritis 💬[1] 46
756PRALIA 60mg Subcutaneous Injection Syringe(denosumab)[1] Denosumab[1] D03684 [1] TNFSF11 💬[8] Breast cancer, Chemical carcinogenesis - receptor activation, Cytokine-cytokine receptor interaction, NF-kappa B signaling pathway, Osteoclast differentiation, Parathyroid hormone synthesis, secretion and action, Prolactin signaling pathway, Rheumatoid arthritis 💬[1] 46
757Praluent[1] Alirocumab[1] D10335 [1] PCSK9 💬[1] Cholesterol metabolism 💬[1] 79
758Pramipexol[1] Pramipexole[2] D00559 ,
D05575 		[3] DRD2,
DRD3,
DRD4 💬		[8] Alcoholism, Cocaine addiction, Dopaminergic synapse, Gap junction, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway 💬[1] 6
759Pramipexol Extended Release[1] Pramipexole[2] D00559 ,
D05575 		[3] DRD2,
DRD3,
DRD4 💬		[8] Alcoholism, Cocaine addiction, Dopaminergic synapse, Gap junction, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway 💬[1] 6
760Pramipexol Immediate Release[1] Pramipexole[2] D00559 ,
D05575 		[3] DRD2,
DRD3,
DRD4 💬		[8] Alcoholism, Cocaine addiction, Dopaminergic synapse, Gap junction, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway 💬[1] 6
761Pramipexole[1] Pramipexole[2] D00559 ,
D05575 		[3] DRD2,
DRD3,
DRD4 💬		[8] Alcoholism, Cocaine addiction, Dopaminergic synapse, Gap junction, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway 💬[3] 2, 6, 20
762Pramipexole 0.125 mg tablets[1] Pramipexole[2] D00559 ,
D05575 		[3] DRD2,
DRD3,
DRD4 💬		[8] Alcoholism, Cocaine addiction, Dopaminergic synapse, Gap junction, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway 💬[1] 6
763Pramipexole 0.5 mg tablets[1] Pramipexole[2] D00559 ,
D05575 		[3] DRD2,
DRD3,
DRD4 💬		[8] Alcoholism, Cocaine addiction, Dopaminergic synapse, Gap junction, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway 💬[1] 6
764PRAMIPEXOLE DIHYDROCHLORIDE[1] Pramipexole[2] D00559 ,
D05575 		[3] DRD2,
DRD3,
DRD4 💬		[8] Alcoholism, Cocaine addiction, Dopaminergic synapse, Gap junction, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway 💬[1] 6
765Pramipexole dihydrochloride extended-release tablets[1] Pramipexole[2] D00559 ,
D05575 		[3] DRD2,
DRD3,
DRD4 💬		[8] Alcoholism, Cocaine addiction, Dopaminergic synapse, Gap junction, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway 💬[1] 6
766PRAMIPEXOLE DIHYDROCHLORIDE MONOHYDRATE[1] Pramipexole[2] D00559 ,
D05575 		[3] DRD2,
DRD3,
DRD4 💬		[8] Alcoholism, Cocaine addiction, Dopaminergic synapse, Gap junction, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway 💬[1] 6
767Pramipexole dihydrochloride monohydrate extended release[2] Manganese citrate,
Pramipexole		[2] D00559 ,
D05575 		[3] DRD2,
DRD3,
DRD4 💬		[8] Alcoholism, Cocaine addiction, Dopaminergic synapse, Gap junction, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway 💬[1] 6
768Pramipexole ER[1] Pramipexole[2] D00559 ,
D05575 		[3] DRD2,
DRD3,
DRD4 💬		[8] Alcoholism, Cocaine addiction, Dopaminergic synapse, Gap junction, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway 💬[1] 6
769Pramipexole Extended Release[1] Pramipexole[2] D00559 ,
D05575 		[3] DRD2,
DRD3,
DRD4 💬		[8] Alcoholism, Cocaine addiction, Dopaminergic synapse, Gap junction, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway 💬[1] 6
770Pramipexole extended release tablet[1] Pramipexole[2] D00559 ,
D05575 		[3] DRD2,
DRD3,
DRD4 💬		[8] Alcoholism, Cocaine addiction, Dopaminergic synapse, Gap junction, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway 💬[1] 6
771Pramipexole hydrochloride sustained-release tablet (Siforl®) Specification: 0.26mg/ tablet (in pramipexole)[1] Pramipexole[2] D00559 ,
D05575 		[3] DRD2,
DRD3,
DRD4 💬		[8] Alcoholism, Cocaine addiction, Dopaminergic synapse, Gap junction, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway 💬[1] 6
772Pramipexole Immediate Release[1] Pramipexole[2] D00559 ,
D05575 		[3] DRD2,
DRD3,
DRD4 💬		[8] Alcoholism, Cocaine addiction, Dopaminergic synapse, Gap junction, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway 💬[1] 6
773Pramipexole immediate release tablet[1] Pramipexole[2] D00559 ,
D05575 		[3] DRD2,
DRD3,
DRD4 💬		[8] Alcoholism, Cocaine addiction, Dopaminergic synapse, Gap junction, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway 💬[1] 6
774Pramipexole IR[1] Pramipexole[2] D00559 ,
D05575 		[3] DRD2,
DRD3,
DRD4 💬		[8] Alcoholism, Cocaine addiction, Dopaminergic synapse, Gap junction, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway 💬[1] 6
775Pramipexole or ropinirole[2] Pramipexole,
Ropinirole		[4] D00559 ,
D00784 ,
D05575 ,
D08489 		[3] DRD2,
DRD3,
DRD4 💬		[8] Alcoholism, Cocaine addiction, Dopaminergic synapse, Gap junction, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway 💬[1] 6
776Pramipexole SR[1] Pramipexole[2] D00559 ,
D05575 		[3] DRD2,
DRD3,
DRD4 💬		[8] Alcoholism, Cocaine addiction, Dopaminergic synapse, Gap junction, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway 💬[1] 6
777Prasinezumab[1] Prasinezumab[1] D11420 [1] SNCA 💬[3] Alzheimer disease, Parkinson disease, Pathways of neurodegeneration - multiple diseases 💬[1] 6
778Prasterone[1] Prasterone[1] D08409 [3] AR,
ESR1,
ESR2 💬		[12] Breast cancer, Chemical carcinogenesis - receptor activation, Endocrine and other factor-regulated calcium reabsorption, Endocrine resistance, Estrogen signaling pathway, GnRH secretion, Oocyte meiosis, Pathways in cancer, Prolactin signaling pathway, Prostate cancer, Proteoglycans in cancer, Thyroid hormone signaling pathway 💬[1] 49
779Prasterone (GL701)[1] Prasterone[1] D08409 [3] AR,
ESR1,
ESR2 💬		[12] Breast cancer, Chemical carcinogenesis - receptor activation, Endocrine and other factor-regulated calcium reabsorption, Endocrine resistance, Estrogen signaling pathway, GnRH secretion, Oocyte meiosis, Pathways in cancer, Prolactin signaling pathway, Prostate cancer, Proteoglycans in cancer, Thyroid hormone signaling pathway 💬[1] 49
780Pravastatin[1] Pravastatin[2] D00893 ,
D08410 		[1] HMGCR 💬[4] AMPK signaling pathway, Bile secretion, Metabolic pathways, Terpenoid backbone biosynthesis 💬[9] 13, 46, 49, 67, 79, 96, 164, 265, 333
781Pravastatin sodium[1] Pravastatin[2] D00893 ,
D08410 		[1] HMGCR 💬[4] AMPK signaling pathway, Bile secretion, Metabolic pathways, Terpenoid backbone biosynthesis 💬[1] 265
782Praxol hydrochloride sustained release tablet Specification: 0.375mg/ tablet (in pramipexole hydrochloride)[1] Pramipexole[2] D00559 ,
D05575 		[3] DRD2,
DRD3,
DRD4 💬		[8] Alcoholism, Cocaine addiction, Dopaminergic synapse, Gap junction, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway 💬[1] 6
783PRD2175434----[1] 113
784PRD4862257----[1] 46
785PRD5973697----[1] 97
786PRD7255830----[1] 79
787PRD7255977----[1] 79
788PRD7256003----[1] 79
789PRD806998----[1] 13
790Pre and post-CPB Drug: Dobutamine Hydrochloride[1] Dobutamine[4] D00632 ,
D03879 ,
D03880 ,
D03881 		[1] ADRB1 💬[11] Adrenergic signaling in cardiomyocytes, Calcium signaling pathway, Chemical carcinogenesis - receptor activation, Dilated cardiomyopathy, Gap junction, Neuroactive ligand-receptor interaction, Regulation of lipolysis in adipocytes, Renin secretion, Salivary secretion, cAMP signaling pathway, cGMP-PKG signaling pathway 💬[1] 58
791Pre liver transplantation laparoscopic hand assisted staging----[1] 94
792Pre-filled syringe----[1] 46
793Pre-filled Syringe (PFS)----[1] 46
794Prebiotics----[1] 96
795Prebiotics (Prebiotin Prebiotic Fiber Stick Pac)----[1] 13
796Precedentemente denominato MEDI2070 e AMG 139----[1] 96
797Pred----[1] 46
798Pred + Meth----[1] 46
799Predinose oral----[1] 70
800PredniHEXAL----[1] 46
801PredniHEXAL® 10mg Tabletten----[1] 46
802PredniHEXAL® 20mg Tabletten----[1] 46
803PredniHEXAL® 5mg Tabletten----[1] 46
804PredniHEXAL® 5mg Tabletten, PredniHEXAL® 10mg Tabletten----[1] 46
805PredniHEXAL® 5mg Tabletten, PredniHEXAL® 20mg Tabletten----[1] 46
806Predniso----[1] 46
807Prednisolene tablets BP 1 mg----[1] 46
808Prednisolon----[7] 46, 50, 51, 66, 95, 96, 97
809Prednisolon 1 mg JENAPHARM----[1] 41
810Prednisolon 10 mg JENAPHARM----[1] 41
811Prednisolon 20 mg JENAPHARM----[1] 41
812Prednisolon 5 mg JENAPHARM----[1] 41
813Prednisolon Jenapharm----[2] 96, 97
814Prednisolon Pfizer----[2] 46, 50
815Prednisolona[1] Prednisolone[8] D00472 ,
D00980 ,
D00981 ,
D00982 ,
D01239 ,
D01998 ,
D02156 ,
D03301 		[1] NR3C1 💬[1] Neuroactive ligand-receptor interaction 💬[1] 51
816PREDNISOLONE[1] Prednisolone[8] D00472 ,
D00980 ,
D00981 ,
D00982 ,
D01239 ,
D01998 ,
D02156 ,
D03301 		[1] NR3C1 💬[1] Neuroactive ligand-receptor interaction 💬[43] 3, 11, 13, 14, 25, 26, 35, 38, 39, 40, 41, 43, 44, 45, 46, 49, 50, 51, 56, 60, 61, 63, 64, 65, 66, 75, 81, 84, 85, 95, 96, 97, 107, 113, 145, 162, 222, 269, 271, 296, 299, 300, 307
817Prednisolone & dipyridamole[2] Dipyridamole,
Prednisolone		[9] D00302 ,
D00472 ,
D00980 ,
D00981 ,
D00982 ,
D01239 ,
D01998 ,
D02156 ,
D03301 		[3] NR3C1,
PDE4A,
PDE5A 💬		[7] Metabolic pathways, Morphine addiction, Neuroactive ligand-receptor interaction, Parathyroid hormone synthesis, secretion and action, Purine metabolism, cAMP signaling pathway, cGMP-PKG signaling pathway 💬[1] 46
818Prednisolone + mabthera[2] Prednisolone,
Rituximab		[9] D00472 ,
D00980 ,
D00981 ,
D00982 ,
D01239 ,
D01998 ,
D02156 ,
D02994 ,
D03301 		[2] MS4A1,
NR3C1 💬		[2] Hematopoietic cell lineage, Neuroactive ligand-receptor interaction 💬[1] 61
819Prednisolone 1mg Tablets[1] Prednisolone[8] D00472 ,
D00980 ,
D00981 ,
D00982 ,
D01239 ,
D01998 ,
D02156 ,
D03301 		[1] NR3C1 💬[1] Neuroactive ligand-receptor interaction 💬[1] 81
820Prednisolone 2,5 mg Tablets[1] Prednisolone[8] D00472 ,
D00980 ,
D00981 ,
D00982 ,
D01239 ,
D01998 ,
D02156 ,
D03301 		[1] NR3C1 💬[1] Neuroactive ligand-receptor interaction 💬[1] 81
821Prednisolone 20 mg[1] Prednisolone[8] D00472 ,
D00980 ,
D00981 ,
D00982 ,
D01239 ,
D01998 ,
D02156 ,
D03301 		[1] NR3C1 💬[1] Neuroactive ligand-receptor interaction 💬[1] 46
822Prednisolone 40 mg[1] Prednisolone[8] D00472 ,
D00980 ,
D00981 ,
D00982 ,
D01239 ,
D01998 ,
D02156 ,
D03301 		[1] NR3C1 💬[1] Neuroactive ligand-receptor interaction 💬[1] 46
823Prednisolone 5 mg[1] Prednisolone[8] D00472 ,
D00980 ,
D00981 ,
D00982 ,
D01239 ,
D01998 ,
D02156 ,
D03301 		[1] NR3C1 💬[1] Neuroactive ligand-receptor interaction 💬[2] 46, 51
824Prednisolone 5 mg JENAPHARM[1] Prednisolone[8] D00472 ,
D00980 ,
D00981 ,
D00982 ,
D01239 ,
D01998 ,
D02156 ,
D03301 		[1] NR3C1 💬[1] Neuroactive ligand-receptor interaction 💬[1] 41
825Prednisolone 5 mg Tablets[1] Prednisolone[8] D00472 ,
D00980 ,
D00981 ,
D00982 ,
D01239 ,
D01998 ,
D02156 ,
D03301 		[1] NR3C1 💬[1] Neuroactive ligand-receptor interaction 💬[1] 81
826Prednisolone 5mg Gastro-resistant Tablets[1] Prednisolone[8] D00472 ,
D00980 ,
D00981 ,
D00982 ,
D01239 ,
D01998 ,
D02156 ,
D03301 		[1] NR3C1 💬[1] Neuroactive ligand-receptor interaction 💬[1] 51
827Prednisolone 5mg Tablet[1] Prednisolone[8] D00472 ,
D00980 ,
D00981 ,
D00982 ,
D01239 ,
D01998 ,
D02156 ,
D03301 		[1] NR3C1 💬[1] Neuroactive ligand-receptor interaction 💬[1] 81
828PREDNISOLONE ACETATE[3] Acetate,
Prednisolone,
Prednisolone acetate		[8] D00472 ,
D00980 ,
D00981 ,
D00982 ,
D01239 ,
D01998 ,
D02156 ,
D03301 		[1] NR3C1 💬[1] Neuroactive ligand-receptor interaction 💬[1] 222
829Prednisolone and chlorambucil[2] Chlorambucil,
Prednisolone		[9] D00266 ,
D00472 ,
D00980 ,
D00981 ,
D00982 ,
D01239 ,
D01998 ,
D02156 ,
D03301 		[1] NR3C1 💬[1] Neuroactive ligand-receptor interaction 💬[1] 222
830Prednisolone and mycophenolate mofetil[3] Mycophenolate mofetil,
Mycophenolic acid,
Prednisolone		[12] D00472 ,
D00752 ,
D00980 ,
D00981 ,
D00982 ,
D01239 ,
D01998 ,
D02156 ,
D03301 ,
D05094 ,
D05095 ,
D05096 		[3] IMPDH1,
IMPDH2,
NR3C1 💬		[4] Drug metabolism - other enzymes, Metabolic pathways, Neuroactive ligand-receptor interaction, Purine metabolism 💬[1] 222
831Prednisolone and taper[1] Prednisolone[8] D00472 ,
D00980 ,
D00981 ,
D00982 ,
D01239 ,
D01998 ,
D02156 ,
D03301 		[1] NR3C1 💬[1] Neuroactive ligand-receptor interaction 💬[1] 51
832Prednisolone Labesfal[1] Prednisolone[8] D00472 ,
D00980 ,
D00981 ,
D00982 ,
D01239 ,
D01998 ,
D02156 ,
D03301 		[1] NR3C1 💬[1] Neuroactive ligand-receptor interaction 💬[1] 46
833Prednisolone sodium metasulphobenzoate[1] Prednisolone[8] D00472 ,
D00980 ,
D00981 ,
D00982 ,
D01239 ,
D01998 ,
D02156 ,
D03301 		[1] NR3C1 💬[1] Neuroactive ligand-receptor interaction 💬[1] 97
834PREDNISOLONE SODIUM PHOSPHATE[2] Phosphate ion,
Prednisolone		[8] D00472 ,
D00980 ,
D00981 ,
D00982 ,
D01239 ,
D01998 ,
D02156 ,
D03301 		[1] NR3C1 💬[1] Neuroactive ligand-receptor interaction 💬[3] 3, 13, 97
835PREDNISOLONE SODIUM SUCCINATE[1] Prednisolone[8] D00472 ,
D00980 ,
D00981 ,
D00982 ,
D01239 ,
D01998 ,
D02156 ,
D03301 		[1] NR3C1 💬[1] Neuroactive ligand-receptor interaction 💬[1] 95
836Prednisolone Tablets B.P. 5mg[1] Prednisolone[8] D00472 ,
D00980 ,
D00981 ,
D00982 ,
D01239 ,
D01998 ,
D02156 ,
D03301 		[1] NR3C1 💬[1] Neuroactive ligand-receptor interaction 💬[1] 97
837Prednisolone Tablets BP[1] Prednisolone[8] D00472 ,
D00980 ,
D00981 ,
D00982 ,
D01239 ,
D01998 ,
D02156 ,
D03301 		[1] NR3C1 💬[1] Neuroactive ligand-receptor interaction 💬[1] 46
838Prednisolone Tablets BP 1 mg[1] Prednisolone[8] D00472 ,
D00980 ,
D00981 ,
D00982 ,
D01239 ,
D01998 ,
D02156 ,
D03301 		[1] NR3C1 💬[1] Neuroactive ligand-receptor interaction 💬[1] 46
839Prednisolone Tablets USP 5 mg[1] Prednisolone[8] D00472 ,
D00980 ,
D00981 ,
D00982 ,
D01239 ,
D01998 ,
D02156 ,
D03301 		[1] NR3C1 💬[1] Neuroactive ligand-receptor interaction 💬[1] 46
840Prednisolone-Dipyridamole[2] Dipyridamole,
Prednisolone		[9] D00302 ,
D00472 ,
D00980 ,
D00981 ,
D00982 ,
D01239 ,
D01998 ,
D02156 ,
D03301 		[3] NR3C1,
PDE4A,
PDE5A 💬		[7] Metabolic pathways, Morphine addiction, Neuroactive ligand-receptor interaction, Parathyroid hormone synthesis, secretion and action, Purine metabolism, cAMP signaling pathway, cGMP-PKG signaling pathway 💬[1] 46
841Prednisolone/Prednisone[2] Prednisolone,
Prednisone		[9] D00472 ,
D00473 ,
D00980 ,
D00981 ,
D00982 ,
D01239 ,
D01998 ,
D02156 ,
D03301 		[1] NR3C1 💬[1] Neuroactive ligand-receptor interaction 💬[1] 49
842Prednisoloni----[1] 51
843Prednisolonum[1] Prednisolone[8] D00472 ,
D00980 ,
D00981 ,
D00982 ,
D01239 ,
D01998 ,
D02156 ,
D03301 		[1] NR3C1 💬[1] Neuroactive ligand-receptor interaction 💬[1] 51
844Prednison----[3] 46, 84, 113
845Prednison 10 mg GALEN----[1] 35
846Prednison 5 mg GALEN----[1] 35
847PREDNISON 5, 20 Léciva por. tablet nob----[1] 50
848Prednison 5, 20 Léciva por. tablet nob.----[1] 50
849Prednison 50 mg GALEN----[1] 35
850Prednison acis® 20 mg----[2] 43, 44
851Prednison acis® 5 mg----[2] 43, 44
852Prednison acis¿ 20 mg----[2] 43, 44
853Prednison acis¿ 5 mg----[2] 43, 44
854Prednison20 mg GALEN----[1] 35
855Prednisona[1] Prednisone[1] D00473 [1] NR3C1 💬[1] Neuroactive ligand-receptor interaction 💬[3] 46, 49, 222
856Prednisone[1] Prednisone[1] D00473 [1] NR3C1 💬[1] Neuroactive ligand-receptor interaction 💬[48] 2, 6, 11, 13, 14, 19, 26, 35, 40, 41, 42, 43, 44, 45, 46, 49, 50, 51, 53, 61, 63, 64, 65, 66, 79, 81, 84, 85, 86, 95, 96, 97, 113, 127, 162, 164, 205, 222, 224, 228, 251, 283, 284, 285, 288, 299, 300, 331
857Prednisone (and methylprednisolone)[2] Methylprednisolone,
Prednisone		[7] D00407 ,
D00473 ,
D00751 ,
D00979 ,
D05000 ,
D05001 ,
D05002 		[1] NR3C1 💬[1] Neuroactive ligand-receptor interaction 💬[1] 43
858Prednisone + Inhibace/Cozaar[1] Prednisone[1] D00473 [1] NR3C1 💬[1] Neuroactive ligand-receptor interaction 💬[1] 66
859Prednisone - Azathioprine[2] Azathioprine,
Prednisone		[3] D00238 ,
D00473 ,
D03033 		[1] NR3C1 💬[1] Neuroactive ligand-receptor interaction 💬[1] 11
860Prednisone 0,5 mg/kg orally on alternate days[1] Prednisone[1] D00473 [1] NR3C1 💬[1] Neuroactive ligand-receptor interaction 💬[1] 222
861Prednisone 1 mg[1] Prednisone[1] D00473 [1] NR3C1 💬[1] Neuroactive ligand-receptor interaction 💬[1] 46
862Prednisone 15 mg[1] Prednisone[1] D00473 [1] NR3C1 💬[1] Neuroactive ligand-receptor interaction 💬[1] 46
863Prednisone 2 mg[1] Prednisone[1] D00473 [1] NR3C1 💬[1] Neuroactive ligand-receptor interaction 💬[1] 46
864Prednisone 3 mg[1] Prednisone[1] D00473 [1] NR3C1 💬[1] Neuroactive ligand-receptor interaction 💬[1] 46
865Prednisone 4 mg[1] Prednisone[1] D00473 [1] NR3C1 💬[1] Neuroactive ligand-receptor interaction 💬[1] 46
866Prednisone 5 mg[1] Prednisone[1] D00473 [1] NR3C1 💬[1] Neuroactive ligand-receptor interaction 💬[2] 46, 66
867Prednisone 5 mg tablets[1] Prednisone[1] D00473 [1] NR3C1 💬[1] Neuroactive ligand-receptor interaction 💬[1] 113
868Prednisone 7.5 mg[1] Prednisone[1] D00473 [1] NR3C1 💬[1] Neuroactive ligand-receptor interaction 💬[1] 46
869Prednisone Acetate[3] Acetate,
Prednisone,
Prednisone acetate		[2] D00473 ,
D08416 		[1] NR3C1 💬[1] Neuroactive ligand-receptor interaction 💬[4] 40, 46, 49, 224
870Prednisone Acetate Tablets[3] Acetate,
Prednisone,
Prednisone acetate		[2] D00473 ,
D08416 		[1] NR3C1 💬[1] Neuroactive ligand-receptor interaction 💬[1] 224
871Prednisone alone[1] Prednisone[1] D00473 [1] NR3C1 💬[1] Neuroactive ligand-receptor interaction 💬[2] 11, 66
872Prednisone and Belimumab[2] Belimumab,
Prednisone		[2] D00473 ,
D03068 		[2] NR3C1,
TNFSF13B 💬		[5] Cytokine-cytokine receptor interaction, Intestinal immune network for IgA production, NF-kappa B signaling pathway, Neuroactive ligand-receptor interaction, Rheumatoid arthritis 💬[1] 300
873Prednisone and cyclophosphamide[2] Cyclophosphamide,
Prednisone		[3] D00287 ,
D00473 ,
D07760 		[1] NR3C1 💬[1] Neuroactive ligand-receptor interaction 💬[1] 66
874Prednisone and Mycophenolate mofetil[3] Mycophenolate mofetil,
Mycophenolic acid,
Prednisone		[5] D00473 ,
D00752 ,
D05094 ,
D05095 ,
D05096 		[3] IMPDH1,
IMPDH2,
NR3C1 💬		[4] Drug metabolism - other enzymes, Metabolic pathways, Neuroactive ligand-receptor interaction, Purine metabolism 💬[1] 300
875Prednisone and ustekinumab treatment[2] Prednisone,
Ustekinumab		[2] D00473 ,
D09214 		[4] IL12A,
IL12B,
IL23A,
NR3C1 💬		[29] African trypanosomiasis, Alcoholic liver disease, Allograft rejection, Amoebiasis, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Herpes simplex virus 1 infection, Inflammatory bowel disease, Influenza A, JAK-STAT signaling pathway, Legionellosis, Leishmaniasis, Lipid and atherosclerosis, Malaria, Measles, Neuroactive ligand-receptor interaction, Pathways in cancer, Pertussis, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Th1 and Th2 cell differentiation, Th17 cell differentiation, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus 💬[1] 41
876PREDNISONE ARROW 20mg[1] Prednisone[1] D00473 [1] NR3C1 💬[1] Neuroactive ligand-receptor interaction 💬[1] 66
877PREDNISONE ARROW 5 mg[1] Prednisone[1] D00473 [1] NR3C1 💬[1] Neuroactive ligand-receptor interaction 💬[1] 66
878Prednisone Capsule[1] Prednisone[1] D00473 [1] NR3C1 💬[1] Neuroactive ligand-receptor interaction 💬[1] 41
879Prednisone Capsules[1] Prednisone[1] D00473 [1] NR3C1 💬[1] Neuroactive ligand-receptor interaction 💬[1] 41
880Prednisone discontinuation[1] Prednisone[1] D00473 [1] NR3C1 💬[1] Neuroactive ligand-receptor interaction 💬[1] 49
881PREDNISONE DOC GENERICI - 5 MG COMPRESSE 30 COMPRESSE IN BLISTER PVC-PVDC/ALU[1] Prednisone[1] D00473 [1] NR3C1 💬[1] Neuroactive ligand-receptor interaction 💬[1] 300
882Prednisone in full dose[1] Prednisone[1] D00473 [1] NR3C1 💬[1] Neuroactive ligand-receptor interaction 💬[1] 66
883Prednisone or Prednisolone[2] Prednisolone,
Prednisone		[9] D00472 ,
D00473 ,
D00980 ,
D00981 ,
D00982 ,
D01239 ,
D01998 ,
D02156 ,
D03301 		[1] NR3C1 💬[1] Neuroactive ligand-receptor interaction 💬[2] 66, 84
884Prednisone plus cyclophosphamide[2] Cyclophosphamide,
Prednisone		[3] D00287 ,
D00473 ,
D07760 		[1] NR3C1 💬[1] Neuroactive ligand-receptor interaction 💬[1] 66
885Prednisone plus exercise[1] Prednisone[1] D00473 [1] NR3C1 💬[1] Neuroactive ligand-receptor interaction 💬[1] 113
886PredniSONE Tablets USP, 1 mg[1] Prednisone[1] D00473 [1] NR3C1 💬[1] Neuroactive ligand-receptor interaction 💬[2] 41, 46
887PredniSONE Tablets USP, 10 mg[1] Prednisone[1] D00473 [1] NR3C1 💬[1] Neuroactive ligand-receptor interaction 💬[1] 41
888PredniSONE Tablets USP, 1mg[1] Prednisone[1] D00473 [1] NR3C1 💬[1] Neuroactive ligand-receptor interaction 💬[1] 41
889PredniSONE Tablets USP, 2.5 mg[1] Prednisone[1] D00473 [1] NR3C1 💬[1] Neuroactive ligand-receptor interaction 💬[1] 41
890PredniSONE Tablets USP, 2.5mg[1] Prednisone[1] D00473 [1] NR3C1 💬[1] Neuroactive ligand-receptor interaction 💬[1] 41
891PredniSONE Tablets USP, 20mg[1] Prednisone[1] D00473 [1] NR3C1 💬[1] Neuroactive ligand-receptor interaction 💬[1] 41
892PredniSONE Tablets USP, 5 mg[1] Prednisone[1] D00473 [1] NR3C1 💬[1] Neuroactive ligand-receptor interaction 💬[2] 41, 46
893PredniSONE Tablets USP, 5mg[1] Prednisone[1] D00473 [1] NR3C1 💬[1] Neuroactive ligand-receptor interaction 💬[1] 41
894PredniSONE Tablets, USP[1] Prednisone[1] D00473 [1] NR3C1 💬[1] Neuroactive ligand-receptor interaction 💬[3] 41, 43, 44
895Prednisone therapy and pharmacokinetic[1] Prednisone[1] D00473 [1] NR3C1 💬[1] Neuroactive ligand-receptor interaction 💬[1] 41
896Prednisone treatment[1] Prednisone[1] D00473 [1] NR3C1 💬[1] Neuroactive ligand-receptor interaction 💬[1] 41
897Prednisone with daily edasalonexent[2] Edasalonexent,
Prednisone		[2] D00473 ,
D12181 		[2] NR3C1,
RELA 💬		[77] AGE-RAGE signaling pathway in diabetic complications, Acute myeloid leukemia, Adipocytokine signaling pathway, Alcoholic liver disease, Alzheimer disease, Amoebiasis, Antifolate resistance, Apoptosis, B cell receptor signaling pathway, C-type lectin receptor signaling pathway, Cellular senescence, Chagas disease, Chemical carcinogenesis - reactive oxygen species, Chemical carcinogenesis - receptor activation, Chemokine signaling pathway, Chronic myeloid leukemia, Cocaine addiction, Coronavirus disease - COVID-19, Cytosolic DNA-sensing pathway, Diabetic cardiomyopathy, Epithelial cell signaling in Helicobacter pylori infection, Epstein-Barr virus infection, Fluid shear stress and atherosclerosis, HIF-1 signaling pathway, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, IL-17 signaling pathway, Inflammatory bowel disease, Influenza A, Insulin resistance, Kaposi sarcoma-associated herpesvirus infection, Legionellosis, Leishmaniasis, Lipid and atherosclerosis, Longevity regulating pathway, MAPK signaling pathway, Measles, Mitophagy - animal, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Neuroactive ligand-receptor interaction, Neurotrophin signaling pathway, Neutrophil extracellular trap formation, Non-alcoholic fatty liver disease, Osteoclast differentiation, PD-L1 expression and PD-1 checkpoint pathway in cancer, PI3K-Akt signaling pathway, Pancreatic cancer, Pathogenic Escherichia coli infection, Pathways in cancer, Pathways of neurodegeneration - multiple diseases, Pertussis, Prolactin signaling pathway, Prostate cancer, RIG-I-like receptor signaling pathway, Ras signaling pathway, Relaxin signaling pathway, Salmonella infection, Shigellosis, Small cell lung cancer, Sphingolipid signaling pathway, T cell receptor signaling pathway, TNF signaling pathway, Th1 and Th2 cell differentiation, Th17 cell differentiation, Toll-like receptor signaling pathway, Toxoplasmosis, Transcriptional misregulation in cancer, Tuberculosis, Viral carcinogenesis, Yersinia infection, cAMP signaling pathway 💬[1] 113
898Prednisone, ciclosporin and mycophenolate mofetil[4] Cyclosporine,
Mycophenolate mofetil,
Mycophenolic acid,
Prednisone		[6] D00184 ,
D00473 ,
D00752 ,
D05094 ,
D05095 ,
D05096 		[8] IMPDH1,
IMPDH2,
NR3C1,
PPP3CA,
PPP3CB,
PPP3CC,
PPP3R1,
PPP3R2 💬		[37] Alzheimer disease, Amphetamine addiction, Amyotrophic lateral sclerosis, Axon guidance, B cell receptor signaling pathway, C-type lectin receptor signaling pathway, Calcium signaling pathway, Cellular senescence, Dopaminergic synapse, Drug metabolism - other enzymes, Glucagon signaling pathway, Glutamatergic synapse, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Kaposi sarcoma-associated herpesvirus infection, Lipid and atherosclerosis, Long-term potentiation, MAPK signaling pathway, Metabolic pathways, Natural killer cell mediated cytotoxicity, Neuroactive ligand-receptor interaction, Oocyte meiosis, Osteoclast differentiation, Oxytocin signaling pathway, PD-L1 expression and PD-1 checkpoint pathway in cancer, Pathways of neurodegeneration - multiple diseases, Prion disease, Purine metabolism, Renin secretion, T cell receptor signaling pathway, Th1 and Th2 cell differentiation, Th17 cell differentiation, Tuberculosis, VEGF signaling pathway, Wnt signaling pathway, cGMP-PKG signaling pathway 💬[1] 222
899Prednisone, cyclophosphamide[2] Cyclophosphamide,
Prednisone		[3] D00287 ,
D00473 ,
D07760 		[1] NR3C1 💬[1] Neuroactive ligand-receptor interaction 💬[1] 40
900Prednisone, FK506, MMF[1] Prednisone[1] D00473 [1] NR3C1 💬[1] Neuroactive ligand-receptor interaction 💬[1] 222
901Prednisone, low dose rituximab[2] Prednisone,
Rituximab		[2] D00473 ,
D02994 		[2] MS4A1,
NR3C1 💬		[2] Hematopoietic cell lineage, Neuroactive ligand-receptor interaction 💬[1] 61
902Prednisone, methylprednisolone,cyclophosphamides[2] Methylprednisolone,
Prednisone		[7] D00407 ,
D00473 ,
D00751 ,
D00979 ,
D05000 ,
D05001 ,
D05002 		[1] NR3C1 💬[1] Neuroactive ligand-receptor interaction 💬[3] 42, 43, 45
903Prednisone/Prednisolone[2] Prednisolone,
Prednisone		[9] D00472 ,
D00473 ,
D00980 ,
D00981 ,
D00982 ,
D01239 ,
D01998 ,
D02156 ,
D03301 		[1] NR3C1 💬[1] Neuroactive ligand-receptor interaction 💬[1] 35
904Prednizolon----[1] 51
905Prednizolonas----[1] 51
906Prefilled liquid etanercept(Yisaipu)[1] Etanercept[1] D00742 [2] LTA,
TNF 💬		[67] AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Alcoholic liver disease, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antifolate resistance, Antigen processing and presentation, Apoptosis, Asthma, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Dilated cardiomyopathy, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, Graft-versus-host disease, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Influenza A, Insulin resistance, Legionellosis, Leishmaniasis, Lipid and atherosclerosis, MAPK signaling pathway, Malaria, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Non-alcoholic fatty liver disease, Osteoclast differentiation, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway 💬[1] 271
907Prefilled Syringe delivery of Golimumab[1] Golimumab[1] D04358 [1] TNF 💬[67] AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Alcoholic liver disease, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antifolate resistance, Antigen processing and presentation, Apoptosis, Asthma, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Dilated cardiomyopathy, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, Graft-versus-host disease, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Influenza A, Insulin resistance, Legionellosis, Leishmaniasis, Lipid and atherosclerosis, MAPK signaling pathway, Malaria, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Non-alcoholic fatty liver disease, Osteoclast differentiation, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway 💬[1] 97
908Prefolic----[1] 337
909PREFOLIC 15*30CPR GASTROR 15MG----[1] 337
910PREFOLIC*30CPR GASTROR 15MG----[1] 299
911Pregabalin[1] Pregabalin[1] D02716 [4] CACNA2D1,
CACNA2D2,
CACNA2D3,
CACNA2D4 💬		[7] Adrenergic signaling in cardiomyocytes, Arrhythmogenic right ventricular cardiomyopathy, Cardiac muscle contraction, Dilated cardiomyopathy, Hypertrophic cardiomyopathy, MAPK signaling pathway, Oxytocin signaling pathway 💬[5] 13, 36, 46, 70, 298
912Pregabalin 75mg[1] Pregabalin[1] D02716 [4] CACNA2D1,
CACNA2D2,
CACNA2D3,
CACNA2D4 💬		[7] Adrenergic signaling in cardiomyocytes, Arrhythmogenic right ventricular cardiomyopathy, Cardiac muscle contraction, Dilated cardiomyopathy, Hypertrophic cardiomyopathy, MAPK signaling pathway, Oxytocin signaling pathway 💬[1] 70
913Preimplantation factor[1] Preimplantation factor---[1] 95
914Preladenant[1] Preladenant[1] D09717 [1] ADORA2A 💬[7] Alcoholism, Calcium signaling pathway, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, Vascular smooth muscle contraction, cAMP signaling pathway 💬[1] 6
915Preladenant 10 mg tablet[1] Preladenant[1] D09717 [1] ADORA2A 💬[7] Alcoholism, Calcium signaling pathway, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, Vascular smooth muscle contraction, cAMP signaling pathway 💬[1] 6
916Preladenant 2 mg tablet[1] Preladenant[1] D09717 [1] ADORA2A 💬[7] Alcoholism, Calcium signaling pathway, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, Vascular smooth muscle contraction, cAMP signaling pathway 💬[1] 6
917Preladenant 5 mg tablet[1] Preladenant[1] D09717 [1] ADORA2A 💬[7] Alcoholism, Calcium signaling pathway, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, Vascular smooth muscle contraction, cAMP signaling pathway 💬[1] 6
918Premarin and Provera----[1] 49
919Premarin ®----[1] 6
920PREOTACT[1] Parathyroid hormone[1] D05364 [2] PTH1R,
PTH2R 💬		[3] Endocrine and other factor-regulated calcium reabsorption, Neuroactive ligand-receptor interaction, Parathyroid hormone synthesis, secretion and action 💬[1] 235
921Preparative regimen 4-6 weeks after Leukapheresis----[1] 96
922Prepulsid----[1] 13
923Prescribe N-acetylcysteine tablets[1] Acetylcysteine[1] D00221 --[1] 90
924Preservative free artificial tear gel.----[1] 157
925PREVENAR----[1] 65
926Prevenar 13[1] Streptococcus pneumoniae type 1 capsular polysaccharide antigen---[5] 13, 14, 46, 96, 222
927PREVENAR 13 - 0.5 ML SOSPENSIONE INIETTABILE - USO INTRAMUSCOLARE - FLACONCINO MONODOSE (0,5 ML VETRO TIPO I) - 1 FLACONCINO MONODOSE[1] Streptococcus pneumoniae type 1 capsular polysaccharide antigen---[1] 222
928Prevenar 13 sospensione per iniezione[1] Streptococcus pneumoniae type 1 capsular polysaccharide antigen---[1] 14
929Prevenar 13 suspension for injection[1] Streptococcus pneumoniae type 1 capsular polysaccharide antigen---[1] 222
930Prevenar vaccination----[1] 46
931Prevenar vaccine----[1] 46
932Prevenar13----[2] 19, 265
933Prevenar® (7-valent pneumococcal conjugate vaccine)----[1] 65
934Prevenar® and Pneumo23®----[1] 49
935Previously known as R935788----[1] 46
936Previously referred to as MEDI2070 and AMG 139----[2] 96, 97
937Previously referred to as MEDI2070 and AMG 139, AGN-151-598----[1] 96
938Previously termed sc.AAV9.CB.SMN and AVXS-101----[1] 3
939PrGCD[1] Taliglucerase alfa[1] D09675 [1] GBA 💬[4] Lysosome, Metabolic pathways, Other glycan degradation, Sphingolipid metabolism 💬[1] 19
940Pridia (Donepezil Hydrochloride) 5mg[1] Donepezil[2] D00670 ,
D07869 		[1] ACHE 💬[2] Cholinergic synapse, Glycerophospholipid metabolism 💬[1] 6
941Pridia 10mg----[1] 6
942Pridia 5mg----[1] 6
943Pridiopidine----[1] 8
944Pridopidina----[1] 8
945Pridopidine[1] Pridopidine[1] D09953 [1] DRD2 💬[8] Alcoholism, Cocaine addiction, Dopaminergic synapse, Gap junction, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway 💬[3] 2, 6, 8
946Pridopidine (90 mg)[1] Pridopidine[1] D09953 [1] DRD2 💬[8] Alcoholism, Cocaine addiction, Dopaminergic synapse, Gap junction, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway 💬[1] 8
947PRIDOPIDINE HYDROCHLORIDE[1] Pridopidine[1] D09953 [1] DRD2 💬[8] Alcoholism, Cocaine addiction, Dopaminergic synapse, Gap junction, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway 💬[1] 8
948PRIM-DJ2727----[2] 6, 97
949Primary Cervical Dystonia (Trihexyphenidyl)[1] Trihexyphenidyl[2] D00787 ,
D08638 		[5] CHRM1,
CHRM2,
CHRM3,
CHRM4,
CHRM5 💬		[13] Alzheimer disease, Calcium signaling pathway, Cholinergic synapse, Gastric acid secretion, Insulin secretion, Neuroactive ligand-receptor interaction, PI3K-Akt signaling pathway, Pancreatic secretion, Pathways of neurodegeneration - multiple diseases, Regulation of actin cytoskeleton, Salivary secretion, Taste transduction, cAMP signaling pathway 💬[1] 6
950Primavanserin tartrate----[1] 6
951PRIMUS[1] Florasulam---[1] 46
952Primus FGTI (Flexible Great toe Implant)[1] Florasulam---[1] 46
953Prior Donepezil 5mg[1] Donepezil[2] D00670 ,
D07869 		[1] ACHE 💬[2] Cholinergic synapse, Glycerophospholipid metabolism 💬[1] 6
954Prior Donzepezil 10mg----[1] 6
955PRIVIGEN[1] Human immunoglobulin G---[4] 11, 14, 51, 65
956PRIVIGEN - 100 MG/ML - SOLUZIONE PER INFUSIONE USO ENDOVENOSO FLACONCINO(VETRO) 1 FLACONCINO DA 100 ML----[1] 51
957Privigen 100 mg/ml, solution pour perfusion----[1] 53
958PRIVIGEN 100mg/ml----[1] 85
959Privigen®[1] Human immunoglobulin G---[3] 14, 63, 65
960Privigen® 100mg/ml at the dose of 2g/kg of body weight----[1] 53
961PRM-151[1] PRM-151---[1] 85
962PRN1008----[2] 35, 61
963PRN1008 (Rilzabrutinib)----[1] 35
964PRN1008 Freebase----[1] 35
965PRN2246----[2] 11, 13
966PRO044----[1] 113
967PRO044 IV----[1] 113
968PRO044 IV 6 mg/kg----[1] 113
969PRO044 IV 9 mg/kg----[1] 113
970PRO044 SC----[1] 113
971PRO044 SC 6 mg/kg----[1] 113
972PRO045----[1] 113
973PRO045, 0.15 mg/kg/week----[1] 113
974PRO045, 1.0 mg/kg/week----[1] 113
975PRO045, 3.0 mg/kg/week----[1] 113
976PRO045, 6.0 mg/kg/week----[1] 113
977PRO045, 9.0 mg/kg/week----[1] 113
978PRO045, selected dose----[1] 113
979PRO051----[1] 113
980PRO053----[1] 113
981PRO145223----[1] 97
982PRO145223 (RO5490261)----[1] 97
983PRO283698----[1] 46
984Probenecid[1] Probenecid[1] D00475 --[1] 25
985Probiotic----[7] 2, 6, 93, 96, 97, 193, 266
986Probiotic - VSL#3----[1] 96
987Probiotic Capsule----[1] 6
988Probiotic capsules containing Lactobacillus rhamnosus GR-1 and L. reuteri RC-14[1] Lactobacillus delbrueckii bulgaricus---[1] 46
989Probiotic Formula Capsule----[1] 97
990Probiotic Mixture----[2] 96, 97
991Probiotic Product - Cap----[1] 53
992Probiotic treatment----[1] 294
993Probiotic-Lactobacillus plantarum PS128[1] Lactobacillus plantarum---[1] 156
994Probiotics----[5] 6, 94, 96, 97, 291
995Probiotics (Visbiome®)----[1] 13
996Probiotics with prebiotic----[1] 6
997Probucol[1] Probucol[1] D00476 --[1] 66
998Procaptan----[1] 58
999PROCAPTAN - 10 MG COMPRESSE RIVESTITE CON FILM 60 COMPRESSE IN CONTENITORE PER COMPRESSE PP----[1] 58
1000PROCAPTAN - 5 MG COMPRESSE RIVESTITE CON FILM 10 COMPRESSE IN CONTENITORE PER COMPRESSE PP----[1] 58
1001Procarbazine[1] Procarbazine[2] D00478 ,
D08423 		--[1] 65
1002Prochymal[1] Remestemcel-L[1] D09719 --[1] 96
1003PROCHYMAL (remestemcel-L)[1] Remestemcel-L[1] D09719 --[1] 96
1004PROCHYMAL adult human mesenchymal stem cells[1] Remestemcel-L[1] D09719 --[1] 96
1005Prochymal®[1] Remestemcel-L[1] D09719 --[1] 96
1006Prochymal™ adult human mesenchymal stem cells[1] Remestemcel-L[1] D09719 --[1] 96
1007PROCYSBI[1] Cysteamine[2] D03634 ,
D03635 		--[1] 19
1008Prodarsan----[1] 192
1009Products containing aminosalicylate----[1] 97
1010Products containing azathioprine or 6-mercaptopurine[2] Azathioprine,
Mercaptopurine		[4] D00161 ,
D00238 ,
D03033 ,
D04931 		[1] HPRT1 💬[3] Drug metabolism - other enzymes, Metabolic pathways, Purine metabolism 💬[1] 97
1011Profilassi per Herpes Zoster----[1] 107
1012Progerinin----[2] 191, 333
1013Progesterone[1] Progesterone[1] D00066 [1] PGR 💬[5] Breast cancer, Chemical carcinogenesis - receptor activation, Estrogen signaling pathway, Oocyte meiosis, Progesterone-mediated oocyte maturation 💬[1] 76
1014Prograf[1] Tacrolimus[2] D00107 ,
D08556 		[5] PPP3CA,
PPP3CB,
PPP3CC,
PPP3R1,
PPP3R2 💬		[33] Alzheimer disease, Amphetamine addiction, Amyotrophic lateral sclerosis, Axon guidance, B cell receptor signaling pathway, C-type lectin receptor signaling pathway, Calcium signaling pathway, Cellular senescence, Dopaminergic synapse, Glucagon signaling pathway, Glutamatergic synapse, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Kaposi sarcoma-associated herpesvirus infection, Lipid and atherosclerosis, Long-term potentiation, MAPK signaling pathway, Natural killer cell mediated cytotoxicity, Oocyte meiosis, Osteoclast differentiation, Oxytocin signaling pathway, PD-L1 expression and PD-1 checkpoint pathway in cancer, Pathways of neurodegeneration - multiple diseases, Prion disease, Renin secretion, T cell receptor signaling pathway, Th1 and Th2 cell differentiation, Th17 cell differentiation, Tuberculosis, VEGF signaling pathway, Wnt signaling pathway, cGMP-PKG signaling pathway 💬[3] 60, 222, 226
1015Prograft capsules----[1] 299
1016Progressive spacing of TNF-blocker injections----[1] 46
1017Progynova 21 mite----[1] 65
1018Prohance (Gadoteridol)[1] Gadoteridol[1] D01137 --[1] 13
1019Prolastin----[3] 231, 298, 299
1020Prolastin (drug)----[1] 299
1021Prolastin-C[1] Alpha-1-proteinase inhibitor---[2] 231, 298
1022Prolastin-C, 120 mg/kg[1] Alpha-1-proteinase inhibitor---[1] 231
1023Prolastin-C, 60 mg/kg[1] Alpha-1-proteinase inhibitor---[1] 231
1024Proleukin[1] Aldesleukin[1] D00748 [3] IL2RA,
IL2RB,
IL2RG 💬		[14] Cytokine-cytokine receptor interaction, Endocytosis, Hematopoietic cell lineage, Human T-cell leukemia virus 1 infection, Inflammatory bowel disease, JAK-STAT signaling pathway, Measles, PI3K-Akt signaling pathway, Pathways in cancer, Primary immunodeficiency, Th1 and Th2 cell differentiation, Th17 cell differentiation, Transcriptional misregulation in cancer, Viral protein interaction with cytokine and cytokine receptor 💬[3] 2, 49, 65
1025Proleukin 18 MUI[1] Aldesleukin[1] D00748 [3] IL2RA,
IL2RB,
IL2RG 💬		[14] Cytokine-cytokine receptor interaction, Endocytosis, Hematopoietic cell lineage, Human T-cell leukemia virus 1 infection, Inflammatory bowel disease, JAK-STAT signaling pathway, Measles, PI3K-Akt signaling pathway, Pathways in cancer, Primary immunodeficiency, Th1 and Th2 cell differentiation, Th17 cell differentiation, Transcriptional misregulation in cancer, Viral protein interaction with cytokine and cytokine receptor 💬[1] 2
1026PROLEUKIN® S[1] Aldesleukin[1] D00748 [3] IL2RA,
IL2RB,
IL2RG 💬		[14] Cytokine-cytokine receptor interaction, Endocytosis, Hematopoietic cell lineage, Human T-cell leukemia virus 1 infection, Inflammatory bowel disease, JAK-STAT signaling pathway, Measles, PI3K-Akt signaling pathway, Pathways in cancer, Primary immunodeficiency, Th1 and Th2 cell differentiation, Th17 cell differentiation, Transcriptional misregulation in cancer, Viral protein interaction with cytokine and cytokine receptor 💬[1] 65
1027Prolia[1] Denosumab[1] D03684 [1] TNFSF11 💬[8] Breast cancer, Chemical carcinogenesis - receptor activation, Cytokine-cytokine receptor interaction, NF-kappa B signaling pathway, Osteoclast differentiation, Parathyroid hormone synthesis, secretion and action, Prolactin signaling pathway, Rheumatoid arthritis 💬[1] 274
1028Proline[1] Proline[1] D00035 --[2] 94, 97
1029Prolonged release tablet[1] Manganese citrate---[1] 6
1030Prolonged-release Fampridine[1] Dalfampridine[1] D04127 [4] KCNA4,
KCNC3,
KCND2,
KCND3 💬		[4] Cortisol synthesis and secretion, Cushing syndrome, Serotonergic synapse, Spinocerebellar ataxia 💬[1] 13
1031Prolopa®----[1] 6
1032Prolotherapy solution of 20% dextrose[1] Dextrose, unspecified form---[1] 70
1033Promacta[1] Eltrombopag---[2] 63, 65
1034Promethazine[1] Promethazine[4] D00480 ,
D00494 ,
D01242 ,
D03290 		[1] HRH1 💬[3] Calcium signaling pathway, Inflammatory mediator regulation of TRP channels, Neuroactive ligand-receptor interaction 💬[1] 96
1035Promethera HepaStem----[1] 251
1036Prometic's Immune Globulin Intravenous 10%----[1] 65
1037Promiten----[1] 97
1038Promixin----[1] 299
1039Promixin 1 million International Units (IU) Powder for Nebuliser Solution----[1] 299
1040PROMIXIN*NEBUL 30MONOD 1MUI----[1] 299
1041Promixin, 1 million International Units (IU) Powder for Nebuliser Solution----[1] 299
1042Promixin,1 millón de Unidades Internacionales,polvo para solución para inhalación por nebulizador----[1] 299
1043Promixin/Tadim----[1] 299
1044Propagermanium----[1] 222
1045Propanoic acid[2] Naproxen,
Propanoic acid		[2] D00118 ,
D02310 		[2] PTGS1,
PTGS2 💬		[23] Alzheimer disease, Arachidonic acid metabolism, C-type lectin receptor signaling pathway, Chemical carcinogenesis - DNA adducts, Human cytomegalovirus infection, Human papillomavirus infection, IL-17 signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Leishmaniasis, Metabolic pathways, MicroRNAs in cancer, NF-kappa B signaling pathway, Ovarian steroidogenesis, Oxytocin signaling pathway, Pathways in cancer, Pathways of neurodegeneration - multiple diseases, Platelet activation, Regulation of lipolysis in adipocytes, Retrograde endocannabinoid signaling, Serotonergic synapse, Small cell lung cancer, TNF signaling pathway, VEGF signaling pathway 💬[2] 6, 271
1046Propanolol[1] Propranolol[2] D00483 ,
D08443 		[3] ADRB1,
ADRB2,
ADRB3 💬		[12] Adrenergic signaling in cardiomyocytes, Calcium signaling pathway, Chemical carcinogenesis - receptor activation, Dilated cardiomyopathy, Gap junction, Neuroactive ligand-receptor interaction, Regulation of lipolysis in adipocytes, Renin secretion, Salivary secretion, Thermogenesis, cAMP signaling pathway, cGMP-PKG signaling pathway 💬[1] 296
1047Propantheline[1] Propantheline[1] D00481 [5] CHRM1,
CHRM2,
CHRM3,
CHRM4,
CHRM5 💬		[13] Alzheimer disease, Calcium signaling pathway, Cholinergic synapse, Gastric acid secretion, Insulin secretion, Neuroactive ligand-receptor interaction, PI3K-Akt signaling pathway, Pancreatic secretion, Pathways of neurodegeneration - multiple diseases, Regulation of actin cytoskeleton, Salivary secretion, Taste transduction, cAMP signaling pathway 💬[1] 26
1048Propantheline Bromide[1] Propantheline[1] D00481 [5] CHRM1,
CHRM2,
CHRM3,
CHRM4,
CHRM5 💬		[13] Alzheimer disease, Calcium signaling pathway, Cholinergic synapse, Gastric acid secretion, Insulin secretion, Neuroactive ligand-receptor interaction, PI3K-Akt signaling pathway, Pancreatic secretion, Pathways of neurodegeneration - multiple diseases, Regulation of actin cytoskeleton, Salivary secretion, Taste transduction, cAMP signaling pathway 💬[1] 26
1049Prophylactic vaccine (tetanus, diphtheria, pertussis, poliomyelitis, influenza, hepatitis A, hepatitis B, tick-borne encephalitis, meningococcal, pneumococcal)----[1] 13
1050PROPIONYL L-CARNITINE[1] Levocarnitine[3] D02030 ,
D02176 ,
D04713 		--[1] 97
1051PROPIONYL L-CARNITINE HYDROCHLORIDE[1] Levocarnitine[3] D02030 ,
D02176 ,
D04713 		--[1] 97
1052Propionyl-L-Carnitine[2] Levocarnitine,
Levocarnitine propionate		[3] D02030 ,
D02176 ,
D04713 		--[1] 97
1053Propionylcarnitinhydrochlorid----[1] 97
1054Propiverine[1] Propiverine[1] D08441 [9] CACNA1C,
CACNA1D,
CACNA1F,
CACNA1S,
CHRM1,
CHRM2,
CHRM3,
CHRM4,
CHRM5 💬		[43] Adrenergic signaling in cardiomyocytes, Aldosterone synthesis and secretion, Alzheimer disease, Amphetamine addiction, Arrhythmogenic right ventricular cardiomyopathy, Calcium signaling pathway, Carbohydrate digestion and absorption, Cardiac muscle contraction, Cellular senescence, Chemical carcinogenesis - receptor activation, Cholinergic synapse, Circadian entrainment, Cortisol synthesis and secretion, Cushing syndrome, Dilated cardiomyopathy, Dopaminergic synapse, GABAergic synapse, Gastric acid secretion, Glutamatergic synapse, GnRH secretion, GnRH signaling pathway, Growth hormone synthesis, secretion and action, Hypertrophic cardiomyopathy, Insulin secretion, Long-term potentiation, MAPK signaling pathway, Neuroactive ligand-receptor interaction, Oxytocin signaling pathway, PI3K-Akt signaling pathway, Pancreatic secretion, Pathways of neurodegeneration - multiple diseases, Prion disease, Regulation of actin cytoskeleton, Renin secretion, Retrograde endocannabinoid signaling, Salivary secretion, Serotonergic synapse, Taste transduction, Tight junction, Type II diabetes mellitus, Vascular smooth muscle contraction, cAMP signaling pathway, cGMP-PKG signaling pathway 💬[1] 226
1055Propiverine Hydrochloride[1] Propiverine[1] D08441 [9] CACNA1C,
CACNA1D,
CACNA1F,
CACNA1S,
CHRM1,
CHRM2,
CHRM3,
CHRM4,
CHRM5 💬		[43] Adrenergic signaling in cardiomyocytes, Aldosterone synthesis and secretion, Alzheimer disease, Amphetamine addiction, Arrhythmogenic right ventricular cardiomyopathy, Calcium signaling pathway, Carbohydrate digestion and absorption, Cardiac muscle contraction, Cellular senescence, Chemical carcinogenesis - receptor activation, Cholinergic synapse, Circadian entrainment, Cortisol synthesis and secretion, Cushing syndrome, Dilated cardiomyopathy, Dopaminergic synapse, GABAergic synapse, Gastric acid secretion, Glutamatergic synapse, GnRH secretion, GnRH signaling pathway, Growth hormone synthesis, secretion and action, Hypertrophic cardiomyopathy, Insulin secretion, Long-term potentiation, MAPK signaling pathway, Neuroactive ligand-receptor interaction, Oxytocin signaling pathway, PI3K-Akt signaling pathway, Pancreatic secretion, Pathways of neurodegeneration - multiple diseases, Prion disease, Regulation of actin cytoskeleton, Renin secretion, Retrograde endocannabinoid signaling, Salivary secretion, Serotonergic synapse, Taste transduction, Tight junction, Type II diabetes mellitus, Vascular smooth muscle contraction, cAMP signaling pathway, cGMP-PKG signaling pathway 💬[1] 226
1056PROPOFOL[1] Propofol[1] D00549 [16] GABRA1,
GABRA2,
GABRA3,
GABRA4,
GABRA5,
GABRA6,
GABRB1,
GABRB2,
GABRB3,
GABRD,
GABRE,
GABRG1,
GABRG2,
GABRG3,
GABRP,
GABRQ 💬		[7] GABAergic synapse, Morphine addiction, Neuroactive ligand-receptor interaction, Nicotine addiction, Retrograde endocannabinoid signaling, Serotonergic synapse, Taste transduction 💬[9] 6, 21, 22, 34, 46, 70, 84, 98, 296
1057Propofol dosage[1] Propofol[1] D00549 [16] GABRA1,
GABRA2,
GABRA3,
GABRA4,
GABRA5,
GABRA6,
GABRB1,
GABRB2,
GABRB3,
GABRD,
GABRE,
GABRG1,
GABRG2,
GABRG3,
GABRP,
GABRQ 💬		[7] GABAergic synapse, Morphine addiction, Neuroactive ligand-receptor interaction, Nicotine addiction, Retrograde endocannabinoid signaling, Serotonergic synapse, Taste transduction 💬[1] 84
1058Propofol Injection[1] Propofol[1] D00549 [16] GABRA1,
GABRA2,
GABRA3,
GABRA4,
GABRA5,
GABRA6,
GABRB1,
GABRB2,
GABRB3,
GABRD,
GABRE,
GABRG1,
GABRG2,
GABRG3,
GABRP,
GABRQ 💬		[7] GABAergic synapse, Morphine addiction, Neuroactive ligand-receptor interaction, Nicotine addiction, Retrograde endocannabinoid signaling, Serotonergic synapse, Taste transduction 💬[1] 70
1059Propofol-Lipuro[1] Propofol[1] D00549 [16] GABRA1,
GABRA2,
GABRA3,
GABRA4,
GABRA5,
GABRA6,
GABRB1,
GABRB2,
GABRB3,
GABRD,
GABRE,
GABRG1,
GABRG2,
GABRG3,
GABRP,
GABRQ 💬		[7] GABAergic synapse, Morphine addiction, Neuroactive ligand-receptor interaction, Nicotine addiction, Retrograde endocannabinoid signaling, Serotonergic synapse, Taste transduction 💬[1] 6
1060Propolipid----[1] 46
1061Proposed INN - FILGOTINIB[1] Filgotinib[1] D10871 [1] JAK1 💬[27] Coronavirus disease - COVID-19, EGFR tyrosine kinase inhibitor resistance, Epstein-Barr virus infection, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human papillomavirus infection, Influenza A, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Leishmaniasis, Measles, NOD-like receptor signaling pathway, Necroptosis, Osteoclast differentiation, PD-L1 expression and PD-1 checkpoint pathway in cancer, PI3K-Akt signaling pathway, Pancreatic cancer, Pathways in cancer, Signaling pathways regulating pluripotency of stem cells, Th1 and Th2 cell differentiation, Th17 cell differentiation, Toxoplasmosis, Tuberculosis, Viral carcinogenesis 💬[1] 46
1062Propranolol[1] Propranolol[2] D00483 ,
D08443 		[3] ADRB1,
ADRB2,
ADRB3 💬		[12] Adrenergic signaling in cardiomyocytes, Calcium signaling pathway, Chemical carcinogenesis - receptor activation, Dilated cardiomyopathy, Gap junction, Neuroactive ligand-receptor interaction, Regulation of lipolysis in adipocytes, Renin secretion, Salivary secretion, Thermogenesis, cAMP signaling pathway, cGMP-PKG signaling pathway 💬[6] 6, 158, 167, 215, 227, 278
1063Propranolol HCl CF 40 mg tablet[1] Propranolol[2] D00483 ,
D08443 		[3] ADRB1,
ADRB2,
ADRB3 💬		[12] Adrenergic signaling in cardiomyocytes, Calcium signaling pathway, Chemical carcinogenesis - receptor activation, Dilated cardiomyopathy, Gap junction, Neuroactive ligand-receptor interaction, Regulation of lipolysis in adipocytes, Renin secretion, Salivary secretion, Thermogenesis, cAMP signaling pathway, cGMP-PKG signaling pathway 💬[1] 6
1064Propranolol Hydrochloride[1] Propranolol[2] D00483 ,
D08443 		[3] ADRB1,
ADRB2,
ADRB3 💬		[12] Adrenergic signaling in cardiomyocytes, Calcium signaling pathway, Chemical carcinogenesis - receptor activation, Dilated cardiomyopathy, Gap junction, Neuroactive ligand-receptor interaction, Regulation of lipolysis in adipocytes, Renin secretion, Salivary secretion, Thermogenesis, cAMP signaling pathway, cGMP-PKG signaling pathway 💬[1] 215
1065Propranolol treatment[1] Propranolol[2] D00483 ,
D08443 		[3] ADRB1,
ADRB2,
ADRB3 💬		[12] Adrenergic signaling in cardiomyocytes, Calcium signaling pathway, Chemical carcinogenesis - receptor activation, Dilated cardiomyopathy, Gap junction, Neuroactive ligand-receptor interaction, Regulation of lipolysis in adipocytes, Renin secretion, Salivary secretion, Thermogenesis, cAMP signaling pathway, cGMP-PKG signaling pathway 💬[1] 227
1066Propsoed INN - FILGOTINIB[1] Filgotinib[1] D10871 [1] JAK1 💬[27] Coronavirus disease - COVID-19, EGFR tyrosine kinase inhibitor resistance, Epstein-Barr virus infection, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human papillomavirus infection, Influenza A, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Leishmaniasis, Measles, NOD-like receptor signaling pathway, Necroptosis, Osteoclast differentiation, PD-L1 expression and PD-1 checkpoint pathway in cancer, PI3K-Akt signaling pathway, Pancreatic cancer, Pathways in cancer, Signaling pathways regulating pluripotency of stem cells, Th1 and Th2 cell differentiation, Th17 cell differentiation, Toxoplasmosis, Tuberculosis, Viral carcinogenesis 💬[1] 46
1067Propylene glycol[1] Propylene glycol[1] D00078 --[2] 28, 51
1068Propylene Glycol-Free Melphalan Hydrochloride[2] Melphalan,
Propylene glycol		[2] D00078 ,
D00369 		--[1] 28
1069ProSavin----[1] 6
1070PROSCAR*30CPR RIV 5MG[1] Finasteride[1] D00321 [1] SRD5A2 💬[3] Metabolic pathways, Prostate cancer, Steroid hormone biosynthesis 💬[1] 6
1071Prostacyclin[1] Epoprostenol[2] D00106 ,
D01337 		[1] PTGIR 💬[3] Neuroactive ligand-receptor interaction, Platelet activation, Vascular smooth muscle contraction 💬[1] 86
1072Prostanoids----[1] 51
1073PROTEASA----[1] 299
1074PROTEASE----[1] 299
1075Protease inhibitor----[1] 265
1076Protease inhibitors----[1] 265
1077ProTectis----[1] 66
1078Protein----[2] 46, 67
1079Protein intake----[1] 240
1080Protein-carbohydrate supplementation----[1] 113
1081Proteína recombinante estimulante de la megacariopoyesis----[1] 63
1082Prothrombin[1] Prothrombin---[1] 288
1083Prothrombin Complex Concentrate[2] Factor IX Complex (Human),
Prothrombin		---[1] 288
1084Proton pump inhibitor (PPI)----[1] 298
1085Prototype capsule GDC-0134----[1] 2
1086Provigil[1] Modafinil[1] D01832 --[2] 13, 113
1087Provigil (modafinil)[1] Modafinil[1] D01832 --[1] 13
1088PROVIGIL - 100 MG COMPRESSE 30 COMPRESSE[1] Modafinil[1] D01832 --[1] 113
1089PROZAC----[1] 17
1090PRP----[1] 90
1091PRP injection----[1] 53
1092PRTX-100----[1] 46
1093PRTX-100 (Staphylococcal protein A)[1] Bevifimod---[1] 63
1094PRTX-100 at 1.5 mcg/kg----[1] 46
1095PRTX-100 at 12.0 mcg/kg----[1] 46
1096PRTX-100 at 240 mcg----[1] 46
1097PRTX-100 at 3.0 mcg/kg----[1] 46
1098PRTX-100 at 420 mcg----[1] 46
1099PRTX-100 at 6.0 mcg/kg----[1] 46
1100PRU-PLA-PLA-PRU----[1] 99
1101PRU-PLA-PRU-PLA----[1] 99
1102PRUCALOPRIDE[1] Prucalopride[1] D09205 [1] HTR4 💬[4] Calcium signaling pathway, Neuroactive ligand-receptor interaction, Serotonergic synapse, cAMP signaling pathway 💬[3] 13, 51, 96
1103PRUCALOPRIDE SUCCINATE[1] Prucalopride[1] D09205 [1] HTR4 💬[4] Calcium signaling pathway, Neuroactive ligand-receptor interaction, Serotonergic synapse, cAMP signaling pathway 💬[1] 51
1104PRV-300----[1] 97
1105PRV-6527----[1] 96
1106PRV-6527 (JNJ-40346527)[1] JNJ-40346527---[1] 96
1107PRV-6527(JNJ-40346527)[1] JNJ-40346527---[1] 96
1108PRX-102----[1] 19
1109PRX-102 (pegunigalsidase alfa)[1] Pegunigalsidase alfa[1] D11685 --[1] 19
1110PRX-112----[1] 19
1111PRX002----[1] 6
1112PRX002, ELT2, anti-alpha-synuclein monoclonal antibody----[1] 6
1113PRX102----[1] 19
1114PS----[4] 6, 46, 90, 97
1115PS-QD----[1] 97
1116PS-SP----[1] 97
1117PS128----[1] 6
1118PS188----[1] 113
1119PS188 (company code)----[1] 113
1120PS220----[1] 113
1121PS524----[1] 113
1122PsAer IgY----[1] 299
1123Pseudoephedrine[1] Pseudoephedrine[4] D00485 ,
D05648 ,
D05649 ,
D08449 		[9] ADRA1A,
ADRA1B,
ADRA1D,
ADRA2A,
ADRA2B,
ADRA2C,
ADRB1,
ADRB2,
ADRB3 💬		[14] AMPK signaling pathway, Adrenergic signaling in cardiomyocytes, Calcium signaling pathway, Chemical carcinogenesis - receptor activation, Dilated cardiomyopathy, Gap junction, Neuroactive ligand-receptor interaction, Regulation of lipolysis in adipocytes, Renin secretion, Salivary secretion, Thermogenesis, Vascular smooth muscle contraction, cAMP signaling pathway, cGMP-PKG signaling pathway 💬[1] 17
1124Pseudoephedrine + 480 ml water[2] Pseudoephedrine,
Water		[5] D00001 ,
D00485 ,
D05648 ,
D05649 ,
D08449 		[9] ADRA1A,
ADRA1B,
ADRA1D,
ADRA2A,
ADRA2B,
ADRA2C,
ADRB1,
ADRB2,
ADRB3 💬		[14] AMPK signaling pathway, Adrenergic signaling in cardiomyocytes, Calcium signaling pathway, Chemical carcinogenesis - receptor activation, Dilated cardiomyopathy, Gap junction, Neuroactive ligand-receptor interaction, Regulation of lipolysis in adipocytes, Renin secretion, Salivary secretion, Thermogenesis, Vascular smooth muscle contraction, cAMP signaling pathway, cGMP-PKG signaling pathway 💬[1] 17
1125Pseudoephedrine + 50 ml water[2] Pseudoephedrine,
Water		[5] D00001 ,
D00485 ,
D05648 ,
D05649 ,
D08449 		[9] ADRA1A,
ADRA1B,
ADRA1D,
ADRA2A,
ADRA2B,
ADRA2C,
ADRB1,
ADRB2,
ADRB3 💬		[14] AMPK signaling pathway, Adrenergic signaling in cardiomyocytes, Calcium signaling pathway, Chemical carcinogenesis - receptor activation, Dilated cardiomyopathy, Gap junction, Neuroactive ligand-receptor interaction, Regulation of lipolysis in adipocytes, Renin secretion, Salivary secretion, Thermogenesis, Vascular smooth muscle contraction, cAMP signaling pathway, cGMP-PKG signaling pathway 💬[1] 17
1126Psilocybin[1] Psilocybin---[1] 6
1127Psilocybin therapy[1] Psilocybin---[1] 6
1128Psilocybine[1] Psilocybin---[1] 6
1129Psorcutan-Ointment----[1] 36
1130PSRS11.EFS.IL2RG.pre* retroviral vector----[1] 65
1131PSRS11.EFS.IL2RG.pre* retroviral vector transduce----[1] 65
1132PSRS11.EFS.IL2RG.pre* retroviral vector transduced cells----[1] 65
1133Psychiatric evaluation----[1] 78
1134Psyllium[1] Plantago seed[1] D05525 --[3] 6, 28, 97
1135Psyllium husk[1] Plantago seed[1] D05525 --[1] 97
1136Psyllium Husk Powder[1] Plantago seed[1] D05525 --[1] 97
1137PT320 2.0 mg----[1] 6
1138PT320 2.5 mg----[1] 6
1139PTC-0161480----[2] 246, 299
1140PTC-124----[2] 246, 299
1141PTC-C124----[2] 246, 299
1142PTC0161480, PTC124 Compound 1a, RPS2505, PTC-C124, 291844----[1] 113
1143PTC124----[4] 19, 113, 246, 299
1144PTC299[1] PTC299---[1] 34
1145PTC743----[2] 18, 21
1146PTC923----[1] 240
1147PTG-100----[1] 97
1148PTG-200----[1] 96
1149PTH----[2] 65, 235
1150PTH 1-34[1] Teriparatide[1] D06078 [1] PTH1R 💬[3] Endocrine and other factor-regulated calcium reabsorption, Neuroactive ligand-receptor interaction, Parathyroid hormone synthesis, secretion and action 💬[2] 65, 235
1151PTH1-84 in parent study----[1] 235
1152PTI-428[1] PTI-428---[1] 299
1153PTI-801[1] PTI-801---[1] 299
1154PTI-808----[1] 299
1155PTL201----[1] 13
1156PTR-01----[1] 36
1157PTX-022----[1] 278
1158PU-AD----[1] 2
1159Puerarin[1] Puerarin---[1] 46
1160Puerarin injection 400 mg[1] Puerarin---[1] 46
1161Puerarin tablet 50 mg[1] Puerarin---[1] 46
1162Pulmaquin®----[1] 299
1163Pulmonary endarterectomy----[1] 88
1164Pulmonary Endarteriectomy----[1] 88
1165Pulmonary Function Testing----[3] 2, 228, 299
1166Pulmonary function testing.----[2] 231, 299
1167Pulmonary hemodynamics SE----[3] 58, 86, 215
1168Pulmozyme[1] Dornase alfa[1] D03896 --[1] 299
1169Pulmozyme (dornase alfa)[1] Dornase alfa[1] D03896 --[1] 299
1170Pulmozyme (Dornase alpha)[1] Dornase alfa[1] D03896 --[1] 299
1171Pulmozyme single use ampule[1] Dornase alfa[1] D03896 --[1] 299
1172Pulmozyme®[1] Dornase alfa[1] D03896 --[1] 299
1173PUR 0110----[1] 97
1174PUR 0110 Rectal Enema----[1] 97
1175PUR 0110 Rectal Enema 1000 mg----[1] 97
1176PUR 0110 Rectal Enema 250 mg----[1] 97
1177PUR 0110 Rectal Enema 500 mg----[1] 97
1178PUR118----[1] 299
1179Puri Nethol----[1] 96
1180Puri-Nethol----[3] 86, 96, 97
1181Puri-Nethol 50 mg----[1] 96
1182Purified Vero Cell Vaccine)----[1] 65
1183PURINETHOL[1] Mercaptopurine[2] D00161 ,
D04931 		[1] HPRT1 💬[3] Drug metabolism - other enzymes, Metabolic pathways, Purine metabolism 💬[1] 96
1184PURINETHOL - 50 MG COMPRESSE25 COMPRESSE[1] Mercaptopurine[2] D00161 ,
D04931 		[1] HPRT1 💬[3] Drug metabolism - other enzymes, Metabolic pathways, Purine metabolism 💬[1] 96
1185PV----[3] 13, 97, 215
1186PXL065----[1] 20
1187PXL770----[1] 20
1188PXT002331----[1] 6
1189PXT002331 - 20mg----[1] 6
1190PXT002331 - dose 1----[1] 6
1191PXT002331 - dose 2----[1] 6
1192PXT3003----[1] 10
1193PXT3003 Dose 1----[1] 10
1194PXT3003 Dose 2----[1] 10
1195PXT3003 Dose 2 (equivalent to twice Dose 1)----[1] 10
1196PXT3003 High Dose----[1] 10
1197PXT3003 Intermediate Dose----[1] 10
1198PXT3003 Low dose----[1] 10
1199PYM50028----[1] 6
1200Pyrazole[1] Pyrazole---[1] 58
1201Pyridostigmine[1] Pyridostigmine[1] D00487 [1] ACHE 💬[2] Cholinergic synapse, Glycerophospholipid metabolism 💬[4] 3, 6, 11, 256
1202Pyridostigmine Bromide[1] Pyridostigmine[1] D00487 [1] ACHE 💬[2] Cholinergic synapse, Glycerophospholipid metabolism 💬[3] 3, 6, 256
1203Pyridostigmine, Prednisone, Tacrolimus[3] Prednisone,
Pyridostigmine,
Tacrolimus		[4] D00107 ,
D00473 ,
D00487 ,
D08556 		[7] ACHE,
NR3C1,
PPP3CA,
PPP3CB,
PPP3CC,
PPP3R1,
PPP3R2 💬		[36] Alzheimer disease, Amphetamine addiction, Amyotrophic lateral sclerosis, Axon guidance, B cell receptor signaling pathway, C-type lectin receptor signaling pathway, Calcium signaling pathway, Cellular senescence, Cholinergic synapse, Dopaminergic synapse, Glucagon signaling pathway, Glutamatergic synapse, Glycerophospholipid metabolism, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Kaposi sarcoma-associated herpesvirus infection, Lipid and atherosclerosis, Long-term potentiation, MAPK signaling pathway, Natural killer cell mediated cytotoxicity, Neuroactive ligand-receptor interaction, Oocyte meiosis, Osteoclast differentiation, Oxytocin signaling pathway, PD-L1 expression and PD-1 checkpoint pathway in cancer, Pathways of neurodegeneration - multiple diseases, Prion disease, Renin secretion, T cell receptor signaling pathway, Th1 and Th2 cell differentiation, Th17 cell differentiation, Tuberculosis, VEGF signaling pathway, Wnt signaling pathway, cGMP-PKG signaling pathway 💬[1] 11
1204Pyridostigmine, Tacrolimus[2] Pyridostigmine,
Tacrolimus		[3] D00107 ,
D00487 ,
D08556 		[6] ACHE,
PPP3CA,
PPP3CB,
PPP3CC,
PPP3R1,
PPP3R2 💬		[35] Alzheimer disease, Amphetamine addiction, Amyotrophic lateral sclerosis, Axon guidance, B cell receptor signaling pathway, C-type lectin receptor signaling pathway, Calcium signaling pathway, Cellular senescence, Cholinergic synapse, Dopaminergic synapse, Glucagon signaling pathway, Glutamatergic synapse, Glycerophospholipid metabolism, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Kaposi sarcoma-associated herpesvirus infection, Lipid and atherosclerosis, Long-term potentiation, MAPK signaling pathway, Natural killer cell mediated cytotoxicity, Oocyte meiosis, Osteoclast differentiation, Oxytocin signaling pathway, PD-L1 expression and PD-1 checkpoint pathway in cancer, Pathways of neurodegeneration - multiple diseases, Prion disease, Renin secretion, T cell receptor signaling pathway, Th1 and Th2 cell differentiation, Th17 cell differentiation, Tuberculosis, VEGF signaling pathway, Wnt signaling pathway, cGMP-PKG signaling pathway 💬[1] 11
1205PYRIDOXINE[1] Pyridoxine[2] D02179 ,
D08454 		--[3] 93, 145, 320
1206Pyridoxine 10mg[1] Pyridoxine[2] D02179 ,
D08454 		--[1] 93
1207Pyridoxine 10mg BP[1] Pyridoxine[2] D02179 ,
D08454 		--[1] 93
1208Pyridoxine plus prednisolone[2] Prednisolone,
Pyridoxine		[10] D00472 ,
D00980 ,
D00981 ,
D00982 ,
D01239 ,
D01998 ,
D02156 ,
D02179 ,
D03301 ,
D08454 		[1] NR3C1 💬[1] Neuroactive ligand-receptor interaction 💬[1] 145
1209PYRIMETHAMINE[1] Pyrimethamine[1] D00488 --[4] 2, 4, 19, 65
1210Pyrophosphate----[1] 51
1211Pyruvate, creatine, niacinamide[2] Creatine,
Nicotinamide		[1] D00036 --[1] 5
1212PyVST----[1] 25
1213PZN 8881655(RochePharma AG)----[1] 85